Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LDLR,Low-density lipoprotein receptor,42170,-0.237298856044555,0.00477032241375121,-0.246648687975507,-0.227949024113602,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFGE8,Lactadherin,42137,-0.211016471133385,0.00422513340271979,-0.219297732602716,-0.202735209664054,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGRP,Agouti-related protein,42296,-0.194750582290278,0.00497443291609284,-0.20450047080582,-0.185000693774736,1.11253692960092e-308
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.12503887207372,0.00319830146107368,0.118770201210016,0.131307542937425,1.11253693253948e-308
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,0.104654927320039,0.00284372488594144,0.0990812265435939,0.110228628096484,1.01795566433061e-282
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD4,T-cell surface glycoprotein CD4,42100,-0.101919531211507,0.00281811735709748,-0.107443041231418,-0.0963960211915957,1.87143712415772e-273
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPY,Pro-neuropeptide Y,42262,-0.221460141668508,0.00616709388275524,-0.233547645678709,-0.209372637658308,6.12738304426207e-270
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCG,Pro-glucagon,41843,-0.413990633473368,0.0121388162046843,-0.43778271323455,-0.390198553712187,1.98901390311266e-244
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOM,Apolipoprotein M,42199,0.0892803636784614,0.00277911430201442,0.0838332996465131,0.0947274277104097,2.51932669170701e-218
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,-0.101659585190552,0.00316617159087183,-0.107865281508661,-0.095453888872443,3.90730447921153e-218
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,-0.15804679816879,0.00495447047686626,-0.167757560303447,-0.148336036034132,3.35417020257314e-215
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS8,Prostasin,42080,-0.128772902383341,0.0040965753171945,-0.136802190005042,-0.12074361476164,2.25401510257426e-209
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRAP1,Proline-rich acidic protein 1,39966,-0.120664596102099,0.00382742476557958,-0.128166348642635,-0.113162843561563,3.28558907194302e-209
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS4,Galectin-4,42123,-0.173229442805896,0.00553261630291813,-0.184073370759616,-0.162385514852176,7.99436008550772e-208
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR37,Prosaposin receptor GPR37,41900,-0.190618248570981,0.00642478448642001,-0.203210826164364,-0.178025670977598,2.27102123147188e-187
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLTP,Phospholipid transfer protein,42267,0.109268511921976,0.00372198250582066,0.101973426210567,0.116563597633384,9.09170094615665e-184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,-0.0682300705494976,0.00232888604722817,-0.0727946872020648,-0.0636654538969304,5.1429077836178e-183
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPL,Lipoprotein lipase,42145,0.138427046066217,0.00473934205125306,0.129137935645761,0.147716156486673,6.28503844390611e-182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDF15,Growth/differentiation factor 15,42310,-0.130726789111427,0.00451438207756752,-0.13957497798346,-0.121878600239395,5.17312214454701e-179
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,-0.192478308810696,0.00678281146852043,-0.205772619288996,-0.179183998332396,4.22025466659586e-172
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,-0.147236666242821,0.0052041885774811,-0.157436875854684,-0.137036456630958,4.07987966984037e-171
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,-0.152921692880661,0.00540600698262803,-0.163517466566612,-0.142325919194711,5.34831116967285e-171
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL27,C-C motif chemokine 27,42145,-0.173968756903908,0.00616877472144188,-0.186059555357934,-0.161877958449882,4.37557196121671e-170
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA1,Apolipoprotein A-I,39979,0.0764860745231407,0.00270539164588635,0.0711835068972034,0.0817886421490779,5.31730682168914e-170
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,-0.0907407974040454,0.00324179242437618,-0.0970947105558227,-0.084386884252268,1.25176368251345e-167
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFASC,Neurofascin,42296,-0.0803528068510876,0.00288214620333189,-0.0860018134096181,-0.0747038002925571,2.00544908905333e-166
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRIP2,Cysteine-rich protein 2,42016,-0.0992167154856095,0.00359317959056198,-0.106259347483111,-0.092174083488108,2.76574080639626e-163
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,-0.0823821908748347,0.00299607076870688,-0.0882544895815002,-0.0765098921681693,5.68470490408662e-162
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,-0.131319435591883,0.00478082214928489,-0.140689847004482,-0.121949024179285,1.03018898488892e-161
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOF,Apolipoprotein F,39990,0.0703291152858385,0.00256387086566317,0.0653039283891387,0.0753543021825383,1.79875727068113e-160
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.0865469264588224,0.00317679522802443,0.0803204078118945,0.0927734451057502,3.73830858046434e-159
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGF,Placenta growth factor,42296,-0.0700047929852702,0.0025937484428997,-0.0750885399333536,-0.0649210460371867,2.30987583844359e-156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL13,C-X-C motif chemokine 13,42249,-0.152704959675237,0.00568777613513022,-0.163853000900092,-0.141556918450381,9.00619969216728e-155
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS9,Galectin-9,42129,-0.0829907658583225,0.00310930143689268,-0.0890849966746322,-0.0768965350420128,5.27709608991091e-153
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.0894183679148121,0.00335268083530913,-0.095989622352018,-0.0828471134776062,9.53982818593972e-153
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADIPOQ,Adiponectin,39979,0.181964967097084,0.00681851169693105,0.1686006841711,0.195329250023069,3.05253982955863e-152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST3,Cystatin-C,42184,-0.0755409010792484,0.00283901832734882,-0.0811053770008521,-0.0699764251576447,4.18195486093982e-152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGRN,Agrin,42185,-0.0944774378933223,0.00355111591626439,-0.101437625089201,-0.0875172506974441,4.52135597293202e-152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,-0.128801597235563,0.00484838242481806,-0.138304426788206,-0.119298767682919,1.40020475948605e-151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,-0.119609107802062,0.00451120429963011,-0.128451068229337,-0.110767147374787,5.34126951372916e-151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,-0.0960433648973642,0.00369205571851837,-0.10327979410566,-0.0888069356890682,1.24763612273263e-145
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,-0.167502103858026,0.00648620579027604,-0.180215067206967,-0.154789140509085,1.6342998199518e-143
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTH,Parathyroid hormone,39649,-0.213771013208407,0.00826588390271205,-0.229972145657723,-0.197569880759092,3.10313036051876e-143
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTN4R,Reticulon-4 receptor,42262,-0.0862074071389638,0.0033459348092864,-0.0927654393651651,-0.0796493749127625,5.56088401553833e-143
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP5,Retinol-binding protein 5,42070,-0.143620275344437,0.00558814049628549,-0.154573030717156,-0.132667519971717,2.97815904741366e-142
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN1,CCN family member 1,42047,-0.182696756801986,0.00712037442847399,-0.196652690681795,-0.168740822922177,8.57366420932506e-142
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNA4,Ephrin-A4,41992,-0.0813575744478151,0.00320541551615386,-0.0876401888594766,-0.0750749600361535,7.56869541124106e-139
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,-0.144710918932238,0.0057252455092838,-0.155932400130434,-0.133489437734042,9.57410399978005e-138
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,-0.0831245858552559,0.00328194544404965,-0.0895571989255933,-0.0766919727849186,1.11313020527568e-137
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PYY,Peptide YY,39575,-0.251276190790021,0.00994377919334009,-0.270765998008967,-0.231786383571074,5.41906906294937e-137
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.0773485829057775,0.00307452726434984,-0.0833746563439031,-0.0713225094676518,1.54903626727366e-136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,-0.0865187977524946,0.00344211335692847,-0.0932653399320744,-0.0797722555729148,2.51454028737119e-136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.0992280322923379,0.00394820506132661,-0.106966514212538,-0.0914895503721377,2.63504942810045e-136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCS1,Neuronal calcium sensor 1,42262,-0.0705289082835584,0.00280902192325078,-0.0760345912531299,-0.0650232253139869,4.82559860294859e-136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARB2,Lysosome membrane protein 2,41777,-0.0818285780997559,0.00327630462679074,-0.0882501351682657,-0.075407021031246,1.46895318637895e-134
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,-0.0766553218894616,0.00308312033411869,-0.0826982377443342,-0.0706124060345889,1.80177123797644e-133
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL23,C-C motif chemokine 23,42185,-0.103876600185472,0.00419992049240324,-0.112108444350582,-0.0956447560203613,3.87119566812762e-132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,0.0752413608942422,0.00306678881812741,0.0692304548107125,0.0812522669777719,1.68170823234992e-129
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,-0.176916330110515,0.00723283700278926,-0.191092690635982,-0.162739969585048,8.14859287534705e-129
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,-0.135024910865307,0.00554886214180156,-0.145900680663238,-0.124149141067376,5.29997473942446e-128
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,-0.0939203028250646,0.00386341253973875,-0.101492591402953,-0.0863480142471767,7.67925391521226e-128
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGF,Hepatocyte growth factor,42296,-0.0833857963443177,0.00343534165540441,-0.0901190659889103,-0.076652526699725,1.83172327801074e-127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD5,T-cell surface glycoprotein CD5,42239,-0.085652689438851,0.00354193110638978,-0.092594874407375,-0.0787105044703271,1.54061230885665e-126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MVK,Mevalonate kinase,41913,-0.19890200989726,0.00823736860071954,-0.21504725235467,-0.182756767439849,4.12326764430547e-126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF9,Protein turtle homolog A,39958,-0.206274956008751,0.00858203138707791,-0.223095737527424,-0.189454174490079,1.47341163836095e-124
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.067763523765731,0.0028335916686052,-0.0733173634361972,-0.0622096840952648,8.22900422819534e-124
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MENT,Protein MENT,39736,0.0567707603380488,0.002369764406709,0.0521260221008992,0.0614154985751984,1.03767006986926e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KITLG,Kit ligand,42145,0.090597812488317,0.00380132622933076,0.0831472130788287,0.0980484118978052,5.06616358437426e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA1,GDNF family receptor alpha-1,42247,-0.0674561797448558,0.00284305455043794,-0.0730285666637142,-0.0618837928259975,5.5569048757936e-122
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPY30,Protein dpy-30 homolog,42216,-0.14122833353846,0.00598309336326317,-0.152955196530456,-0.129501470546464,9.07134257945354e-121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELN,Elastin,39958,-0.0819448639397526,0.00346590739413777,-0.0887380424322627,-0.0751516854472426,1.11101697171755e-120
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,-0.0861277801900398,0.00369088545436639,-0.093361915680598,-0.0788936446994817,4.21798952498937e-118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,-0.091827019507705,0.0039316981898641,-0.0995331479598387,-0.0841208910555714,8.33881710876918e-118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD72,B-cell differentiation antigen CD72,39736,-0.100996262067276,0.00433450377270448,-0.109491889461777,-0.0925006346727751,2.72464771384248e-117
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL15,C-C motif chemokine 15,42310,-0.100688208210543,0.00433855248059953,-0.109191771072518,-0.0921846453485676,6.71303695450069e-117
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,-0.101844537286868,0.00438777682728812,-0.110444579868353,-0.0932444947053836,7.26689172722438e-117
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,-0.196107680965561,0.00846821949109662,-0.21270539116811,-0.179509970763012,2.22904456184571e-116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,-0.0849044681400208,0.00368840154776681,-0.0921337351736437,-0.0776752011063979,5.04032312759214e-115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,-0.335424116322272,0.0145829038523911,-0.364006607872959,-0.306841624771586,7.72209958270906e-115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,-0.114918004393676,0.00498873672510421,-0.12469592837488,-0.105140080412472,9.64285701727216e-115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,-0.0928313325345465,0.00404845479156648,-0.100766303926017,-0.0848963611430762,3.59885574563575e-114
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,-0.0794800597938806,0.0034666632620358,-0.0862747197874708,-0.0726853998002904,3.67952264997462e-114
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPB1,Beta-ureidopropionase,39958,-0.207969093533413,0.00905492119665969,-0.225716739078866,-0.19022144798796,3.83309988524296e-114
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0842493035880718,0.00367531270401705,-0.0914529164879452,-0.0770456906881984,4.02390660174739e-114
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OCLN,Occludin,39934,-0.101577311138272,0.00442649418246324,-0.1102532397359,-0.0929013825406438,6.01526084227298e-114
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,-0.0814861574423041,0.00357392601796102,-0.0884910524375077,-0.0744812624471005,5.69063676970508e-113
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.0898175470323672,0.00395419321641001,-0.0975677657365308,-0.0820673283282036,3.98570163032167e-112
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL16,C-C motif chemokine 16,42310,-0.115947239267962,0.00511507335861598,-0.12597278305085,-0.105921695485075,1.04121187150157e-111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC13,Mucin-13,41839,-0.118965819048502,0.00525255034119602,-0.129260817717246,-0.108670820379758,1.84140207871371e-111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS15,Enteropeptidase,42070,-0.198564482855291,0.00877354068500209,-0.215760622597895,-0.181368343112686,2.45903640783452e-111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18BP,Interleukin-18-binding protein,42217,-0.0707610891398567,0.00313213925630958,-0.0769000820822235,-0.0646220961974899,5.63305303930699e-111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF23,Fibroblast growth factor 23,42250,-0.113901170709668,0.00504341712205943,-0.123786268268905,-0.104016073150432,6.60595192578385e-111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,0.0611179712703181,0.00271052682744681,0.0558053386885223,0.0664306038521139,3.52063445904508e-110
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AREG,Amphiregulin,42070,-0.087772704793718,0.00391069409475176,-0.0954376652194315,-0.0801077443680046,1.46815034482249e-109
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA3F,Semaphorin-3F,42145,-0.059684778646916,0.00266050041556958,-0.0648993594614324,-0.0544701978323996,1.80236692864326e-109
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,-0.0502748803345166,0.00224323241340787,-0.0546716158647961,-0.0458781448042372,2.86035744162923e-109
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18R1,Interleukin-18 receptor 1,42296,-0.0737059273747805,0.0032975135816855,-0.0801690539948841,-0.0672428007546769,1.00551679880338e-108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,-0.182237366554296,0.00816321935987132,-0.198237276499644,-0.166237456608948,2.08402053733637e-108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAV,Integrin alpha-V,42262,0.037017636251411,0.00165940099272001,0.0337652103056798,0.0402700621971423,2.63581747656901e-108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,-0.0600959007543962,0.00269487389171247,-0.0653778535821526,-0.0548139479266397,3.19278649853708e-108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE4,Ribonuclease 4,39645,-0.0618982368865642,0.00277370845779209,-0.0673347054638367,-0.0564617683092917,6.14302473809433e-108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSD,Cathepsin D,41225,-0.0917313559764492,0.00411988135745029,-0.0998063234370517,-0.0836563885158466,9.33347611179462e-108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,-0.0704740338372179,0.0031712952812755,-0.0766897725885178,-0.0642582950859179,1.66812040521356e-107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,-0.0664767218513389,0.00300727806251293,-0.0723709868538643,-0.0605824568488136,2.12272395028842e-106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.177133898179766,0.00802843169966595,-0.192869624311111,-0.16139817204842,5.31050421539812e-106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,0.0786188868490973,0.0035644470382313,0.071632570654164,0.0856052030440307,6.06221983568317e-106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,-0.0758654514593373,0.00345299778091513,-0.082633327109931,-0.0690975758087436,3.74517678849985e-105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,0.0861228920031708,0.00395023436421389,0.0783804326493116,0.09386535135703,1.34092623896011e-103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,-0.0755828910513828,0.00346991494926686,-0.0823839243519459,-0.0687818577508198,4.30776709608049e-103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,-0.0684724617757921,0.00314956823492919,-0.0746456155162533,-0.0622993080353309,4.88694812404814e-103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.091378938626541,0.00421039596576289,-0.0996313147194363,-0.0831265625336457,1.06864868690356e-102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_E,,42119,-0.0633161509230183,0.00293361752265341,-0.0690660412674189,-0.0575662605786176,1.33503793997968e-101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOD,Apolipoprotein D,39468,0.0910567925117067,0.00422758900183317,0.0827707180681137,0.0993428669552997,8.50350090502137e-101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.0918512761491866,0.00428254484107689,-0.100245064037697,-0.0834574882606759,2.29902175924804e-100
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REN,Renin,42145,-0.173609163116883,0.00811558330418472,-0.189515706393085,-0.157702619840681,7.05677591966694e-100
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEG1,Protein HEG homolog 1,39736,-0.0589155129120509,0.00276328569531215,-0.0643315528748628,-0.0534994729492391,6.79447876700936e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,-0.0729258709904666,0.00343284694282024,-0.0796542509983943,-0.0661974909825389,3.04015592389341e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA11,Integrin alpha-11,42119,0.0717702155712218,0.0033870877850218,0.0651315235125791,0.0784089076298645,4.66967173698258e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,-0.115665205494546,0.00547348770721965,-0.126393241400697,-0.104937169588396,1.66246707699928e-97
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,-0.066838776585721,0.0031664281551089,-0.0730449757697344,-0.0606325774017075,2.47301226756483e-97
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300E,CMRF35-like molecule 2,42232,-0.0877335089403449,0.00417939610067203,-0.0959251252976621,-0.0795418925830277,2.58034581459293e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0736775272263321,0.0035097045800553,-0.0805565482032405,-0.0667985062494237,2.58176323957438e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,-0.198776356475801,0.00950566201939841,-0.217407454033822,-0.18014525891778,1.36506687329141e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNB2,Plexin-B2,42255,-0.0511546945579346,0.0024472778283106,-0.0559513591014234,-0.0463580300144458,1.57518571016968e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLUL1,Clusterin-like protein 1,42123,0.093204828428699,0.00447002926223092,0.0844435710747263,0.101966085782672,4.63650713769254e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMBP,Protein AMBP,42239,-0.0418444345575504,0.00201690323928605,-0.045797564906551,-0.0378913042085497,3.69825461581929e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE6,Ribonuclease K6,39937,-0.0672471667710867,0.00323758981909445,-0.0735928428165118,-0.0609014907256615,4.44224134826191e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH2,Cadherin-2,42145,-0.0727072745672087,0.00353089270397608,-0.0796278242670018,-0.0657867248674155,8.52826274083234e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,-0.133300708130021,0.00648424400774826,-0.146009826385207,-0.120591589874834,1.65077670772178e-92
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADA2,Adenosine deaminase 2,42096,-0.0902694788051013,0.00439366866689132,-0.0988810693922083,-0.0816578882179944,2.18140065498147e-92
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL9,C-X-C motif chemokine 9,42185,-0.133423325189717,0.0065034411226464,-0.146170069790104,-0.12067658058933,3.85326721403183e-92
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,-0.0590395586412367,0.00288187699796247,-0.0646880375572431,-0.0533910797252303,7.16178732168327e-92
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C9,Complement component C9,39990,0.118579040631016,0.0057822579436622,0.107245815061438,0.129912266200594,8.32640487335439e-92
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNF,Tumor necrosis factor,41880,-0.0746244640330096,0.00364568964576489,-0.0817700157387087,-0.0674789123273104,1.04694018218017e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.0595418139505195,0.00291154074652967,-0.0652484338137177,-0.0538351940873214,1.43681647420921e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES1,Liver carboxylesterase 1,42163,-0.173624156745862,0.00849197558571115,-0.190268428893856,-0.156979884597868,1.56516683989068e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,-0.0994351719322064,0.00487144116631742,-0.108983196618189,-0.0898871472462242,6.00452109208384e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL10,C-X-C motif chemokine 10,42185,-0.134174053694362,0.00659683406853989,-0.147103848468701,-0.121244258920024,1.2878727234666e-90
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FURIN,Furin,42181,-0.0671874012901771,0.00330508560449106,-0.0736653690749796,-0.0607094335053746,1.59186506155312e-90
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACY1,Aminoacylase-1,42145,-0.127737283330435,0.00629218786301486,-0.140069971541944,-0.115404595118926,2.76642382630711e-90
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,-0.0566369358091398,0.00279182024595113,-0.062108903491204,-0.0511649681270755,3.62857637449122e-90
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF3,Trefoil factor 3,42143,-0.0731882179497986,0.00361154918225906,-0.0802668543470264,-0.0661095815525709,5.61871258037638e-90
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFA,Protransforming growth factor alpha,42119,-0.0914744112833946,0.00453322996496462,-0.100359542014725,-0.082589280552064,3.09265225699873e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASET2,Ribonuclease T2,42258,-0.0541162484634539,0.00268510426736005,-0.0593790528274796,-0.0488534440994282,4.84416695005172e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHISA5,Protein shisa-5,39966,-0.0524868503450043,0.00260351081404011,-0.0575897315405229,-0.0473839691494856,7.77745226580856e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPY,Pancreatic prohormone,42089,-0.206890304133601,0.0102871274328191,-0.227053073901926,-0.186727534365276,1.15934828381244e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,-0.113842338861603,0.00565740722898491,-0.124930857030414,-0.102753820692793,1.63330141600774e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XCL1,Lymphotactin,42262,-0.109516869155467,0.00546374442533105,-0.120225808229116,-0.0988079300818181,4.16280583826998e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,-0.0718524073180798,0.00358526639157177,-0.0788795294455604,-0.0648252851905991,4.85577847991591e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,-0.0582533508910243,0.00291681087387753,-0.0639703002038243,-0.0525364015782244,1.76572289909485e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,-0.183517410156074,0.00919440139247698,-0.201538436885329,-0.165496383426819,2.33517626258691e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,-0.0766668937250144,0.00384306783288923,-0.0841993066774773,-0.0691344807725515,2.63060391860341e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,-0.109034429519438,0.0054722359686866,-0.119760012018064,-0.0983088470208127,4.57701550187232e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCG2,Secretogranin-2,42193,-0.0659009423556152,0.00330810494361818,-0.0723848280451069,-0.0594170566661236,4.64739946737449e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,-0.0545893894190623,0.00274047088745092,-0.0599607123584661,-0.0492180664796585,4.83985251295525e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,-0.173256222213682,0.00869480867797678,-0.190298047222517,-0.156214397204848,7.36368592229273e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL16,Pro-interleukin-16,42296,-0.0842849175403465,0.00423866834876734,-0.0925927075039304,-0.0759771275767625,9.19824951630682e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP12,Macrophage metalloelastase,42146,-0.108806885230615,0.00547836141919705,-0.119544473612242,-0.0980692968489892,1.49625959327423e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,-0.143353658071695,0.00722726109219602,-0.1575190898124,-0.129188226330991,2.55484216129752e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD83,CD83 antigen,42119,-0.0685174500585931,0.00345938868626801,-0.0752978518836784,-0.0617370482335078,4.35273527468254e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.0828314910590027,0.00419520922520001,-0.0910541011403947,-0.0746088809776107,1.66083386643808e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0711344745389193,0.0036076441460892,-0.0782054570652542,-0.0640634920125845,2.38503284340153e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPPC,C-type natriuretic peptide,42119,-0.103834054213323,0.0052750196683227,-0.114173092763236,-0.0934950156634107,4.56285890187937e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COLEC12,Collectin-12,42123,-0.0539404701389905,0.00274169093227368,-0.0593141843662469,-0.0485667559117341,5.51748991347627e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSO,Cathepsin O,42296,-0.0603125287134387,0.003067234332636,-0.0663243080054053,-0.0543007494214722,6.54511527440744e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSC2,Desmocollin-2,41984,-0.0689055415125118,0.00351597043573426,-0.0757968435665509,-0.0620142394584726,2.44243123670365e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMA,Granzyme A,42296,-0.0665431147672634,0.00340158433798875,-0.0732102200697213,-0.0598760094648054,4.52595064766325e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,-0.167437464812652,0.00856080338728529,-0.184216639451731,-0.150658290173573,5.07953204643317e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,-0.045467205143223,0.00232263749042366,-0.0500195746244533,-0.0409148356619926,6.36448184834312e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12A_IL12B,Interleukin-12,42070,-0.150851169835592,0.00772123264865305,-0.165984785826952,-0.135717553844232,7.64157698043329e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.132843573795387,0.00679974105628054,-0.146171066265697,-0.119516081325077,7.69699361253159e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPT2,Angiopoietin-2,42262,-0.0730696580838401,0.00374312005813542,-0.0804061733977855,-0.0657331427698947,1.00147452459218e-83
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM20A,Pseudokinase FAM20A,39958,-0.0551099053081473,0.00283167032538657,-0.0606599791459049,-0.0495598314703896,5.15048114138729e-83
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSP1,Lymphocyte-specific protein 1,42119,-0.0787991998369526,0.00406010062947968,-0.0867569970707328,-0.0708414026031724,8.7701234740616e-83
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN2,Nectin-2,42129,-0.0601779340298105,0.00310114166985119,-0.0662561717027188,-0.0540996963569022,9.28249722238422e-83
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUOM,Fucose mutarotase,39736,-0.125812734848029,0.00648135885393608,-0.138516198201744,-0.113109271494315,1.41759024230199e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD27,CD27 antigen,42181,-0.0829432282551441,0.00427976778242442,-0.091331573108696,-0.0745548834015922,1.46911090890007e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,-0.0578441864785319,0.00298702455988433,-0.0636987546159052,-0.0519896183411586,1.95507313302592e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTA1,Glutathione S-transferase A1,42119,-0.164422445108062,0.00849154759232016,-0.181065878389009,-0.147779011827114,2.05851903130411e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,-0.116632341388271,0.00602303409580492,-0.128437488216049,-0.104827194560493,2.11640201620885e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ULBP2,UL16-binding protein 2,42016,-0.0762257045193073,0.00394110061147796,-0.0839502617178041,-0.0685011473208105,3.17010700382046e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHBG,Sex hormone-binding globulin,39990,0.0911332178463653,0.00471148952964333,0.0818986983682644,0.100367737324466,4.82090273741968e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INHBC,Inhibin beta C chain,42137,-0.0768197005834135,0.00397686055743592,-0.0846143472759879,-0.0690250538908391,4.92460701899384e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0836260233508324,0.00433138948481278,-0.0921155467410654,-0.0751364999605993,5.93797618934577e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,-0.0972523498037087,0.00504390022783381,-0.107138394250263,-0.0873663053571545,9.31239795963148e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,-0.0823171406955598,0.00429340150154832,-0.0907322076385945,-0.0739020737525251,7.22101664612296e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,-0.0623382230885871,0.00324705775302109,-0.0687024562845084,-0.0559739898926658,8.21924510812621e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,-0.0636460472134877,0.00333722859932414,-0.070187015268163,-0.0571050791588124,4.85810110312914e-80
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0873344243063156,0.00458100980923628,-0.0963132035324187,-0.0783556450802124,5.39984961164719e-80
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG4,Regenerating islet-derived protein 4,42144,-0.0972940282587983,0.00511001306541614,-0.107309653867014,-0.0872784026505826,8.7563389598483e-80
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,-0.0541839166104129,0.00284356566331466,-0.0597573053105097,-0.0486105279103162,1.0485451840339e-79
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THY1,Thy-1 membrane glycoprotein,42249,-0.0556985118737786,0.00293116458793446,-0.0614435944661301,-0.049953429281427,1.73252099878899e-79
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,-0.0724713591351691,0.00381482259015023,-0.0799484114118636,-0.0649943068584747,1.93915545868047e-79
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,-0.0753035790034551,0.00396504285413213,-0.0830750629975541,-0.0675320950093561,2.13722701552171e-79
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MME,Neprilysin,42070,-0.147080212104029,0.00781522172737978,-0.162398046689693,-0.131762377518364,5.19937039410806e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLL1,Delta-like protein 1,42181,-0.0575918591868083,0.0030786873989827,-0.0636260864888144,-0.0515576318848022,4.0612315717492e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL21,C-C motif chemokine 21,42185,-0.0715806464765438,0.00384108240026127,-0.0791091679810559,-0.0640521249720317,1.4858929717738e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12B,Interleukin-12 subunit beta,42296,-0.102468951300753,0.00550220210410326,-0.113253267424795,-0.0916846351767105,1.82621855544633e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300C,CMRF35-like molecule 6,42249,-0.0657491493238441,0.00353511799841922,-0.0726779806007458,-0.0588203180469424,2.86870253279338e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSME1,Proteasome activator complex subunit 1,42002,-0.067619240755871,0.00363905029699337,-0.074751779337978,-0.060486702173764,4.08549806771051e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,-0.0528492937044703,0.00284844787881337,-0.0584322515469445,-0.0472663358619961,6.51671622717386e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B2M,Beta-2-microglobulin,39979,-0.0566623532772881,0.00305952741201287,-0.0626590270048333,-0.0506656795497429,1.82280260931235e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL3,C-C motif chemokine 3,42119,-0.109821325410225,0.00595890410410988,-0.12150077745428,-0.0981418733661694,6.25534346735538e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSTL3,Follistatin-related protein 3,42084,-0.0603940700231941,0.00328169815333772,-0.066826198403736,-0.0539619416426522,1.0135622608761e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,-0.0770771462962026,0.00419614562823597,-0.0853015917275451,-0.0688527008648601,2.7954212435437e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH17,Protocadherin-17,42145,-0.0689917761623195,0.0037623640196486,-0.0763660096408308,-0.0616175426838082,3.28615747603075e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD160,CD160 antigen,42296,-0.0890269731036832,0.00486619037466668,-0.0985647062380299,-0.0794892399693365,6.86599113899133e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSME2,Proteasome activator complex subunit 2,41955,-0.0644786421996874,0.00353705695822573,-0.0714112738378098,-0.0575460105615649,2.33057919218596e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,-0.0497462144369722,0.00273361687063656,-0.0551041035034198,-0.0443883253705245,3.95120393976145e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,-0.0755910184865097,0.00415899931128683,-0.0837426571366319,-0.0674393798363875,6.01459826747492e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,-0.150551037957878,0.00830075880910296,-0.166820525223719,-0.134281550692036,1.22801078320905e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTRK3,NT-3 growth factor receptor,42249,0.0384777449268362,0.00212998364293553,0.0343029769866826,0.0426525128669898,4.16435083190082e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,0.229935288944901,0.0127318493833555,0.204980864153524,0.254889713736278,4.52225718776253e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCLY,Selenocysteine lyase,42224,-0.0881727920704879,0.00488862402548455,-0.0977544951604376,-0.0785910889805382,6.91555430722286e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,-0.0681742937161595,0.00378655108224648,-0.0755959338373626,-0.0607526535949564,1.2712300308167e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,-0.0498700085866838,0.00277393711495305,-0.0553069253319918,-0.0444330918413758,1.94335944076357e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELE,E-selectin,42310,-0.0910604806618986,0.0050687866094282,-0.100995302416378,-0.0811256589074193,2.40675780753265e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNMT,Histamine N-methyltransferase,41961,-0.0862596994711463,0.00480105151231139,-0.0956697604352766,-0.076849638507016,2.44349921752357e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.0765284414064095,0.00427571838701961,-0.0849088494449679,-0.0681480333678511,7.93652052117619e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRDL1,Chordin-like protein 1,42166,-0.0585384907692185,0.00328512526900438,-0.0649773362964671,-0.05209964524197,3.15776719506872e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SULT2A1,Bile salt sulfotransferase,42119,-0.105258208833634,0.00590961648715723,-0.116841057148462,-0.0936753605188055,3.64860134442353e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,-0.0606594474195476,0.0034073375738911,-0.0673378290643742,-0.0539810657747211,4.23580116160706e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,-0.109309963713815,0.00614701007041362,-0.121358103451826,-0.0972618239758043,6.06119650490626e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,-0.138080773181392,0.00775962748455896,-0.153289643051128,-0.122871903311656,6.90530856623106e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD48,CD48 antigen,42166,-0.0548243336408221,0.00308771571025292,-0.0608762564329178,-0.0487724108487263,9.57662662390846e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,-0.0770337678283373,0.00434199168452265,-0.0855440715300017,-0.0685234641266729,1.21484953019752e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KYNU,Kynureninase,42296,-0.0809618621762395,0.00456746177311125,-0.0899140872515375,-0.0720096371009414,1.58232398899045e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,-0.0614351255238102,0.00347979432993509,-0.068255522410483,-0.0546147286371374,5.58084536890016e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,-0.0942387089524835,0.00533910145623459,-0.104703347806703,-0.0837740700982637,5.94416967891331e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0663553572802583,0.00376501226590207,-0.0737347813214264,-0.0589759332390903,9.41592425653232e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,-0.116495080359651,0.00661054028269843,-0.12945173931374,-0.103538421405562,9.67679705730176e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.0994601172652959,0.00563899909479573,-0.110512555491096,-0.0884076790394963,1.11257417622757e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,-0.117271100538536,0.00665663171937373,-0.130318098708509,-0.104224102368564,1.47874677603706e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSL,Cathepsin L1,42145,-0.0432830250329052,0.00245984668458225,-0.0481043245346864,-0.038461725531124,1.53221509422091e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGLN1,Egl nine homolog 1,42119,-0.0986298206573473,0.00561909514591181,-0.109643247143334,-0.0876163941713601,3.2374234667082e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA6,Carbonic anhydrase 6,42103,0.110101140598308,0.00628122420292386,0.0977899411605776,0.122412340036039,4.90282230388494e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.0675890732366179,0.00385666770830984,-0.0751481419449052,-0.0600300045283306,5.19962460511784e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,-0.0869225537891114,0.00496866727024647,-0.0966611416387945,-0.0771839659394284,8.84618871653503e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,-0.0481076887687373,0.00275366452381372,-0.0535048712354122,-0.0427105063020624,1.31843059247917e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOLM2,Protein GOLM2,42249,-0.0398954748066423,0.00228485223111794,-0.0443737851796335,-0.0354171644336511,1.54049403282551e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,-0.0858103131845059,0.00491421589934694,-0.0954421763472259,-0.0761784500217859,1.59920726455399e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,-0.12077041457883,0.00690813444086532,-0.134310358082926,-0.107230471074734,1.59927339562071e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAO1,Hydroxyacid oxidase 1,42262,-0.216595725172032,0.0124223478978142,-0.240943527051748,-0.192247923292316,2.35513782178613e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADM,Pro-adrenomedullin,42262,-0.0457954466708212,0.00263027464491751,-0.0509507849748595,-0.0406401083667828,3.61603048540389e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSS,Cathepsin S,39358,-0.0423088488286126,0.00242714652637427,-0.0470660560203062,-0.037551641636919,3.96257714005206e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EZR,Ezrin,42249,-0.042423916077983,0.00244190446070704,-0.0472100488209688,-0.0376377833349972,6.8822986122951e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,-0.0735210267186047,0.00423179331290897,-0.0818153416119062,-0.0652267118253031,7.1586274863761e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.115121399410476,0.00663421275759839,-0.128124456415369,-0.102118342405583,9.9321449763338e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBS2,Thrombospondin-2,42137,-0.0672248072092469,0.00387581307998424,-0.074821400846016,-0.0596282135724778,1.13541467905043e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,-0.0653782182405258,0.0037775464147209,-0.0727822092133787,-0.0579742272676728,3.05050053176427e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA7A,Semaphorin-7A,42272,-0.0495989980655982,0.00287038200937001,-0.0552249468039634,-0.043973049327233,3.37924165034937e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,-0.0528330231071643,0.00306586741754537,-0.0588421232455532,-0.0468239229687754,7.5202991850373e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM2,Paralemmin-2,39929,-0.067442642551604,0.0039093983506933,-0.0751050633189628,-0.0597802217842451,7.55274765632212e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,-0.0848555809403172,0.00492472843498346,-0.0945080486728847,-0.0752031132077496,7.90059357625271e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA2,Ephrin type-A receptor 2,41614,-0.0561087398366865,0.00325789555820653,-0.0624942151307713,-0.0497232645426017,9.64093225367381e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF21,Fibroblast growth factor 21,42247,-0.207757880554149,0.0120679827436432,-0.23141112673169,-0.184104634376609,1.00112422454044e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL17,C-X-C motif chemokine 17,42296,-0.0736764924568727,0.0042829424068451,-0.0820710595742891,-0.0652819253394563,1.24681671957925e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100P,Protein S100-P,41900,-0.0926435975948236,0.00538659191323344,-0.103201317744761,-0.0820858774448861,1.38296011255575e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,-0.0442124887844415,0.00256879637069177,-0.0492473296709974,-0.0391776478978856,1.47584731689115e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,-0.0820063379148361,0.00477675138070907,-0.0913687706210259,-0.0726439052086463,2.35374297438242e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOC1,Apolipoprotein C-I,39959,0.066743342521517,0.00388635427434255,0.0591260881438056,0.0743605968992284,2.77645806277773e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,-0.0922480132335679,0.00537550755433491,-0.102784008040064,-0.0817120184270715,3.47445482478214e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,-0.0636812427778354,0.00372321979823711,-0.0709787535823801,-0.0563837319732906,6.66738583833302e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCOF1,Treacle protein,39958,-0.0560746732276046,0.00327517470585121,-0.062494015651073,-0.0496553308041363,6.71416692767752e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB6A,Ras-related protein Rab-6A,42119,0.0763315041724276,0.00446446832085719,0.0675811462635475,0.0850818620813076,7.42763227806205e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3B,Protein FAM3B,42070,-0.0603896628933724,0.00354031017409573,-0.0673286708346,-0.0534506549521448,1.4567729397233e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGBL1,Integrin beta-like protein 1,39966,-0.0677436331266187,0.00396963205382907,-0.0755241119521236,-0.0599631543011137,1.70059781759365e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL22,C-C motif chemokine 22,41991,-0.0887346356773235,0.0052139180306633,-0.0989539150174235,-0.0785153563372234,2.82004659660363e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPO,Erythropoietin,42119,-0.124782302648473,0.00733642182817307,-0.139161689431692,-0.110402915865254,3.29584124543966e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUCB2,Nucleobindin-2,42231,-0.0640703897803493,0.003769278230653,-0.0714581751124291,-0.0566826044482694,3.88265048342446e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD302,CD302 antigen,42070,-0.0532641422517484,0.00313393052140606,-0.0594066460737042,-0.0471216384297925,4.0937386700167e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL20,C-C motif chemokine 20,42296,-0.147795170260696,0.00870517474255015,-0.164857312756094,-0.130733027765298,5.40130803888089e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PXN,Paxillin,41839,-0.087497943331266,0.00515497878354325,-0.0976017017470108,-0.0773941849155212,6.11493701607477e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,-0.0986017432745914,0.00580611986870536,-0.109981738217254,-0.0872217483319289,7.1558328047813e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC1,Sialoadhesin,42185,-0.0708959705247088,0.00418166934814882,-0.0790920424470805,-0.0626998986023371,8.13867402301528e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,-0.0813718281741731,0.00479999772475596,-0.0907798237146948,-0.0719638326336514,8.4253374675732e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,-0.0504792337764221,0.00298296541909976,-0.0563258459978576,-0.0446326215549865,1.35618946388083e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,-0.0570649358095642,0.00337228946824223,-0.063674623167319,-0.0504552484518094,1.38101446089617e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAYN,Layilin,41997,-0.0606429281993945,0.00359344836214532,-0.0676860869891993,-0.0535997694095896,3.03885740606619e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR2,TGF-beta receptor type-2,42181,-0.0581043007504523,0.00344417618213813,-0.064854886067443,-0.0513537154334616,3.27187819037302e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,-0.170101378721256,0.0100865137647289,-0.189870945700125,-0.150331811742388,3.79943128174507e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3C,Protein FAM3C,42129,-0.0515112537891758,0.00305797444228573,-0.0575048836960558,-0.0455176238822958,5.01282010763612e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,-0.178699218323276,0.0106163717997559,-0.199507307050798,-0.157891129595755,6.21113766613672e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,-0.142448379257889,0.00847081921178095,-0.15905118491298,-0.125845573602799,8.29145534092556e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSTB,Cystatin-B,41959,-0.0733249288510769,0.00436340898670783,-0.0818772104650243,-0.0647726472371296,9.95721479895636e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,-0.047183301869175,0.00281265597512655,-0.052696107580423,-0.0416704961579269,1.55440239829726e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGN,Mimecan,42137,-0.0727158150900192,0.00434250740118184,-0.0812271295963356,-0.0642045005837028,2.60073441848744e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,-0.0991386201886419,0.00592469244017895,-0.110751017371393,-0.0875262230058912,3.1744045233386e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE1,Ribonuclease pancreatic,39990,-0.0417757869533428,0.00249568616563826,-0.0466673318379938,-0.0368842420686918,3.74514516383949e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPL,N-acetylneuraminate lyase,39958,-0.0782523940500225,0.00468906036204808,-0.0874429523596368,-0.0690618357404083,8.65914131668479e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,-0.0589454463006178,0.0035397989020879,-0.0658834521487101,-0.0520074404525255,1.19496657424627e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,-0.0776969649303875,0.00467314745939946,-0.0868563339508104,-0.0685375959099646,2.4914791953306e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANG,Angiogenin,42152,-0.0546613482757532,0.00329835538051603,-0.0611261248215646,-0.0481965717299417,4.40559089392248e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTA3,Glutathione S-transferase A3,41843,-0.128753974509612,0.00778126207100074,-0.144005248168774,-0.113502700850451,6.90391445126884e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBKS,Ribokinase,41830,-0.0823062536106625,0.0049743608756278,-0.092056000926893,-0.072556506294432,6.97815509509683e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,-0.102995636173811,0.0062301617393884,-0.115206753183012,-0.0907845191646094,8.55136394488057e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH1,Cadherin-1,41697,-0.0665883634432663,0.00403931894400675,-0.0745054285735195,-0.058671298313013,1.90709053193367e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNA1,Ephrin-A1,42113,-0.0487198702777823,0.0029559067228553,-0.0545134474545787,-0.0429262931009859,1.9137500054151e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,-0.0609218185596107,0.00370023753266866,-0.0681742841236412,-0.0536693529955801,2.56918762011593e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,-0.0502261831592337,0.00305505282854956,-0.0562140867031909,-0.0442382796152766,3.7284355360822e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,-0.0781044200241346,0.00475751734701202,-0.0874291540242782,-0.0687796860239911,5.42218251443758e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP7,Matrilysin,41881,-0.0855353469973461,0.00522356016138518,-0.095773524913661,-0.0752971690810311,1.10939179012328e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18,Interleukin-18,42069,-0.0728944460271201,0.0044564093812314,-0.0816290084143336,-0.0641598836399065,1.44822907312079e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,-0.0548513170423127,0.00336333857548352,-0.0614434606502604,-0.048259173434365,3.10730526784807e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEPH,Hephaestin,39958,-0.0458186075298813,0.00281992661731896,-0.0513456636998265,-0.0402915513599361,1.05477826825881e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,-0.0722863360714834,0.00446060787287212,-0.0810291275023127,-0.063543544640654,1.64763461197859e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,-0.0697557968376401,0.00431173955383117,-0.0782068063631492,-0.061304787312131,2.51524808579224e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA1,Ephrin type-A receptor 1,42162,-0.0524958638696994,0.00324531716800629,-0.0588566855189917,-0.0461350422204071,2.61926637495703e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0636953373071042,0.00394530434399908,-0.0714281338213424,-0.055962540792866,4.48012164384046e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAXX,Protein PAXX,39736,-0.0755499118010341,0.00467667891023348,-0.0847162024650917,-0.0663836211369765,4.80433597594447e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD1,Programmed cell death protein 1,42232,-0.0680410293783102,0.00422146545301714,-0.0763151016662238,-0.0597669570903966,6.54792957891155e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELOA,Elongin-A,42070,-0.0872986982739697,0.00541795133593346,-0.0979178828923993,-0.0766795136555402,7.19408856058817e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,-0.0507107501194464,0.00314819156310485,-0.0568812055831319,-0.0445402946557609,7.74189974763915e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STC1,Stanniocalcin-1,42249,-0.0741398761403652,0.00460998070926539,-0.0831754383305254,-0.0651043139502051,1.14626314963907e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.0647519583516531,0.00402319779083873,-0.072637426021697,-0.0568664906816092,1.20871124455585e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN5,CCN family member 5,42137,-0.0612390914504971,0.00381475009162586,-0.0687160016300838,-0.0537621812709105,1.83885705071171e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,-0.0448566347365119,0.00279754010935311,-0.050339813350844,-0.0393734561221798,2.47822519140325e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PENK,Proenkephalin-A,39736,-0.0502947226393945,0.00313356847446987,-0.0564365168493555,-0.0441529284294336,2.49567494897896e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,-0.0804278694952401,0.00501533688268704,-0.0902579297853067,-0.0705978092051735,3.24594022779637e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,-0.0500061594598396,0.00311952210263866,-0.0561204227810114,-0.0438918961386678,3.34774607553587e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMMT,MICOS complex subunit MIC60,39919,-0.0721768292651307,0.00450960138116416,-0.0810156479722125,-0.063338010558049,4.96015416552339e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,-0.12849313295797,0.00805769586381606,-0.14428621685105,-0.112700049064891,9.92901636068486e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,-0.0623709424453804,0.00391153687672023,-0.0700375547237521,-0.0547043301670087,9.94156369186595e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,-0.134249182567715,0.00842281606491904,-0.150757902054957,-0.117740463080474,1.1400969018808e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRD1,Natural killer cells antigen CD94,42296,-0.0756307229985857,0.00475203175873763,-0.0849447052457114,-0.0663167407514599,1.58896049627521e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,-0.122744047964969,0.00773064790948591,-0.137896117867562,-0.107591978062377,2.91268945894793e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,-0.0595300334960547,0.0037569558590028,-0.0668936669797002,-0.0521664000124092,4.95403416260132e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF2,Trefoil factor 2,42166,-0.0930857833744341,0.00588206979703903,-0.104614640176631,-0.0815569265722376,6.57702198857043e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEL1L,Protein sel-1 homolog 1,39638,-0.0502806164679014,0.00317788870120922,-0.0565092783222715,-0.0440519546135313,8.97939415692783e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDCP1,CUB domain-containing protein 1,42016,-0.0888999069533992,0.00563207999102932,-0.0999387837358166,-0.0778610301709817,1.25738650620516e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD59,CD59 glycoprotein,41638,-0.0375598144605871,0.00238068274814286,-0.0422259526469471,-0.0328936762742271,1.46370286917966e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,-0.0744720529265175,0.0047187795079847,-0.0837208607621675,-0.0652232450908675,1.66912277829805e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,-0.0949703686210019,0.00602450694637636,-0.1067784022359,-0.0831623350061043,1.72302354820671e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLA,Alpha-galactosidase A,39713,-0.0624068164045452,0.00396214161300407,-0.0701726139660332,-0.0546410188430572,2.68402278660879e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS2,Trypsin-2,42217,-0.0901160376923929,0.00575712172235544,-0.10139999626821,-0.0788320791165762,9.50683890458273e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDT,D-dopachrome decarboxylase,39966,-0.0643527788632842,0.00410963634846946,-0.0724076661062843,-0.056297891620284,1.07363858883145e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA2,Carboxypeptidase A2,42205,-0.104705312139301,0.00669483111269709,-0.117827181120187,-0.0915834431584146,1.16736687721672e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNCA,Alpha-synuclein,39736,-0.186680471970492,0.0119244701717119,-0.210052433507048,-0.163308510433937,1.16829497952113e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDC1,Syndecan-1,42145,-0.063774382396244,0.00407876868038348,-0.0717687690097956,-0.0557799957826923,1.24818268553788e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,-0.0461268307242882,0.00295623810367364,-0.0519210574074886,-0.0403326040410879,2.11041084748919e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MLN,Promotilin,42119,-0.14029416489224,0.00900192739003993,-0.157937942576718,-0.122650387207762,2.73405185596202e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNCG,Gamma-synuclein,42016,-0.10472236531293,0.00671953656758818,-0.117892656985403,-0.091552073640457,2.76275059574524e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN8,Septin-8,39906,-0.0513888136854062,0.00329466573914269,-0.0578463585341259,-0.0449312688366865,2.77671492850353e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL6,C-X-C motif chemokine 6,42296,-0.118432020737953,0.00760572404301254,-0.133339239862258,-0.103524801613649,3.31656850038094e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300LG,CMRF35-like molecule 9,42137,0.0583836346225555,0.00375126850944204,0.0510311483440491,0.0657361209010619,3.78112715003341e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,-0.0635045399323306,0.00408602118370638,-0.0715131414523951,-0.0554959384122661,5.23213095109933e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,-0.0434136406498717,0.00279412404008199,-0.0488901237684324,-0.037937157531311,5.62664609153787e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UMOD,Uromodulin,42274,0.0842057400659869,0.00541971038767316,0.0735831077061475,0.0948283724258263,5.64009892806528e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.0541772132668691,0.00349660131122857,-0.0610305518368771,-0.0473238746968611,1.09520369053188e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF1,Trefoil factor 1,42084,-0.125344412360561,0.00809014953247906,-0.14120110544422,-0.109487719276902,1.11367315977276e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,0.0305355171441743,0.00197140486674104,0.0266715636053619,0.0343994706829868,1.18959889490372e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,-0.0808537419800934,0.00521937694074278,-0.0910837207839492,-0.0706237631762375,1.45413146575518e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERMAP,Erythroid membrane-associated protein,39657,-0.0697837604511291,0.00451352452852414,-0.0786302685270364,-0.0609372523752217,2.29626994203993e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMNB2,Lamin-B2,39929,-0.0447751275857734,0.00289891597764506,-0.0504570029019577,-0.0390932522695891,2.82180408783481e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,-0.0599379782383055,0.00388538338942879,-0.0675533296815859,-0.052322626795025,3.07890983872675e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300A,CMRF35-like molecule 8,39736,-0.0477238949652159,0.00309247341055116,-0.0537851428498962,-0.0416626470805357,3.52211492478405e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL7,C-C motif chemokine 7,42119,-0.0871138494696439,0.00566342256211081,-0.0982141576913811,-0.0760135412479067,6.08191822395077e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG1A,Lithostathine-1-alpha,42105,-0.0772609830288638,0.00502552112149165,-0.0871110044269874,-0.0674109616307401,6.88604982780991e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG1B,Lithostathine-1-beta,42310,-0.088187290002379,0.00574744620469526,-0.0994522845635817,-0.0769222954411763,1.06866218802014e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRN,Progranulin,42077,-0.0386831443821607,0.00252463869880438,-0.0436314362318173,-0.0337348525325042,1.5049798132134e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,-0.0826086252923696,0.00539610114961868,-0.0931849835456222,-0.072032267039117,1.86797198277112e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO1,Roundabout homolog 1,42144,-0.0369130892977482,0.00241157967873762,-0.0416397854680739,-0.0321863931274224,1.89714903838009e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,0.0996033919684457,0.00651634298966949,0.0868313597086935,0.112375424228198,2.63107797162492e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,-0.0601062259884015,0.00393468080041758,-0.0678182003572199,-0.052394251619583,3.00160476405049e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGR3,Anterior gradient protein 3,41827,-0.0911401118764218,0.00597715067828868,-0.102855327205868,-0.079424896546976,4.69484591430743e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0689111196694821,0.00452296583407654,-0.0777761327042721,-0.0600461066346921,5.47318186079229e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFC1,Cryptic protein,41843,-0.0735175808138844,0.00483426427485864,-0.0829927387926073,-0.0640424228351614,8.61652851975276e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,-0.163661586644902,0.010765128890093,-0.184761239269484,-0.142561934020319,9.08814102680986e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,-0.0526018721408607,0.00347246693541024,-0.0594079073342648,-0.0457958369474567,2.06173239744914e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FMNL1,Formin-like protein 1,41839,-0.0964730211819954,0.00636826822695726,-0.108954826906832,-0.0839912154571592,2.07336371365888e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA5,Integrin alpha-5,42137,-0.0378726556884752,0.00250106749785032,-0.0427747479842618,-0.0329705633926886,2.23370509394796e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK4,Dickkopf-related protein 4,41992,-0.0702216111606188,0.0046407117426957,-0.0793174061763024,-0.0611258161449353,2.65831516879878e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KHK,Ketohexokinase,39638,-0.096582089786928,0.00638097816236699,-0.109088806985167,-0.0840753725886888,3.06222555946265e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPM,Carboxypeptidase M,42195,-0.0516818475597108,0.00342140787662118,-0.0583878069978883,-0.0449758881215333,3.87571425170397e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARA5,Scavenger receptor class A member 5,42249,-0.0464118300385462,0.00307431047929459,-0.0524374785779636,-0.0403861814991288,4.40092808476673e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFI,Complement factor I,39979,-0.0296021120097394,0.00196198827344659,-0.0334476090256947,-0.0257566149937841,6.05091692250751e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.0465504898986952,0.00308674355993639,-0.0526005072761705,-0.0405004725212198,6.7507157725133e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,0.0754239383984341,0.00501060488036002,0.0656031528329285,0.0852447239639398,1.01982516755504e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.0945062529383555,0.00628060779538336,-0.106816244217307,-0.0821962616594041,1.11009426775119e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,-0.0439047455894378,0.00292826413291762,-0.0496441432899563,-0.0381653478889192,2.50759585155402e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR2,Folate receptor beta,42249,-0.0437477203799832,0.00292776580070571,-0.0494861413493664,-0.0380092994106,4.34565646275231e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD2AP,CD2-associated protein,42145,-0.0947368056110182,0.00635977140979529,-0.107201957574217,-0.0822716536478195,8.6341659481333e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,-0.0687832952756408,0.00461610963452939,-0.0778308701593184,-0.0597357203919632,9.6598664079514e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL11,C-X-C motif chemokine 11,42249,-0.117018456878905,0.007866991353904,-0.132437759932557,-0.101599153825253,1.17913819622879e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN4,CCN family member 4,42262,-0.0586265845612042,0.00394356923841479,-0.0663559802684972,-0.0508971888539112,1.32979190417483e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,-0.109412743943503,0.00735946245877581,-0.123837290362704,-0.0949881975243024,1.34019155776236e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD274,Programmed cell death 1 ligand 1,42016,-0.0505053536191322,0.00339777579746049,-0.0571649941821547,-0.0438457130561096,1.39458376325242e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YAP1,Transcriptional coactivator YAP1,39929,-0.0413631979544637,0.00279148678713842,-0.046834512057255,-0.0358918838516724,3.2524894560544e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.085954393856707,0.00582236176943844,-0.0973662229248063,-0.0745425647886077,6.10654325894671e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,-0.101850649498658,0.00690096071035321,-0.11537653249095,-0.0883247665063654,6.59262303800227e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,-0.0936231519550217,0.00634755743331604,-0.106064364524321,-0.0811819393857223,9.0191742538309e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOE,Apolipoprotein E,39979,-0.103774948748519,0.00705693982267378,-0.117606550800959,-0.0899433466960781,1.65770814480785e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,-0.0400004095987657,0.00272394069431977,-0.0453393333596325,-0.034661485837899,1.89920341532559e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0759093338690567,0.00517390443259844,-0.0860501865569497,-0.0657684811811638,2.30067581591492e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,-0.0423953213867968,0.00289779641617961,-0.0480750023625089,-0.0367156404110848,4.19511640615978e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDK,Midkine,42129,-0.0754463710440482,0.00515831010290221,-0.0855566588457365,-0.0653360832423598,4.45030036920094e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THOP1,Thimet oligopeptidase,42081,-0.0461765627649041,0.00315770067147295,-0.0523656560809911,-0.0399874694488171,4.64151326768503e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,-0.0999666635774086,0.00685881393247877,-0.113409938885067,-0.0865233882697502,9.26236907419258e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RETN,Resistin,42105,-0.0630146325551894,0.00432687651424514,-0.0714953105231099,-0.0545339545872689,1.10087275851173e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,-0.112322614111802,0.00771596594854314,-0.127445907370947,-0.0971993208526576,1.4090465648736e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,-0.0989040918867295,0.00680765274536894,-0.112247091267653,-0.0855610925058064,1.82989933270073e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6,Interleukin-6,42070,-0.109344220039984,0.00753786619111563,-0.124118437774571,-0.0945700023053977,2.52344564822138e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRP,Gastrin-releasing peptide,39638,-0.0785462822522043,0.00541310528776384,-0.0891559686162214,-0.0679365958881872,2.83294314720404e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,-0.0576632410235809,0.00398155170876177,-0.065467082372754,-0.0498593996744078,3.50475801071541e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,-0.0392022668439288,0.00271175278252926,-0.0445173022976861,-0.0338872313901714,5.13219600084592e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,-0.0594941713265436,0.00413322391192568,-0.0675952901939179,-0.0513930524591692,1.44190402183754e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP1,Guanylate-binding protein 1,39911,-0.0940833559269161,0.00654383962126961,-0.106909281584605,-0.0812574302692277,1.84053685121164e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,-0.0549995985644667,0.00382823670417601,-0.0625029425046517,-0.0474962546242817,2.18784265719786e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BSG,Basigin,42284,-0.0302309393718786,0.00210774447811473,-0.0343621185489835,-0.0260997601947737,2.56040801907884e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCA,Calcitonin,41997,-0.100139806134883,0.00699359373691864,-0.113847249859244,-0.0864323624105228,3.65810408794986e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JAM2,Junctional adhesion molecule B,42249,-0.0393024690346772,0.00275517803907016,-0.0447026179912547,-0.0339023200780997,7.72505171839113e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,-0.0369899944848492,0.00259435914481911,-0.0420749384086946,-0.0319050505610037,8.66249903237842e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,-0.0893418333872126,0.00626797139579906,-0.101627057322979,-0.0770566094514465,1.05493772062324e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OXT,Oxytocin-neurophysin 1,42249,-0.207899524202494,0.014607996654602,-0.236531197645514,-0.179267850759474,1.23138217831648e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,-0.0480671406643583,0.00338092027960063,-0.0546937444123755,-0.041440536916341,1.51405848789148e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR1,Folate receptor alpha,42110,-0.0421653331804921,0.00297679549940879,-0.0479998523593333,-0.0363308140016508,3.19271516643656e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMOT,Angiomotin,39736,-0.0549430265248457,0.00388282919924839,-0.0625533717553726,-0.0473326812943189,4.56901525987533e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORD,Sorbitol dehydrogenase,42204,-0.0977978211482278,0.00693811485597832,-0.111396526265945,-0.0841991160305103,8.33579805540115e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH3,Cadherin-3,42249,-0.052290523567749,0.00371528581061585,-0.0595724837565561,-0.045008563378942,1.11949049159758e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,-0.0450481100999803,0.00320613308616597,-0.0513321309488656,-0.038764089251095,1.84360198557422e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RLN2,Prorelaxin H2,39709,-0.0733352384710419,0.00522058420870818,-0.08356758352011,-0.0631028934219739,1.91874773352327e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEP1A,Meprin A subunit alpha,39930,-0.108235483958205,0.00770985264743522,-0.123346795147178,-0.0931241727692322,2.12957146326462e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL11,Eotaxin,42296,-0.0528349892763474,0.00377198931689853,-0.0602280883374685,-0.0454418902152263,2.84544311270729e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL14,C-C motif chemokine 14,42152,-0.0571193294232873,0.00408023612748468,-0.0651165922331573,-0.0491220666134174,3.21058536431633e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,-0.0333986878195067,0.00239014879334679,-0.0380833794544664,-0.028713996184547,4.55184161891872e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTYMK,Thymidylate kinase,39958,-0.0952632153081135,0.00681733776439128,-0.10862519732632,-0.0819012332899066,5.21872827585888e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,-0.042486062975488,0.0030459792041496,-0.0484561822156212,-0.0365159437353548,7.42615177724989e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,-0.0898542661507295,0.00644276386665444,-0.102482083329372,-0.0772264489720868,7.60042731721055e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,-0.0467347855550459,0.00335433351874646,-0.0533092792517889,-0.0401602918583028,7.9944896242261e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,-0.0725907602156472,0.00521928459296196,-0.0828205580178526,-0.0623609624134417,1.12956825158947e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALCAM,CD166 antigen,42310,-0.0275371354231083,0.00198594945223187,-0.0314295963494828,-0.0236446744967339,1.99944994524201e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,-0.0726820358671187,0.00524276754589152,-0.0829578602570661,-0.0624062114771713,2.07722995998865e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,-0.0474852656059105,0.00343221345393335,-0.0542124039756199,-0.0407581272362012,3.0714489083596e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F11R,Junctional adhesion molecule A,42137,-0.07752609421951,0.00561215036059774,-0.0885259089262816,-0.0665262795127384,4.11572064251967e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,-0.0278343768421694,0.00202110907038221,-0.0317957506201186,-0.0238730030642203,7.34164764453599e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.0676597601760605,0.00491349691162057,-0.0772902141228368,-0.0580293062292842,7.57771700403019e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPB1,Carboxypeptidase B,42310,-0.0861759259998233,0.006259994805527,-0.0984455158186562,-0.0739063361809903,7.84961294912334e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPON1,Spondin-1,42144,-0.0451376577797694,0.00328930794175551,-0.0515847013456102,-0.0386906142139286,1.43314539057285e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,-0.106112934937706,0.0077345136045125,-0.12127258160255,-0.0909532882728614,1.72033611701751e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLO1,Lactoylglutathione lyase,41900,-0.0782530018819629,0.00570813193503693,-0.0894409404746353,-0.0670650632892905,1.74252197032144e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,-0.111727977359627,0.00816159914938773,-0.127724711692427,-0.0957312430268271,2.59516832438881e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO3,Beta-enolase,39638,-0.0872964982806452,0.00637962140311189,-0.0998005562307445,-0.0747924403305459,2.81166637045095e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD5,Programmed cell death protein 5,42249,-0.0789723909305062,0.00577694769331184,-0.0902952084093974,-0.067649573451615,2.90054807183264e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUCA2A,Guanylin,42083,-0.0484481531878009,0.00354597846093243,-0.0553982709712284,-0.0414980354043733,3.23242960601329e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,-0.0363047106566651,0.00265577177862053,-0.0415100233427613,-0.0310993979705688,3.3347229209414e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,-0.0320371322788718,0.00234971076065286,-0.0366425653697514,-0.0274316991879922,5.33935618432616e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,-0.0623909704710789,0.00458004601241099,-0.0713678606554045,-0.0534140802867534,5.59420188977595e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0559579660113938,0.00411096604701211,-0.0640154594635376,-0.0479004725592501,6.45243919721965e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0569195288548719,0.00419027032152635,-0.0651324586850636,-0.0487065990246803,9.3349693200696e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F9,Coagulation factor IX,42199,-0.0251369728194908,0.00185070236068682,-0.0287643494464369,-0.0215095961925446,9.53237099308962e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS1,Galectin-1,42145,-0.0479431910798996,0.00353442371430815,-0.0548706615599435,-0.0410157205998556,1.21363515595073e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0369781058117114,0.00272770746788495,0.0316317991746569,0.0423244124487659,1.35449771307769e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRC1,Macrophage mannose receptor 1,39990,-0.0390598069337586,0.00288085502551262,-0.0447062827837633,-0.0334133310837539,1.48356948839608e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,-0.0948510291645455,0.00702427301355775,-0.108618604271119,-0.0810834540579723,3.16993152495302e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL25,C-C motif chemokine 25,42296,-0.0668674923140984,0.00496032406684672,-0.076589727485118,-0.0571452571430788,3.72883101007538e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MARCO,Macrophage receptor MARCO,42145,-0.0351602940790792,0.00260947440591215,-0.040274863914667,-0.0300457242434914,4.08798984829045e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,-0.0829498589620444,0.00616290490338845,-0.0950291525726857,-0.070870565351403,5.71494036265434e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHB4,Ephrin type-B receptor 4,42310,-0.0343959585135396,0.00256033417349947,-0.0394142134935986,-0.0293777035334806,6.91576840026963e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWC2,Brorin,41973,-0.0553928831199604,0.00412597837994243,-0.0634798007446476,-0.0473059654952732,7.889854310121e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTNB,Dystrobrevin beta,39900,-0.0618653424008564,0.00461243774929245,-0.0709057203894695,-0.0528249644122432,1.0426555951136e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,-0.0482515099554255,0.00360560040714319,-0.0553184867534262,-0.0411845331574249,1.38795252987798e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFA,Vascular endothelial growth factor A,42253,-0.0762262915630481,0.00571844526852746,-0.087434444289362,-0.0650181388367343,2.76921786168721e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,-0.0509420393783474,0.00382292624803456,-0.0584349748244951,-0.0434491039321996,2.95558483345034e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,-0.0539874940385272,0.00405818520129682,-0.061941537033069,-0.0460334510439855,4.47276888650192e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,-0.140406198173422,0.0105549470600723,-0.161093894411164,-0.119718501935681,4.47552775430729e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,-0.149773992301061,0.0113012943969704,-0.171924529319124,-0.127623455282999,7.79144279497062e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUS,RNA-binding protein FUS,41831,-0.0531923798388894,0.00401960813466782,-0.0610708117828383,-0.0453139478949404,1.0085122042435e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,0.0388656447515337,0.00293889093502776,0.0331054185188793,0.0446258709841881,1.11208104058709e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.0414965836597725,0.00313854575830246,-0.0476481333460453,-0.0353450339734997,1.15153558447944e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDUA,Alpha-L-iduronidase,42262,-0.0629002828251162,0.00475964069333313,-0.0722291785840492,-0.0535713870661833,1.25247171646864e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,-0.0798950721047822,0.0060456920035684,-0.0917446284317762,-0.0680455157777881,1.26208878772174e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOMO1,Nodal modulator 1,42137,-0.0309431126255804,0.00234503057844241,-0.0355393725593276,-0.0263468526918333,1.63973464139774e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0841902054462176,0.00638920682433332,-0.0967130508219109,-0.0716673600705243,2.06763737781283e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,-0.0764177794770212,0.00579987543803114,-0.0877855353355622,-0.0650500236184802,2.37901506110667e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300LF,CMRF35-like molecule 1,42262,-0.0798295261078172,0.00606509831989471,-0.0917171188148108,-0.0679419334008236,2.51489036920983e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0425910907337079,0.00323798318104431,-0.0489375377685547,-0.0362446436988611,2.82559762265893e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAT,Tissue-type plasminogen activator,42272,-0.0678151333611491,0.00516543987987307,-0.0779393955257003,-0.0576908711965978,3.89247235696091e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BST2,Bone marrow stromal antigen 2,42249,-0.0674711811460717,0.0051479997340333,-0.0775612606247769,-0.0573811016673664,5.21200591881453e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,-0.0395018211803417,0.00301485793959738,-0.0454109427419526,-0.0335926996187309,5.57503579481297e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP5,Fatty acid-binding protein 5,42218,-0.0878429424120711,0.00672073542848781,-0.101015583851907,-0.074670300972235,8.31709153555867e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD244,Natural killer cell receptor 2B4,42296,-0.0363401379631841,0.00278066882016129,-0.0417902488507002,-0.030890027075668,8.46461860166778e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC39A5,Zinc transporter ZIP5,42119,-0.0700263429733113,0.00535965961508856,-0.0805312758188849,-0.0595214101277377,8.90832063101024e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD209,CD209 antigen,42171,0.0514502106227871,0.0039410170803535,0.0437258171452942,0.0591746041002799,1.01724137699561e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFR,Epidermal growth factor receptor,42310,0.0209878036535347,0.00161222268132258,0.0178278471981424,0.0241477601089269,1.63651472036917e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTBDN,Retbindin,42070,-0.0394248969258026,0.00302887082719043,-0.0453614837470958,-0.0334883101045093,1.68550816758983e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSM,Oncostatin-M,42051,-0.0907813698639936,0.0069801525767839,-0.10446246891449,-0.0771002708134971,1.93756575970027e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTN,Pleiotrophin,41900,-0.0654241691479877,0.00503546691434233,-0.0752936843000987,-0.0555546539958767,2.3046006286086e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF8,SLAM family member 8,41843,-0.070845701743125,0.0054546818980964,-0.0815368782633939,-0.060154525222856,2.45170532276119e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,-0.075534369427369,0.00582046455851229,-0.0869424799620531,-0.0641262588926849,2.77276753781329e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,-0.0485137070169331,0.00374142713382326,-0.0558469041992267,-0.0411805098346395,3.52710460252804e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIP,Gastric inhibitory polypeptide,39638,-0.0665457146412215,0.00513840407015707,-0.0766169866187294,-0.0564744426637137,4.41009966072811e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3GLB2,Endophilin-B2,39929,-0.086275749770516,0.00667062174749593,-0.0993501683956081,-0.073201331145424,5.39435078718161e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,-0.109318177718188,0.00845964022970585,-0.125899072568412,-0.0927372828679647,5.66236553952011e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,-0.0499713050248785,0.00386694423531548,-0.0575505157260968,-0.0423920943236601,5.68672515151565e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEP,Leptin,42145,-0.0907767154935022,0.00702682625267981,-0.104549294948755,-0.0770041360382498,5.92289452975076e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EEF1D,Elongation factor 1-delta,39958,-0.119586167516838,0.00925393019441502,-0.137723870697892,-0.101448464335785,6.19702370396627e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,-0.0380697989117183,0.00294699147107128,-0.043845902195018,-0.0322936956284185,6.58291481349071e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,-0.0816819829920794,0.0063394464674005,-0.0941072980681843,-0.0692566679159744,9.14432302659476e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.0412595681625236,0.0032053315825061,-0.0475420180642356,-0.0349771182608116,1.07678324060445e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,-0.11310782515435,0.00881198115436539,-0.130379308216906,-0.0958363420917941,1.91420811855527e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,0.0736614203255798,0.00573953034218896,0.0624119408548894,0.0849108997962702,1.95651806511464e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,-0.0674018306363766,0.00525818542350752,-0.0777078740664514,-0.0570957872063019,2.12354940301592e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,-0.0465214342429824,0.00362714931359934,-0.0536306468976371,-0.0394122215883277,2.15875576342974e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPO,Myeloperoxidase,42137,-0.0579648355163505,0.00453575208697753,-0.0668549096068265,-0.0490747614258745,3.49825256357305e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFH,Complement factor H,39418,-0.0304571508794947,0.00238237489242635,-0.0351266056686504,-0.0257876960903391,3.72197782302349e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAB2,Stabilin-2,39966,-0.0363783759422795,0.00284897332240534,-0.0419623636541939,-0.030794388230365,4.39360190005725e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,-0.0471211285297507,0.0036902557119072,-0.0543540297250888,-0.0398882273344126,4.39377508219956e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BECN1,Beclin-1,39638,-0.0771216440143253,0.00603914738002134,-0.0889583728791671,-0.0652849151494835,4.39462019759668e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,-0.125371898522022,0.00983986888092583,-0.144658041528637,-0.106085755515408,6.34729091903912e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G15,Phospholipase A2 group XV,42181,-0.0352455357252653,0.00277571440457342,-0.0406859359582292,-0.0298051354923014,9.83173441342488e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS3,Galectin-3,42196,-0.037883976785922,0.00298921441074011,-0.0437428370309726,-0.0320251165408714,1.33460698810274e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORT1,Sortilin,42129,-0.048816205192911,0.00385210163114039,-0.0563663243899462,-0.0412660859958758,1.35367704172677e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA14,Carbonic anhydrase 14,42262,0.0469243848146639,0.00370900065999919,0.0396547435210655,0.0541940261082623,1.75808673929006e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,-0.160963965740133,0.0127561862093749,-0.185966090710508,-0.135961840769758,2.67875589940538e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,-0.0327792929962459,0.00259781476969719,-0.0378710099448524,-0.0276875760476394,2.98765992124738e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTDH,Protein LYRIC,39657,-0.122024331267466,0.00968222752173623,-0.141001497210069,-0.103047165324863,3.6055455142753e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,-0.0870773229376144,0.00691522417124761,-0.10063116231326,-0.0735234835619691,4.07096417231745e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA2,Annexin A2,39492,-0.0901695232005253,0.00716241362305016,-0.104207853901704,-0.076131192499347,4.31299418431005e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,-0.0674822249081328,0.0053667046914692,-0.0780009661034124,-0.0569634837128531,4.65324674337226e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD46,Membrane cofactor protein,42107,-0.0363146700820559,0.00289676109689977,-0.0419923218319795,-0.0306370183321323,7.48090584764708e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.107002468320033,0.00853647778147349,-0.123733964771721,-0.0902709718683447,8.46796848573737e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,-0.0464447497888669,0.00371417752961085,-0.0537245377469042,-0.0391649618308296,1.10295030536085e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EBI3_IL27,Interleukin-27,42247,-0.038680421877317,0.0030953652150302,-0.0447473376987762,-0.0326135060558578,1.22625371723839e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAMR1,Inactive serine protease PAMR1,42137,-0.0333065088760814,0.00266577755088469,-0.0385314328758154,-0.0280815848763474,1.26375257795406e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN4,Nectin-4,42181,-0.0424089290731442,0.00339561855534017,-0.0490643414416109,-0.0357535167046775,1.3394467447655e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,-0.0399811006851307,0.00320263699299314,-0.0462582691913973,-0.0337039321788642,1.4506233178816e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,-0.0376543361287879,0.00302114764722003,-0.0435757855173392,-0.0317328867402367,2.01004840505016e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,0.0278374098892394,0.00223667764973038,0.0234535216957679,0.032221298082711,2.31719643453511e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.0730797846018434,0.00587332700138537,-0.0845915055245587,-0.0615680636791281,2.40205514460575e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,-0.0474474742647543,0.00381747827351779,-0.0549297316808492,-0.0399652168486595,2.85362964026669e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBS,Cystathionine beta-synthase,39638,-0.0653151738041805,0.00525198443708579,-0.0756090633008687,-0.0550212843074924,2.85996522343456e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD22,B-cell receptor CD22,42296,-0.053566900907047,0.00431114548595128,-0.0620167460595115,-0.0451170557545825,2.95365175481536e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C19orf12,Protein C19orf12,41839,-0.0838016200724692,0.00674549787311789,-0.0970227959037803,-0.0705804442411581,3.06842150657904e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN3,Contactin-3,42137,-0.035411364459964,0.00285782067091846,-0.0410126929749642,-0.0298100359449638,4.52722570129227e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CR2,Complement receptor type 2,42217,-0.058297821997143,0.00471634050083022,-0.0675418493787702,-0.0490537946155157,6.55214700855354e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB8,Serpin B8,42296,-0.0730111038906621,0.00590937010731687,-0.0845934693010032,-0.061428738480321,7.00860070621882e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR2,Cadherin-related family member 2,42070,-0.0822393370818348,0.00665761971746091,-0.0952882717280582,-0.0691904024356114,7.27704620370104e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,-0.0576482701217089,0.00466913408032388,-0.0667997729191438,-0.0484967673242741,8.5702220328409e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.0331984329759004,0.00269151303792122,-0.038473798530226,-0.0279230674215748,9.09446594073443e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSZ,Cathepsin Z,42168,-0.0401832634220228,0.00326085769472052,-0.046574544503675,-0.0337919823403706,1.04537117983085e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,-0.0503196553165974,0.00408363123730077,-0.0583235725417069,-0.0423157380914878,1.0488681655374e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.0606918421847789,0.00492554849884416,-0.0703459172425134,-0.0510377671270443,1.06078258340726e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,-0.0297789384348595,0.00241674742020498,-0.0345157633784612,-0.0250421134912577,1.06342878507764e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.0387781595308321,0.00314747790497896,-0.0449472162245909,-0.0326091028370733,1.07552204404845e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,-0.104362740996927,0.00847722836118362,-0.120978108584847,-0.087747373409007,1.31574713848561e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLIN1,Perilipin-1,41839,-0.0421776142000304,0.00342813598407245,-0.0488967607288124,-0.0354584676712483,1.34232360052159e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,0.0397171151962072,0.00323687956230264,0.033372831254094,0.0460613991383204,1.99024842102797e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDN1,Endothelin-1,39638,-0.0366243195260503,0.00298380440204648,-0.0424725761540614,-0.0307760628980392,2.08381847059293e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSTL1,Follistatin-related protein 1,39638,-0.0289240276722739,0.00236085323253271,-0.033551300008038,-0.0242967553365097,2.75254566524186e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,-0.0550078757967062,0.00449883620078528,-0.0638255947502454,-0.0461901568431671,3.65434962331977e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,-0.0723680409897331,0.00593272449464621,-0.0839961809992397,-0.0607399009802265,4.84416373436433e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,-0.0470160419591948,0.00385635680548694,-0.0545745012979492,-0.0394575826204404,5.17963018633968e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,-0.0507840135096147,0.00416623759694065,-0.0589498391996184,-0.042618187819611,5.82294228373972e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,-0.0500363990122213,0.00411132951866998,-0.0580946048688144,-0.0419781931556281,6.73408243501539e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.0334973730841281,0.0027546024589373,-0.0388963939036453,-0.028098352264611,7.55512415542969e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAST,Gastrin,39929,-0.161398843775094,0.0132816527291977,-0.187430883124321,-0.135366804425866,9.07698443456995e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RSPO3,R-spondin-3,42262,-0.034463637442783,0.00284081780033227,-0.0400316403314342,-0.0288956345541317,1.07053976773501e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN3,CCN family member 3,42299,-0.0415681321756339,0.00343110635238081,-0.0482931006263003,-0.0348431637249675,1.30531198758107e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,-0.0618261896546668,0.00510514949978757,-0.0718322826742505,-0.0518200966350832,1.38540179999969e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,-0.0289619485711469,0.00239195903264179,-0.0336501882751248,-0.024273708867169,1.53981764916954e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAL,Galanin peptides,42185,0.0813614199946321,0.00673134978528337,0.0681679744154767,0.0945548655737875,1.83843809386591e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUSB,Beta-glucuronidase,42211,-0.0745401442049749,0.00617150967419375,-0.0866363031663946,-0.0624439852435551,2.04314495577009e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD7,T-cell antigen CD7,39636,-0.0549602687875856,0.00454799661232338,-0.0638743421477394,-0.0460461954274317,2.07242008075394e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,-0.0665653417224364,0.00552189773025475,-0.0773882612737357,-0.055742422171137,2.91968105266176e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD207,C-type lectin domain family 4 member K,41832,-0.0475289107765601,0.00394900331714284,-0.0552689572781601,-0.0397888642749602,3.43892885294321e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,-0.0302492696350767,0.00251437344696083,-0.0351774415911199,-0.0253210976790335,3.61970803296102e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGR1,Prostaglandin reductase 1,39958,-0.101867627206695,0.00849615015528001,-0.118520081511044,-0.085215172902346,6.34471031834399e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,-0.0525751426072742,0.00439851164248402,-0.0611962254265429,-0.0439540597880055,9.84301392700594e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,-0.0524354122828309,0.00438898641991007,-0.0610378256658546,-0.0438329988998071,9.88864214399093e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPL14,60S ribosomal protein L14,39638,-0.0474345631878774,0.00396894892195569,-0.0552137030749105,-0.0396554233008442,1.0156879848466e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,-0.0619336834491731,0.00520296542679621,-0.0721314956856936,-0.0517358712126525,1.79469895253131e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,-0.0625939149142373,0.00527517875984702,-0.0729332652835374,-0.0522545645449371,2.57621330825044e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,-0.0329407844026721,0.00277816662105098,-0.0383859909799321,-0.0274955778254122,2.84505913112339e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP20,Centrosomal protein 20,41843,-0.0903622489796563,0.00762095970529579,-0.105299330002036,-0.0754251679572766,2.87986322361658e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCXR,L-xylulose reductase,42181,-0.0647465102095655,0.00548098944806147,-0.0754892495277659,-0.054003770891365,4.80293388434333e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.0342711574452418,0.00290241951633079,-0.0399598996972501,-0.0285824151932334,5.10168702520677e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPIND1,Heparin cofactor 2,39959,-0.0349262733542344,0.00295948496806385,-0.0407268638916396,-0.0291256828168293,5.89341868848047e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,-0.101725435718667,0.00862165632629737,-0.11862388211821,-0.0848269893191245,6.1548272413601e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,-0.0511702572774778,0.004343280098848,-0.0596830862712199,-0.0426574282837358,6.98249251068628e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,-0.0462646150076673,0.00393097535352968,-0.0539693267005855,-0.0385599033147491,8.09829792256447e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFC,Platelet-derived growth factor C,41843,-0.0333131996122193,0.00283162118262007,-0.0388631771301546,-0.0277632220942839,8.54084536462859e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLK1,Protein delta homolog 1,42310,-0.0687770230793746,0.00584717724541724,-0.0802374904803924,-0.0573165556783569,8.66459019199287e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,0.0397154851283028,0.00338456529441569,0.033081737151248,0.0463492331053575,1.20474910621705e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH17,Cadherin-17,42145,-0.0809656363795364,0.00690093489206414,-0.0944914687679821,-0.0674398039910906,1.23462734401784e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MATN2,Matrilin-2,42144,-0.0350981652034898,0.00299397653484991,-0.0409663592117956,-0.029229971195184,1.38189099760709e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,-0.063999065999171,0.00545661107884514,-0.0746940237137075,-0.0533041082846345,1.38236142868648e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUMB,Protein numb homolog,39657,-0.100022657708934,0.00853192525690102,-0.11674523121246,-0.0833000842054083,1.48735297699983e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WDR46,WD repeat-containing protein 46,39919,-0.0436432315871109,0.00372349226696436,-0.050941276430361,-0.0363451867438607,1.51264839046168e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,-0.101453163821586,0.00866915338235278,-0.118444704450997,-0.0844616231921745,1.75907228620481e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASSF2,Ras association domain-containing protein 2,41843,-0.0677121857843453,0.00578616314472009,-0.0790530655479967,-0.0563713060206939,1.76943062378434e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INHBB,Inhibin beta B chain,39736,-0.0620310819482632,0.00530550256777578,-0.0724298669811038,-0.0516322969154227,2.14021561050663e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TALDO1,Transaldolase,39948,-0.0523396398959413,0.00448549927421203,-0.0611312184733969,-0.0435480613184857,2.78114207084325e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,-0.0579544887014137,0.00497848676991228,-0.0677123227704418,-0.0481966546323857,3.8346635446738e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,-0.0644163600048852,0.00553434618533949,-0.0752636785281506,-0.0535690414816198,3.907174141197e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,-0.052523247040723,0.00451247031616333,-0.0613676888604031,-0.0436788052210429,3.93738935163628e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,-0.0569897820835221,0.00489818342716404,-0.0665902216007636,-0.0473893425662806,4.11634369703555e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2,Complement C2,42199,-0.026518802132902,0.00228508998684853,-0.0309975785071252,-0.0220400257586789,5.43077266736828e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIAE,Sialate O-acetylesterase,42147,-0.0544214632200559,0.00469463628580171,-0.0636229503402273,-0.0452199760998846,6.31159546267768e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FEN1,Flap endonuclease 1,41843,-0.0753678216881886,0.00652031735021311,-0.0881476436946063,-0.062587999681771,9.34628385193823e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,-0.0793752458131268,0.006870654099609,-0.0928417278483604,-0.0659087637778931,9.96736208310014e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.0489019056529576,0.00423882939909774,-0.0572100112751892,-0.040593800030726,1.19589108268143e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,-0.0328341722188261,0.00284968174127056,-0.0384195484317164,-0.0272487960059358,1.42071360938906e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTSS1,Protein MTSS 1,39930,-0.130643510982837,0.0113373398894332,-0.152864697166126,-0.108422324799548,1.48986552680833e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,-0.035451762772075,0.00307890824881545,-0.0414864229397533,-0.0294171026043967,1.55551812225254e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGFR,Opioid growth factor receptor,42070,-0.0373624994988609,0.00324877609443221,-0.043730100643948,-0.0309948983537738,1.8199345286055e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL1,Fc receptor-like protein 1,42145,-0.053294072984694,0.00463499338666284,-0.0623786600225531,-0.0442094859468348,1.86494282685542e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN8,Tetraspanin-8,39930,-0.11155281359543,0.00969791552367644,-0.130560728021835,-0.0925448991690238,1.88529766113445e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,-0.0276277906935152,0.00240749286898054,-0.0323464767167171,-0.0229091046703133,2.41391757283214e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOST,Sclerostin,42129,-0.0449143331159669,0.00391723630412282,-0.0525921162720477,-0.0372365499598862,2.70343808821818e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,-0.0534922589332182,0.00467195800448224,-0.0626492966220034,-0.044335221244433,3.25204885549206e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6AP2,Renin receptor,41843,-0.045648435786563,0.00398969883928207,-0.0534682455115559,-0.0378286260615701,3.59124571678724e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,-0.061028048603251,0.00533432915618376,-0.0714833337493711,-0.0505727634571308,3.63081187326518e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,-0.094288632276347,0.00824344018642748,-0.110445775041745,-0.0781314895109491,3.70322492629726e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,-0.0982521934419479,0.00859956276864482,-0.115107336468492,-0.081397050415404,4.32648761403424e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,-0.112928907864871,0.00988990289091861,-0.132313117531071,-0.0935446981986705,4.61716501111329e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,-0.105564521379298,0.00925041681640159,-0.123695338339445,-0.0874337044191507,4.99879773155301e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NADK,NAD kinase,42145,-0.0630904472018332,0.00553049304561575,-0.0739302135712401,-0.0522506808324263,5.24341946430602e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD248,Endosialin,39966,0.0468427273127495,0.00411000814857374,0.0387871113415449,0.054898343283954,6.27358091881231e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS22,Brain-specific serine protease 4,39657,-0.0400423915773861,0.00352137712163237,-0.0469442907357856,-0.0331404924189867,8.5126009420051e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,-0.0613957381285434,0.00540403388648553,-0.071987644546055,-0.0508038317110317,9.59524249525243e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN1,Dynactin subunit 1,42262,-0.0732590155978631,0.00646175098364772,-0.0859240475258127,-0.0605939836699136,1.16299361007204e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QDPR,Dihydropteridine reductase,42081,-0.0483212589692083,0.00426210921415025,-0.0566749930289427,-0.0399675249094738,1.16676990638197e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXLNA,Alpha-taxilin,42016,-0.100762266777759,0.00889151364865376,-0.11818963352912,-0.0833349000263976,1.2364626761343e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,-0.0682101538938335,0.00602005690546456,-0.080009465428544,-0.056410842359123,1.25575260729466e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,-0.0388255595866971,0.00343189643819746,-0.0455520766055642,-0.0320990425678301,1.62618502115629e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,-0.102803874604145,0.0090916961039267,-0.120623598967841,-0.0849841502404487,1.64023787836033e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH9,Protocadherin-9,39930,-0.0388625097147895,0.00344293002363695,-0.045610652561118,-0.0321143668684611,2.16758020187116e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,0.0593403329954733,0.00526286904013349,0.0490251096768116,0.0696555563141349,2.34935891814582e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,-0.0733144033318156,0.00650353901748142,-0.0860613398060792,-0.060567466857552,2.55500927873557e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,-0.0481105449934653,0.00427152989534736,-0.0564827435883461,-0.0397383463985845,2.68888028040578e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL4,C-C motif chemokine 4,42148,-0.0708372019916251,0.00629293332705794,-0.0831713513126587,-0.0585030526705916,2.89716772337767e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PI3,Elafin,41966,-0.06394050180015,0.00568276115264892,-0.0750787136593419,-0.0528022899409581,3.07582392640672e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COCH,Cochlin,39958,-0.0525008626086611,0.00466777773378271,-0.0616497069668752,-0.043352018250447,3.398222354236e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,-0.0725822472800212,0.00646301203976672,-0.085249750877964,-0.0599147436820784,3.9152632214984e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL19,Interleukin-19,41756,-0.0834081214785084,0.00743392838474845,-0.0979786211126154,-0.0688376218444015,4.41193180180587e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,-0.0753318016113819,0.00672207509988371,-0.088507068807154,-0.0621565344156098,5.11035244738341e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F7,Coagulation factor VII,42194,-0.0351322549374459,0.00313796378427899,-0.0412826639546327,-0.0289818459202591,5.71869496706977e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,-0.0336153963389788,0.00300262720622971,-0.039500545663189,-0.0277302470147686,5.77012786860419e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,-0.0563161271899123,0.00503247243911386,-0.0661797731705754,-0.0464524812092491,6.11690972735177e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,-0.0251049077532261,0.00224250833167209,-0.0295002240833034,-0.0207095914231489,6.15526499318939e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD63,CD63 antigen,41992,-0.0569810842601681,0.00509642299179968,-0.0669700733240955,-0.0469920951962407,6.81238425503518e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,-0.027604381626882,0.00247169585284944,-0.0324489054984669,-0.0227598577552971,7.80580352018395e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NSFL1C,NSFL1 cofactor p47,42249,-0.0709746632904217,0.0063563523831328,-0.083433113961362,-0.0585162126194814,7.97920439729961e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,-0.0562627027784566,0.00503974918634144,-0.0661406111836858,-0.0463847943732274,8.19232929586739e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,-0.0319134441631631,0.00285922017494257,-0.0375175157060506,-0.0263093726202757,8.37646256664452e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIT,Citron Rho-interacting kinase,39649,-0.0519306390710587,0.00465416457701212,-0.0610528016420024,-0.0428084765001149,9.33355272293848e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCF2,Neutrophil cytosol factor 2,42097,-0.0936560013173832,0.00840804030741222,-0.110135760319911,-0.0771762423148553,1.08230302991725e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPB6,Heat shock protein beta-6,42262,-0.045826821377673,0.00411570259284585,-0.0538935984596509,-0.0377600442956951,1.13057199366552e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,-0.081718557127398,0.00734821754997218,-0.0961210635253435,-0.0673160507294526,1.32423626937891e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRB1,Chymotrypsinogen B,42137,-0.065517910050207,0.00589812352678472,-0.0770782321627051,-0.053957587937709,1.51924164463673e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.0388134091949206,0.0034978900748776,-0.0456692737416807,-0.0319575446481605,1.73208012910256e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,-0.0771589642209732,0.00695618959311628,-0.0907930958234811,-0.0635248326184653,1.81264458616757e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRPK2,SRSF protein kinase 2,42119,-0.095547897390949,0.00861587257142621,-0.112435007630944,-0.0786607871509536,1.86602046851201e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGH,Gamma-glutamyl hydrolase,41933,-0.0381171336760644,0.00343723611466602,-0.0448541164608098,-0.031380150891319,1.87918094800815e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,-0.038610940062377,0.00348675522724614,-0.0454449803077795,-0.0317768998169746,2.23813686276977e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD14,Monocyte differentiation antigen CD14,41932,-0.0462146293753601,0.00417505395028607,-0.0543977351179208,-0.0380315236327994,2.35106737196802e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL32,Interleukin-32,42119,0.049754471817196,0.00449920132172738,0.0409360372266104,0.0585729064077817,2.63640073361154e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLF4,Krueppel-like factor 4,39586,-0.0457389159960865,0.00413565132406961,-0.053844792591263,-0.0376330394009101,2.77500626486315e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSN,Gelsolin,39943,0.0212058468541662,0.00192495372861834,0.0174329375460743,0.0249787561622582,4.42572187281483e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLSCR3,Phospholipid scramblase 3,39911,-0.0645406975437308,0.00586145701260584,-0.0760291532884382,-0.0530522417990233,4.6930919707993e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRG1,Scrapie-responsive protein 1,39958,-0.0305683107449423,0.00277885894796656,-0.0360148742829568,-0.0251217472069279,5.27226333540401e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,-0.0271214788363184,0.00246718969711261,-0.0319571706426591,-0.0222857870299776,5.43892115284543e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,-0.0550201178305146,0.00500536325234572,-0.0648306298051123,-0.045209605855917,5.50232379766035e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YES1,Tyrosine-protein kinase Yes,42070,-0.126877315209952,0.0115551720608792,-0.149525452449275,-0.104229177970629,6.25473775114351e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA1,Carboxypeptidase A1,42310,-0.0718123738846614,0.00654419120752887,-0.084638988651418,-0.0589857591179048,6.69837737592114e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,-0.035592855543908,0.00324542368250105,-0.0419538859616101,-0.029231825126206,7.65758555261438e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHB6,Ephrin type-B receptor 6,41997,-0.0362264646906875,0.00331064284860476,-0.0427153246739528,-0.0297376047074222,9.46690567351444e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSNL1,Visinin-like protein 1,39929,-0.0430301048431607,0.00394026636453678,-0.0507530269176528,-0.0353071827686686,1.26135585040609e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREML2,Trem-like transcript 2 protein,42137,-0.0379838919247132,0.00348115181157924,-0.0448069494754086,-0.0311608343740179,1.32624455908595e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,-0.0559940864856496,0.00513283452897656,-0.0660544421624436,-0.0459337308088555,1.43130716974414e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL18,C-C motif chemokine 18,42020,-0.0774295877568533,0.00710102121844056,-0.0913475893449968,-0.0635115861687098,1.43928081727466e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,-0.0358926464526297,0.00329209510836187,-0.042345152865019,-0.0294401400402405,1.45216475249988e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,-0.0569948472774736,0.00523427883890678,-0.0672540338017309,-0.0467356607532163,1.78354594758364e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFX1,Transcriptional repressor NF-X1,39575,-0.0747471435606689,0.00687202143021178,-0.088216305563884,-0.0612779815574538,2.04654635450073e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,-0.0364660508344928,0.00335516639670799,-0.0430421769720405,-0.0298899246969452,2.10736899377816e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,-0.0623656602589375,0.00574402591097822,-0.0736239510444548,-0.0511073694734201,2.39549501188941e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY6D,Lymphocyte antigen 6D,42041,-0.0436853136282439,0.00402696719306898,-0.0515781693266591,-0.0357924579298286,2.63923935207365e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3D,Protein FAM3D,39930,-0.0965005387009941,0.0089014065583422,-0.113947295555345,-0.0790537818466434,2.99232226695997e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS7_LGALS7B,Galectin-7,42076,-0.0482283369970505,0.00445103348331064,-0.0569523626243393,-0.0395043113697616,3.03257037279583e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STC2,Stanniocalcin-2,42113,-0.0262763258696397,0.00242581333266082,-0.0310309200016549,-0.0215217317376245,3.14229580782155e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMN,Protein amnionless,41913,-0.0517539845938982,0.00478570146128035,-0.0611339594580076,-0.0423740097297887,3.81895964332166e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HYAL1,Hyaluronidase-1,42077,-0.0252263916438575,0.00233277466508036,-0.029798629987415,-0.0206541533003,3.82325226212731e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL19,C-C motif chemokine 19,42249,-0.123474530753305,0.0114223465655564,-0.145862330021795,-0.101086731484814,3.97898167941973e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEFL,Neurofilament light polypeptide,41797,-0.0518066100825455,0.00479429308831329,-0.0612034245356396,-0.0424097956294515,4.19144730299081e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0385458226645915,0.00356965111104559,-0.0455423388422408,-0.0315493064869421,4.5173669450736e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,-0.055125332670286,0.0051064887502827,-0.0651340506208401,-0.045116614719732,4.91132434407936e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD6,T-cell differentiation antigen CD6,42284,-0.0567536364420662,0.00527333653426073,-0.0670893760492172,-0.0464178968349152,6.63956703433108e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,-0.0400805707110288,0.00372644042845052,-0.0473843939507918,-0.0327767474712658,7.16007409189577e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA3G,Semaphorin-3G,39736,-0.049787683693349,0.00462881281061332,-0.0588601568021511,-0.0407152105845469,7.51927015895422e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL6,Fc receptor-like protein 6,42119,-0.0746828345145589,0.00694884261443346,-0.0883025660388485,-0.0610631029902693,7.81323974729609e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HJV,Hemojuvelin,39934,-0.0459738012169567,0.00428745337120674,-0.054377209824522,-0.0375703926093915,1.06741907280359e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,-0.0408717142633738,0.00381329764396228,-0.0483457776455399,-0.0333976508812078,1.07455467978474e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGRN,Neugrin,39929,-0.0243865126858455,0.00227908205028908,-0.0288535135044121,-0.019919511867279,1.3612266924549e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0390445893256974,0.00364969150368961,-0.0461979846729291,-0.0318911939784658,1.39199895686276e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,-0.061583359128047,0.00576001666401632,-0.072872991789519,-0.0502937264665751,1.4929118166594e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R9B,Neurabin-2,42296,-0.102485482604464,0.00959300861219493,-0.121287779484366,-0.0836831857245618,1.54922963488912e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,-0.0601325189930965,0.0056334351110828,-0.0711740518108187,-0.0490909861753742,1.7127714540986e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTA,Lymphotoxin-alpha,42119,-0.0432009688891081,0.00405378069860612,-0.051146379058376,-0.0352555587198401,2.05973366475794e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0644139436372883,0.00604599205580541,-0.0762640880666669,-0.0525637992079097,2.13380532868372e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FETUB,Fetuin-B,42199,-0.0346739841893304,0.00325519962427795,-0.0410541754529152,-0.0282937929257456,2.17128206007756e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,-0.0593736871628363,0.00558087637537073,-0.0703122048585629,-0.0484351694671096,2.51250450849992e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WNT9A,Protein Wnt-9a,41913,-0.0313877307525952,0.00295327690905365,-0.0371761534943403,-0.02559930801085,2.81068843807631e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPON2,Spondin-2,42070,-0.0375306689233554,0.00353173712967787,-0.0444528736975241,-0.0306084641491868,2.84527293403633e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,-0.0656776204609786,0.00618230432044591,-0.0777949369290525,-0.0535603039929046,2.95581784350629e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NBN,Nibrin,41913,-0.0584162302609983,0.00550711151413098,-0.069210168828695,-0.0476222916933016,3.50124129628396e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,-0.0740611633961824,0.00698559749140718,-0.0877529344793405,-0.0603693923130244,3.89601775325457e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,-0.085751473558295,0.00809073280573075,-0.101609309857527,-0.0698936372590628,4.00384048344261e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP8,Neutrophil collagenase,42224,-0.0766917625956511,0.00724490187636746,-0.0908917702733313,-0.0624917549179708,4.38755066033365e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK11,Kallikrein-11,42062,-0.0345628619874063,0.00326520338877697,-0.0409626606294091,-0.0281630633454034,4.41888174579464e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGMB,RGM domain family member B,42249,-0.0299872897407458,0.00283676131581186,-0.0355473419197371,-0.0244272375617545,5.1217359293294e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLIT2,Slit homolog 2 protein,41839,-0.0552314908724563,0.00522828621726108,-0.065478931858288,-0.0449840498866246,5.55361963991651e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,-0.0438396834970601,0.00415156978580763,-0.051976760277243,-0.0357026067168771,5.7793174628192e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POF1B,Protein POF1B,39657,-0.0488001992588862,0.00462355432554202,-0.0578623657369485,-0.0397380327808238,6.41736462429619e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,-0.0671836133460327,0.00636764878927206,-0.0796642049730059,-0.0547030217190594,6.63843348899341e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,-0.104074702685868,0.0098961085993534,-0.1234710755406,-0.0846783298311349,9.1036473014497e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,-0.0389048185683691,0.00370055745661382,-0.0461579111833322,-0.031651725953406,9.45366269430757e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL8,Interleukin-8,42035,-0.0721074461902367,0.00686900404487675,-0.0855706941181952,-0.0586441982622783,1.1148926818319e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0275454354583729,0.00263209475823884,0.0223865297322248,0.0327043411845211,1.56303679118187e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLVRB,Flavin reductase,42137,-0.0672561268601981,0.00643741084529849,-0.0798734521169832,-0.0546388016034131,1.87602455349737e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSAP,Prosaposin,39886,-0.0303061592366867,0.00289963077768444,-0.0359894355609483,-0.0246228829124252,1.87989582590046e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,0.0420285783243308,0.00402334087402008,0.0341428302112514,0.0499143264374101,1.90587315766175e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NIT2,Omega-amidase NIT2,39903,-0.0775993326217714,0.0074292524593424,-0.0921606674420825,-0.0630379978014603,2.0137159803884e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEK,Angiopoietin-1 receptor,42181,-0.0233733935616885,0.00223976692345955,-0.0277633367316692,-0.0189834503917078,2.12655869259368e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCN1,Ficolin-1,39978,-0.0591906960262748,0.00567156729817027,-0.0703069679306886,-0.0480744241218611,2.20158461958905e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADA,Adenosine deaminase,42296,-0.0374750060621933,0.00359544110292403,-0.0445220706239244,-0.0304279415004622,2.42393812517408e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,-0.0519042261233125,0.00498308535246092,-0.0616710734141359,-0.0421373788324891,2.74238446152007e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,-0.0892094369166147,0.00857460175064154,-0.106015656347872,-0.0724032174853573,2.9612478769077e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMB1,Laminin subunit beta-1,39638,-0.0332467054937044,0.00319442874325579,-0.0395077858304858,-0.0269856251569231,2.99179766206864e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAT,Linker for activation of T-cells family member 1,42296,-0.0796977908949283,0.00767400883343689,-0.0947388482084646,-0.064656733581392,3.58247485666775e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,-0.0641177589694969,0.00617704560786216,-0.0762247683609067,-0.0520107495780871,3.80049644566239e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,-0.0386321530560111,0.00374086024278888,-0.0459642391318773,-0.0313000669801449,6.57196613614116e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH15,Cadherin-15,42230,-0.0722504947858691,0.00699680852833496,-0.0859642395014056,-0.0585367500703326,6.6263354598415e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,-0.0823668127301631,0.00797592254867556,-0.0979996209255673,-0.066734004534759,6.86661800238235e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRR3,Small proline-rich protein 3,39929,-0.0661399900047767,0.00640506062933646,-0.0786939088382762,-0.0535860711712772,6.91505652031613e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB1A1,Uteroglobin,42165,-0.0559618277590678,0.00542492642219069,-0.0665946835465616,-0.0453289719715741,7.39507427649916e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRELP,Prolargin,42123,-0.0243960989390473,0.00236866872745767,-0.0290386896448643,-0.0197535082332303,8.74548014045983e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPT,Dermatopontin,42310,-0.0264535392618046,0.0025698672771184,-0.0314904791249567,-0.0214165993986525,9.25421920275166e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEFTY2,Left-right determination factor 2,42247,-0.0536977050626599,0.00521658668321469,-0.0639222149617607,-0.0434731951635591,9.27163479015908e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLIN3,Perilipin-3,42145,-0.0446494028111271,0.00433815960255528,-0.0531521956321354,-0.0361466099901187,9.42132777247625e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PVR,Poliovirus receptor,42249,-0.0389361091172728,0.00378401561719674,-0.0463527797269784,-0.0315194385075672,9.66364010039266e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,-0.0289937020248905,0.00281818198412154,-0.0345173387137687,-0.0234700653360123,9.83774280589523e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPR,Nucleoprotein TPR,39575,-0.0510218684780219,0.00496959772972994,-0.0607622800282926,-0.0412814569277513,1.28493351830353e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,-0.0740699498800274,0.00723415917854511,-0.0882489018699758,-0.0598909978900789,1.69702240320681e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL2,Fc receptor-like protein 2,42229,-0.0518369371638715,0.00506867683990326,-0.0617715437700819,-0.0419023305576611,1.8411891239561e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,-0.0586623502806696,0.00573920605567297,-0.0699111941497886,-0.0474135064115506,1.96101360024996e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,-0.0316324864803245,0.00309639751910485,-0.03770142561777,-0.0255635473428789,2.06074814164498e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNMBP,Dynamin-binding protein,42016,-0.0626074054391077,0.00613069744959265,-0.0746235724403093,-0.0505912384379061,2.14922223408449e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,-0.0687139033652151,0.00673570422867047,-0.0819158836534092,-0.0555119230770209,2.49902588137472e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,-0.0787378907211861,0.00773010922897824,-0.0938889048099835,-0.0635868766323888,2.8054425156311e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMSB10,Thymosin beta-10,42137,-0.0781506738408486,0.00767913499366862,-0.0932017784284391,-0.0630995692532581,3.07026194659264e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGL1,Fibrinogen-like protein 1,39990,-0.0671109919075163,0.00659468379157826,-0.0800365721390097,-0.0541854116760229,3.20385013389649e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPG,Macrophage-capping protein,42015,-0.0606477187631001,0.00596295518213896,-0.0723351109200925,-0.0489603266061078,3.27870046811273e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.0306966395025524,0.00301878572171038,-0.0366134595171047,-0.024779819488,3.47960877301354e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GM2A,Ganglioside GM2 activator,39733,-0.0397680901925922,0.00391349413605387,-0.0474385386992577,-0.0320976416859266,3.74259684271675e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5E,5'-nucleotidase,42181,-0.0552262228466312,0.00544196742021565,-0.0658924789902539,-0.0445599667030085,4.11407092497799e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA2,Carbonic anhydrase 2,42103,-0.0679720553387169,0.00670085669940877,-0.0811057344695581,-0.0548383762078757,4.30817185063409e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,-0.055141076367122,0.00543605534661206,-0.0657957448464816,-0.0444864078877623,4.31917285910378e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTSS2,Protein MTSS 2,39919,-0.103832090468241,0.0102338420803282,-0.123890420945684,-0.0837737599907978,4.37821055017757e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,-0.0165624354980939,0.00163322031385921,-0.0197635473132579,-0.0133613236829298,4.42009274200634e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,-0.0336507998381863,0.00332146786358863,-0.04016087685082,-0.0271407228255526,4.89285991445538e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GET3,ATPase GET3,39958,-0.0555918289240528,0.00550050730803,-0.0663728232477916,-0.044810834600314,6.51309397071804e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0208322177251727,0.00206312766053904,-0.0248759479398292,-0.0167884875105161,6.88785199983246e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CILP,Cartilage intermediate layer protein 1,39966,-0.0566549569817879,0.00561524395266968,-0.0676608351290204,-0.0456490788345553,7.74666640198322e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,-0.0518018076095725,0.00514163499666915,-0.0618794122030441,-0.041724203016101,8.63274959508896e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,-0.100066894002141,0.00993209467396974,-0.119533799563122,-0.0805999884411602,8.63664182330586e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,-0.0535086702675222,0.0053136657117511,-0.0639234550625543,-0.04309388547249,9.10577098889115e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA1,Carbonic anhydrase 1,41890,-0.0574224286149222,0.00570622535977854,-0.0686066303200881,-0.0462382269097562,9.77914724454998e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,-0.0864369070461258,0.0085973716616607,-0.103287755502981,-0.0695860585892708,1.07062837328074e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGMN,Legumain,42185,-0.036962126853003,0.00367662412661465,-0.0441683101411677,-0.0297559435648382,1.07534559117177e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA9,Carbonic anhydrase 9,42262,-0.0474665797588615,0.00472843381252756,-0.0567343100314155,-0.0381988494863075,1.24602917220962e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,-0.0250858869402157,0.00249951101311796,-0.0299849285259269,-0.0201868453545045,1.2736288128819e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,-0.0622824020295495,0.00620574754670577,-0.0744456672210928,-0.0501191368380062,1.28281774174697e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.0219764553723104,0.00218902336162755,-0.0262669411611004,-0.0176859695835204,1.28407958739125e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MET,Hepatocyte growth factor receptor,42158,0.0195179191415429,0.00194527371410306,0.0157051826619009,0.0233306556211849,1.31263439885594e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,-0.067637597770914,0.00674310718764816,-0.0808540878587044,-0.0544211076831236,1.35727629456535e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMPD3,AMP deaminase 3,39929,-0.0702324220059998,0.00700559085414865,-0.0839633800801311,-0.0565014639318684,1.48077188047247e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,-0.0525741496325704,0.00525556901672797,-0.0628750649053573,-0.0422732343597836,1.78045811667138e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR5,Cadherin-related family member 5,42145,-0.0391842770335434,0.00392027692635104,-0.0468680198091914,-0.0315005342578953,1.92691436510788e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,-0.0654665343310086,0.00655567531102004,-0.0783156579406079,-0.0526174107214093,2.10663649950529e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,-0.0659538719798517,0.00660939594774781,-0.0789082880374374,-0.052999455922266,2.28212357700489e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,-0.0782422395958943,0.00784479810546645,-0.0936180438826086,-0.0628664353091801,2.47614117374676e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPL,Periplakin,39657,-0.032779415225275,0.00328711306732423,-0.0392221568372305,-0.0263366736133195,2.53298428486881e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAT,Catalase,39827,-0.0530255466453896,0.00531968120731199,-0.0634521218117211,-0.0425989714790581,2.63486206491178e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG2,Desmoglein-2,42137,0.0272275836943488,0.00273375103713094,0.0218694316615722,0.0325857357271255,2.74848297961282e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,-0.0531348208532612,0.00533285718582174,-0.0635872209374718,-0.0426824207690506,2.75084420727467e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN3,Ataxin-3,39929,-0.0618643559177661,0.00621118561571982,-0.0740382797245769,-0.0496904321109552,2.83820600469329e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN3,Calsyntenin-3,39929,-0.0306022250738679,0.00307683770842383,-0.0366328269823786,-0.0245716231653572,3.26808182951909e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH9,Myosin-9,39966,-0.114421318281321,0.011550564085921,-0.137060423889726,-0.0917822126729157,4.85399470379117e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK1,Dickkopf-related protein 1,42249,-0.0590290269069779,0.00596536695377633,-0.0707211461363795,-0.0473369076775763,5.21536499475663e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,-0.047429854813585,0.00479382544065306,-0.056825752677265,-0.038033956949905,5.31180062329277e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,-0.0240620077871775,0.00243253484498422,-0.0288297760833466,-0.0192942394910085,5.41134021934049e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,-0.0429123465465989,0.00433944691875153,-0.0514176625073519,-0.0344070305858459,5.56617855599458e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,-0.0617084372959414,0.00625556792501587,-0.0739693504289725,-0.0494475241629103,7.10274280215549e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POSTN,Periostin,39966,0.0379394961228823,0.00384698549833045,0.0303994045461546,0.04547958769961,7.50221958169904e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.110390172586669,0.0112047026868108,-0.132351389852818,-0.0884289553205196,8.00709872927165e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,0.0447476580444507,0.00454148350262716,0.0358463503793014,0.0536489657095999,8.20772379997299e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,-0.0360657416400287,0.00366291806044398,-0.0432450610384989,-0.0288864222415585,8.84748464939912e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP43,Centrosomal protein 43,41797,-0.0701445527931771,0.00713543127429708,-0.0841299980907994,-0.0561591074955548,9.96248074673303e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.034568421547589,0.00351885742238377,-0.0414653820954611,-0.0276714609997168,1.06253493435175e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,0.0654591310891795,0.00666390804253092,0.0523978713258189,0.0785203908525401,1.06777454697595e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,-0.0727192382138652,0.00743559291231256,-0.0872930003219978,-0.0581454761057326,1.63712550575578e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.033692557457585,0.00344502788504348,-0.0404448121122702,-0.0269403028028998,1.69176588653813e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,-0.0546814302804021,0.005599098424522,-0.0656556631924652,-0.043707197368339,1.86299852052501e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,-0.0629994831563823,0.00645507520399842,-0.0756514305562193,-0.0503475357565454,1.98883691564422e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A4,Protein S100-A4,42181,-0.0552731485277143,0.00567035866405075,-0.0663870515092537,-0.0441592455461748,2.23338820777662e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNLY,Granulysin,42137,-0.0531555696197032,0.00545422319544942,-0.063845847082784,-0.0424652921566223,2.27808591801355e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,-0.0700478544602723,0.00718798125274518,-0.0841362977156528,-0.0559594112048917,2.29861444475588e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,-0.0532451470942755,0.00546703514716027,-0.0639605359827096,-0.0425297582058413,2.42685366866471e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C7,Complement component C7,39722,-0.0329141617772198,0.00338629241523028,-0.0395512949110712,-0.0262770286433685,3.04294484613454e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.0326418550306987,0.0033592530010548,-0.0392259909127661,-0.0260577191486313,3.12699622815521e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPACT,Protein IMPACT,39929,-0.0535767157031378,0.00551690532750267,-0.064389850145043,-0.0427635812612325,3.29169133368915e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINH1,Serpin H1,39757,-0.127707595778556,0.0131511137048313,-0.153483778640025,-0.101931412917087,3.32075478419612e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,-0.103190518414677,0.0106323342232037,-0.124029893492157,-0.0823511433371982,3.38446825395498e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RILP,Rab-interacting lysosomal protein,42224,-0.057593038964053,0.00593791417208499,-0.0692313507413396,-0.0459547271867665,3.58399258583309e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPE,Carboxypeptidase E,42134,0.0383876327717887,0.00395840058137225,0.0306291676322991,0.0461460979112783,3.63855090394789e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,-0.0679070489458107,0.00701637565237259,-0.081659145224461,-0.0541549526671604,4.39710524221948e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,-0.0441033814175333,0.00455818542188583,-0.0530374248444295,-0.035169337990637,4.51484635205946e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,-0.0785281018891719,0.00813790958348256,-0.0944784046727977,-0.062577799105546,5.8051522146996e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,-0.0345560521312547,0.0035842899329392,-0.0415812603998156,-0.0275308438626939,6.31753527468952e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFRC,Transferrin receptor protein 1,42200,-0.0365303851500695,0.00379663102442712,-0.0439717819579467,-0.0290889883421924,7.59373759651796e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,-0.0278043429223204,0.00289130249227807,-0.0334712958071854,-0.0221373900374553,8.24172057326132e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK10,Kallikrein-10,42138,-0.0397929717542574,0.00414019661374526,-0.0479077571171981,-0.0316781863913167,8.40314559066045e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DRAXIN,Draxin,42016,-0.0413467625559539,0.0043021574150072,-0.049778991089368,-0.0329145340225398,8.46976546842511e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP2B1,AP-2 complex subunit beta,39649,-0.0475823529354438,0.00495048088056279,-0.0572852954613469,-0.0378794104095407,8.68599607876048e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD164,Sialomucin core protein 24,42137,-0.026209611066451,0.00273059474648835,-0.0315615767695682,-0.0208576453633339,9.51370112977309e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIMAP8,GTPase IMAP family member 8,39560,-0.049054914850704,0.00511370876890377,-0.0590777840377553,-0.0390320456636526,1.04288359131572e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,-0.0367038491670822,0.00382768121462369,-0.0442061043477447,-0.0292015939864198,1.08107506449595e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,-0.0459139002444085,0.0047927497601867,-0.0553076897743745,-0.0365201107144426,1.17371979382327e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP1,Interstitial collagenase,41693,-0.0875348042167391,0.00914044316757187,-0.10545007282518,-0.0696195356082983,1.18032033970625e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA2,Apolipoprotein A-II,39990,0.0481514785976933,0.00502832763831082,0.0382959564266041,0.0580070007687825,1.21639179361018e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,-0.123798034852053,0.0129352172169845,-0.149151060597342,-0.098445009106763,1.243388117423e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHMP6,Charged multivesicular body protein 6,39958,-0.0558003661996465,0.00583359843114763,-0.0672342191246959,-0.0443665132745972,1.34862808879969e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNGR1,Interferon gamma receptor 1,42185,-0.0209487475692859,0.0021910137772964,-0.0252431345727869,-0.016654360565785,1.36094425016534e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAC1,Cartilage acidic protein 1,42310,0.0299372374999914,0.00313562972343734,0.0237914032420542,0.0360830717579285,1.55095582907909e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,-0.0705756870574295,0.00739954670756089,-0.0850787986042488,-0.0560725755106102,1.70843198798073e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.0294974874528722,0.00309283849718764,-0.03555945090736,-0.0234355239983844,1.76404707528251e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MILR1,Allergin-1,41913,-0.0494176702075343,0.00518735048931679,-0.0595848771665951,-0.0392504632484734,1.90263734604504e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNPEP,Aspartyl aminopeptidase,39929,-0.0551754638053138,0.00579104898319692,-0.0665259198123797,-0.0438250077982478,1.93428439207381e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNN,Tenascin-N,39966,-0.041821593166037,0.00439546627662748,-0.0504367070682269,-0.0332064792638472,2.18867132979673e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,-0.0913519516902717,0.00960921395796228,-0.110186011047878,-0.0725178923326656,2.29333948648205e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLRX,Glutaredoxin-1,42057,-0.053437661504642,0.005629684563595,-0.0644718432492882,-0.0424034797599958,2.63922914669799e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,-0.0865927186018734,0.00913416469396585,-0.104495681402046,-0.0686897558017003,3.04539384917237e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,-0.0512028276123658,0.00541265942801602,-0.0618116400912772,-0.0405940151334544,3.59749973294912e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,-0.0742078985353108,0.00785223928007789,-0.0895982875242635,-0.0588175095463582,4.03162960624211e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17C,Interleukin-17C,41913,-0.067896107913686,0.00718974044207194,-0.081987999180147,-0.053804216647225,4.19831614821183e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,-0.0638093535205091,0.00676347236118743,-0.0770657593484365,-0.0505529476925818,4.69283455167306e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,-0.0212042041233442,0.00224981281191092,-0.0256138372346896,-0.0167945710119988,4.99537566388113e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,-0.0909215793997757,0.00965368745407141,-0.109842806809756,-0.0720003519897957,5.32806089891005e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,-0.0602597551806298,0.00639703925461217,-0.0727979521196697,-0.04772155824159,5.39053641585809e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,-0.0223399824045987,0.00237431329003842,-0.026993636453074,-0.0176863283561233,5.80666862624081e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,-0.0227982338170272,0.00242707852606453,-0.0275553077281137,-0.0180411599059407,6.73273435994353e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBIN,Erbin,42070,-0.097456537512635,0.0103857361978268,-0.117812580460375,-0.0771004945648946,7.37549889011219e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,-0.0509688256278218,0.00543706982899484,-0.0616254824926517,-0.0403121687629919,8.05638778746089e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBD,Thrombomodulin,42145,-0.0280647601138695,0.00299521367184942,-0.0339353789106944,-0.0221941413170447,8.39432341763834e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD276,CD276 antigen,42123,-0.0339940770970357,0.00363666654129471,-0.0411219435179733,-0.0268662106760981,1.035265159729e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP6,Gastrotropin,41881,-0.0538210984491725,0.00576475811589674,-0.0651200243563301,-0.0425221725420149,1.15478878030733e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPPK1,Epiplakin,39638,-0.070389666334947,0.00754447851387469,-0.0851768442221413,-0.0556024884477526,1.26121852216245e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA10,Annexin A10,41839,-0.0772645333511545,0.00828535022968613,-0.0935038198013393,-0.0610252469009696,1.27827514214794e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,0.105318864255925,0.0112934233886506,0.0831837544141696,0.12745397409768,1.32035342325376e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKD1,Polycystin-1,39958,-0.025816143509056,0.00276937883265743,-0.0312441260210646,-0.0203881609970475,1.35213126922513e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP7,Retinoid-binding protein 7,39930,-0.0592575668639847,0.00636092353343865,-0.0717249769895244,-0.0467901567384449,1.43241601790212e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH7,Protocadherin-7,39930,-0.0330771777494896,0.00355458453376228,-0.0400441634356637,-0.0261101920633155,1.57826980278891e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FYB1,FYN-binding protein 1,42115,-0.0869667729590062,0.00935170595542351,-0.105296116631636,-0.0686374292863761,1.62368736308639e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALB2,Calretinin,41839,-0.0276981332465366,0.00298039739986979,-0.0335397121502813,-0.0218565543427918,1.72434566256422e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,-0.0680096538229833,0.00731836940096715,-0.082353657848879,-0.0536656497970877,1.72990629994906e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROK1,Prokineticin-1,42119,-0.0467748222491474,0.00503918785302289,-0.0566516304410723,-0.0368980140572225,1.90909219416399e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASAH2,Neutral ceramidase,42016,-0.0499464502543626,0.00538177750188627,-0.0604947341580597,-0.0393981663506655,1.9390338437188e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX15,Sorting nexin-15,39736,-0.0510039202983809,0.00549460083883155,-0.0617733379424907,-0.040234502654271,1.96060867035631e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAL,Integrin alpha-L,39657,-0.0413336339655127,0.00445368183127606,-0.0500628503548138,-0.0326044175762116,1.99568085111612e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAG1,Dystroglycan,42185,-0.0445995067515789,0.00480747744680686,-0.0540221625473204,-0.0351768509558375,2.00077800416218e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATG4A,Cysteine protease ATG4A,41843,-0.0547737279983195,0.00590972986076916,-0.0663567985254271,-0.043190657471212,2.17777249195747e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,-0.0512209609624562,0.00553112456055864,-0.0620619651011511,-0.0403799568237612,2.40859604760043e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,-0.0351842072202359,0.00380684778990588,-0.0426456288884514,-0.0277227855520204,2.85253576459816e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARF6,ADP-ribosylation factor 6,39930,-0.102298439672633,0.0110739011393513,-0.124003285905762,-0.0805935934395048,2.96356750363934e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA3,Carbonic anhydrase 3,42287,-0.0549171275445918,0.00595353980509399,-0.066586065562576,-0.0432481895266075,3.26655626001096e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRLB,Fc receptor-like B,41843,-0.0577641978857499,0.00626197706857033,-0.0700376729401478,-0.0454907228313521,3.27178838293368e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,-0.0655556262758883,0.00711583878623523,-0.0795026702969093,-0.0516085822548672,3.64331747691928e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,-0.0723925275793049,0.00786206992983144,-0.0878021846417745,-0.0569828705168353,3.81290158819854e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SARG,Specifically androgen-regulated gene protein,39915,-0.102938186243665,0.0112030265029311,-0.12489611818941,-0.0809802542979198,4.67986095224956e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL4,Myosin light chain 4,39638,-0.0482160429474359,0.0052507706612747,-0.0585075534435343,-0.0379245324513375,4.95524933342243e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0376199066103632,0.00410435262650863,0.0295753754624063,0.0456644377583201,5.62663726620807e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,-0.0272699871782044,0.0029809055984778,-0.0331125621512209,-0.0214274122051879,6.60464464478367e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.0543466481018878,0.00594232940805839,-0.0659936137416823,-0.0426996824620934,6.7678587841367e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,-0.0650403276774761,0.00710962119555461,-0.0789751852207631,-0.051105470134189,6.77543408072088e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCR,Breakpoint cluster region protein,42119,-0.0855876840024299,0.00935940733566542,-0.103932122380334,-0.0672432456245257,6.83099556967505e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST13,Hsc70-interacting protein,39736,-0.0506415532625587,0.00553660607764896,-0.0614933011747506,-0.0397898053503667,6.89031015902432e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA12,Carbonic anhydrase 12,42070,-0.0303299148727403,0.00331924436867788,-0.036835633835349,-0.0238241959101317,7.28613660964438e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHPS,Deoxyhypusine synthase,39919,-0.0375166894430317,0.00410619419479514,-0.0455648300648302,-0.0294685488212333,7.53821448715838e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.0416798014770684,0.00456355479576277,-0.0506243688767634,-0.0327352340773733,7.79618522358959e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BACH1,Transcription regulator protein BACH1,42119,-0.0692694690140468,0.0076016863430736,-0.0841687742464711,-0.0543701637816226,9.17840122098244e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,-0.0198000407683338,0.00217368756510694,-0.0240604683959434,-0.0155396131407242,9.47485372048732e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,-0.0338180411318573,0.00371192131609491,-0.0410934069114033,-0.0265426753523113,9.56064404263387e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,-0.0365804179882555,0.00402791467844483,-0.0444751307580073,-0.0286857052185036,1.21281039586971e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,-0.0712918201737104,0.0078552435485536,-0.0866880975288754,-0.0558955428185453,1.28713066617533e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNL1,Interferon lambda-1,41839,-0.041785284604368,0.00460790934297194,-0.0508167869165931,-0.032753782292143,1.37874715893642e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,-0.0554803085769882,0.00611682287463872,-0.0674692814112801,-0.0434913357426964,1.38426359283337e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XG,Glycoprotein Xg,42261,-0.0317869569048221,0.0035062285213178,-0.0386591648066049,-0.0249147490030392,1.40248528298041e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTBS,Di-N-acetylchitobiase,39860,-0.0254282587314532,0.00280407157411278,-0.0309242390167142,-0.0199322784461921,1.40834837775103e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,-0.0546906597760935,0.00603538168444511,-0.066520007877606,-0.0428613116745811,1.46175221006404e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,-0.062003474810352,0.00685037354093006,-0.075430206950575,-0.0485767426701291,1.60587938944502e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL16,C-X-C motif chemokine 16,42295,-0.0213632068704659,0.002361918144063,-0.0259925664328293,-0.0167338473081024,1.6975925929418e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.0264186953918753,0.00292091964266442,-0.0321436978914976,-0.0206936928922531,1.70515892984922e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,-0.0540714517875625,0.00598057900876461,-0.0657933866447412,-0.0423495169303839,1.76315622495321e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,-0.0454213389002812,0.00503703961727571,-0.0552939365501416,-0.0355487412504208,2.17981088552192e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,-0.0517213600072298,0.00575591367456705,-0.0630029508093812,-0.0404397692050783,2.91293489196953e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,-0.0407873075418021,0.0045450000873532,-0.0496955077130144,-0.0318791073705898,3.23687465909642e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,-0.071900127883854,0.00801267402412574,-0.0876049689711404,-0.0561952867965675,3.26060277046946e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GH1,Somatotropin,42129,0.161080292803469,0.0180013917587841,0.125797564956252,0.196363020650686,4.07728491946361e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,-0.0681670710610397,0.00761763191210026,-0.0830976296087562,-0.0532365125133232,4.17888941905318e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMPR,GMP reductase 1,42296,-0.0431083552742414,0.00482567989540674,-0.0525666878692386,-0.0336500226792442,4.66367332866647e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,-0.03199001892909,0.00358329209596052,-0.0390132714371726,-0.0249667664210074,5.02571885648609e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0576558003398437,0.00646412983982403,-0.0703254948258988,-0.0449861058537886,5.28752951219767e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2,Microtubule-associated protein 2,39929,-0.0425378975245867,0.00476876699913801,-0.0518846808428972,-0.0331911142062762,5.37217913671064e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFPI,Tissue factor pathway inhibitor,42152,0.0281478876075442,0.0031581979602916,0.0219578196053727,0.0343379556097157,5.6119671371679e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,-0.0390681240092898,0.00439147266635895,-0.0476754104353533,-0.0304608375832262,6.49395121641855e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASAH1,Acid ceramidase,39876,-0.0428461475468907,0.00481530894760186,-0.0522841530841903,-0.033408142009591,6.55829206223107e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,-0.0354305146376078,0.00399008786941573,-0.0432510868616627,-0.027609942413553,7.54709140026509e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,-0.0385520568882559,0.0043517759869773,-0.0470815378227314,-0.0300225759537804,9.07571543046408e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,-0.0352319014393491,0.0039811503953502,-0.0430349562142355,-0.0274288466644627,9.85315646092125e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARF2,Scavenger receptor class F member 2,42249,-0.0254809742798714,0.00288140269663648,-0.0311285235652789,-0.0198334249944639,1.04242489392018e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,-0.0649134838552404,0.00735935908246864,-0.079337827656879,-0.0504891400536019,1.30573330631687e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AOC3,Membrane primary amine oxidase,42217,-0.0265071877960185,0.00300635975355342,-0.0323996529129832,-0.0206147226790538,1.31635568892264e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,-0.0989292180439406,0.0112260364914877,-0.120932249567256,-0.0769261865206247,1.40261858071372e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,-0.0500510985362076,0.00568309367306989,-0.0611899621354246,-0.0389122349369906,1.44118320765131e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,-0.0749032487074535,0.00850717805924719,-0.091577317703578,-0.058229179711329,1.50210742180498e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,-0.0231492003930315,0.00263771027285806,-0.0283191125278333,-0.0179792882582297,1.89184105116263e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOL1,Apolipoprotein L1,39990,0.0477403441274863,0.00544003627462792,0.0370778730292156,0.058402815225757,1.93925216228619e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,-0.0304672490630914,0.00347449287170603,-0.0372772550916352,-0.0236572430345476,2.01891292094835e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,0.030588957405806,0.00348945539742628,0.0237496248268505,0.0374282899847615,2.06659762520287e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBP1,Z-DNA-binding protein 1,39657,-0.0369271543419808,0.00421381990410135,-0.0451862413540194,-0.0286680673299421,2.17192058736929e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.105213820377376,0.0120168742134949,-0.128766893835826,-0.081660746918926,2.27025669332071e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LUZP2,Leucine zipper protein 2,39919,-0.0400374188772474,0.00458024389666881,-0.0490146969147182,-0.0310601408397765,2.62820194594862e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,-0.0419132925412217,0.00479689648767942,-0.0513152096570733,-0.03251137542537,2.65991054289757e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ING1,Inhibitor of growth protein 1,41820,-0.0421358807551343,0.00482701774646315,-0.051596835538202,-0.0326749259720665,2.87008721982391e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAMDC2,MAM domain-containing protein 2,39958,-0.0316295226991958,0.00362325480684803,-0.0387311021206179,-0.0245279432777736,2.91254672935311e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF19,Fibroblast growth factor 19,42185,-0.0686151856002531,0.00787187626412728,-0.0840440630779426,-0.0531863081225637,3.19861040122335e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,0.0464134255804051,0.00532580619044835,0.0359748454471263,0.0568520057136839,3.24784950953281e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,-0.0549776798607868,0.00630661772304968,-0.0673386505979641,-0.0426167091236094,3.25187100927134e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP2,Methionine aminopeptidase 2,42247,-0.049229074020745,0.00564918152393132,-0.0603014698076504,-0.0381566782338397,3.25721153269845e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A12,Protein S100-A12,41910,-0.0649045947163561,0.00744989442157471,-0.0795063877826425,-0.0503028016500697,3.33044233990164e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,-0.12089468712933,0.0139008459519372,-0.148140345195127,-0.0936490290635335,3.80086257659264e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,-0.0545254627711831,0.00627041551468607,-0.0668154771799678,-0.0422354483623984,3.9210360225898e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS8,Galectin-8,42249,-0.0535745935693589,0.00616439653262942,-0.0656568107733125,-0.0414923763654052,3.99880236125683e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,-0.0176076375496536,0.00202730804026218,-0.0215811613085674,-0.0136341137907397,4.20978069791415e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFB,Vascular endothelial growth factor B,39657,-0.0261187540166804,0.0030097562178443,-0.0320178762036553,-0.0202196318297056,4.5905722369421e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS3BP,Galectin-3-binding protein,39979,-0.0275448312730667,0.00317556801193576,-0.0337689445764608,-0.0213207179696726,4.73802786792535e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,-0.0563053160876903,0.00650849981729621,-0.0690619757295908,-0.0435486564457897,5.80945766359692e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAX1BP1,Tax1-binding protein 1,39929,-0.0546449386824094,0.00632195650720202,-0.0670359734365254,-0.0422539039282935,6.17368921989697e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,-0.0636306495213249,0.00736958273676121,-0.0780750316853769,-0.0491862673572729,6.5680035795154e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL5,C-C motif chemokine 5,42217,-0.0881097031216991,0.0102216525305601,-0.108144142081597,-0.0680752641618014,7.43296347582724e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS1,"Nitric oxide synthase, brain",41839,-0.0513056869890977,0.00595820371833181,-0.0629837662770281,-0.0396276077011674,8.05895592621664e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNG,Interferon gamma,41913,-0.0996353692876677,0.0115887511439469,-0.122349321529804,-0.0769214170455316,9.04157135110686e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN1,Tetraspanin-1,41900,-0.0635239280823888,0.00739233772324706,-0.0780129100199531,-0.0490349461448246,9.39217515857889e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,-0.0953104372837387,0.011091983672612,-0.117050725282058,-0.0735701492854192,9.60422947552071e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESYT2,Extended synaptotagmin-2,39929,-0.0729699727935305,0.00849214926448932,-0.0896145853519296,-0.0563253602351314,9.61191691859119e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,-0.049953897669678,0.00584231399723278,-0.0614048331042543,-0.0385029622351018,1.35871454919155e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA4,Ephrin type-A receptor 4,39736,-0.0254439102475138,0.0029761361448713,-0.0312771370914615,-0.019610683403566,1.39986068140842e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,-0.0817507105536119,0.00960388313970821,-0.10057432150744,-0.0629270995997838,1.88552212918625e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,-0.0686664492271452,0.00806490027065523,-0.0844736537576294,-0.0528592446966609,1.8943092222033e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,-0.0866444606363074,0.0101782529141197,-0.106593836347982,-0.0666950849246328,1.91301305616426e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEPR,Leptin receptor,42145,0.0270716774602399,0.0031870457186043,0.0208250678517754,0.0333182870687043,2.19744156803926e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,-0.0196886835279629,0.00232090632095712,-0.0242376599170389,-0.0151397071388869,2.41355053075917e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,-0.0630600585313646,0.0074346332520321,-0.0776319397053475,-0.0484881773573817,2.49709356805911e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,-0.0568629709463179,0.00670730875224261,-0.0700092961007134,-0.0437166457919224,2.57957006919517e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSE,Cathepsin E,39736,-0.0458086805652765,0.00540640189937935,-0.05640522828806,-0.035212132842493,2.6911323614769e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,P4HB,Protein disulfide-isomerase,42073,-0.0331211240218513,0.00391168779098586,-0.0407880320921835,-0.025454215951519,2.77104058747209e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SBSN,Suprabasin,39954,0.0306225848324308,0.00361604023782354,0.0235351459662967,0.0377100236985649,2.79020854781811e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CR1,Complement receptor type 1,39970,-0.0305543245704036,0.00361394081551918,-0.0376376485688212,-0.0234710005719861,3.1424620566169e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,-0.0742182661473556,0.00878974824566125,-0.0914461727088516,-0.0569903595858595,3.44761804825253e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,-0.038292884748896,0.00454143724428276,-0.0471941017476902,-0.0293916677501018,3.8234772368796e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDK2,Protein sidekick-2,39736,-0.0337982198273645,0.00400896835319038,-0.0416557977996176,-0.0259406418551113,3.86056895176149e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0260005621854276,0.00308507030249783,-0.0320472999783233,-0.0199538243925318,3.87360332580885e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,-0.0231605503012162,0.00274870087029256,-0.0285480040069896,-0.0177730965954427,4.00678787086309e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,-0.10698531202388,0.0127040393003827,-0.13188522905263,-0.0820853949951302,4.09146888642302e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,-0.0336399873680555,0.00399527561328889,-0.0414707275701017,-0.0258092471660093,4.21945976345711e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA9,Serpin A9,42025,-0.0617030437802319,0.00733058447429743,-0.0760709893498549,-0.047335098210609,4.24316296204629e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SWAP70,Switch-associated protein 70,39930,-0.0314509838020378,0.00373708739519786,-0.0387756750966256,-0.02412629250745,4.3664655471794e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APLP1,Amyloid-like protein 1,42145,0.0433490033014912,0.00515373974953523,0.0332476733924022,0.0534503332105803,4.46223833922475e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC39A14,Zinc transporter ZIP14,41839,-0.028764566724246,0.00342076762295976,-0.0354692712652472,-0.0220598621832449,4.562752301937e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,-0.0356236856930317,0.00423867464970629,-0.043931488006456,-0.0273158833796073,4.8284920135318e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,-0.0278672745530991,0.00331790387070623,-0.0343703661396833,-0.0213641829665149,4.93922712052542e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF6,SLAM family member 6,41843,-0.032965310642739,0.00392878827704585,-0.0406657356657489,-0.0252648856197292,5.31851751270071e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE3,Eosinophil cationic protein,42081,-0.0926819482447232,0.0110462075380717,-0.114332515019344,-0.0710313814701026,5.32397585058615e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17RB,Interleukin-17 receptor B,41934,0.0459616585486303,0.00548065592759775,0.0352195729305387,0.0567037441667219,5.5234702325402e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,-0.0339772704378834,0.00405379507543383,-0.0419227087857337,-0.0260318320900331,5.84698587082189e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L15,Bcl-2-like protein 15,39657,-0.0483503750573247,0.00577113008514397,-0.0596617900242069,-0.0370389600904426,6.03529495139925e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,-0.0298591112361381,0.00356638091774079,-0.03684921783491,-0.0228690046373661,6.19002564559879e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRND,Prion-like protein doppel,39929,-0.0416593602159882,0.00497694841945119,-0.0514141791181126,-0.0319045413138639,6.41267520423038e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,-0.0334618235161599,0.00399798356622193,-0.0412978713059548,-0.0256257757263649,6.4540858232563e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY75,Lymphocyte antigen 75,42119,-0.0328095950087776,0.00392369285496063,-0.0405000330045005,-0.0251191570130548,6.76983653481258e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOLA1,BolA-like protein 1,39586,-0.0465477909793538,0.00556935936158715,-0.0574637353280646,-0.035631846630643,7.15727465569481e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,-0.0572220877729509,0.00685020627954868,-0.0706484920808663,-0.0437956834650355,7.42217875383189e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOLGA3,Golgin subfamily A member 3,39934,-0.066147529600513,0.0079246643948561,-0.081679871814431,-0.0506151873865951,7.81058597608742e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,-0.0642574024707308,0.0076997609532415,-0.0793489339390842,-0.0491658710023775,7.92128528920078e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A13,Protein S100-A13,39657,-0.030294261363104,0.00363000492153844,-0.0374090710093193,-0.0231794517168887,7.93339256560901e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST7,Cystatin-F,42148,-0.0797852930501868,0.00956999812600649,-0.0985424893771595,-0.0610280967232141,8.34745455315696e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,-0.044858708075586,0.00537961364801291,-0.0554027508256913,-0.0343146653254807,8.40638808317647e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKLR,Pyruvate kinase PKLR,42143,-0.052594766488175,0.00631340411866168,-0.0649690385607519,-0.0402204944155981,8.80712619819207e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPO,Lactoperoxidase,41647,-0.0519655757641294,0.00623943265944494,-0.0641948637766415,-0.0397362877516174,8.99317351214351e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX8,Syntaxin-8,42119,-0.0403560211999804,0.00485177595154396,-0.0498655020650066,-0.0308465403349543,9.81376339892286e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFM,Afamin,39979,-0.0170822997156219,0.00205715278581948,-0.0211143191758281,-0.0130502802554158,1.12173044121253e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,-0.0966526483581144,0.0116585154125195,-0.119503338566653,-0.0738019581495761,1.25899512120114e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,-0.0611606687232173,0.00737955131051565,-0.075624589291828,-0.0466967481546067,1.26099169524947e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,-0.0168962303816379,0.00204119954356805,-0.0208969814870313,-0.0128954792762445,1.39772746032547e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCN2,Transcobalamin-2,42286,-0.0253014404438894,0.00306437333612715,-0.0313076121826986,-0.0192952687050802,1.63457050474608e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEMIP2,Cell surface hyaluronidase,39657,-0.0272877481808235,0.00330412272064541,-0.0337638287132885,-0.0208116676483585,1.64035763317656e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGA,Fibrinogen alpha chain,39735,-0.0261226626542105,0.00316421940464362,-0.032324532687312,-0.019920792621109,1.68134020993128e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNM3,Dynamin-3,39934,-0.0463135667838773,0.00562375287556953,-0.0573361224199936,-0.035291011147761,1.98661070655512e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D17,TBC1 domain family member 17,41839,-0.035881653368739,0.00436727615129743,-0.0444415146252819,-0.027321792112196,2.29773294012931e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLMP,CXADR-like membrane protein,42262,-0.0184317863808113,0.00224407974166381,-0.0228301826744723,-0.0140333900871502,2.33965684883008e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACYP1,Acylphosphatase-1,39701,-0.0544617070156193,0.00663324556390991,-0.0674628683208827,-0.0414605457103559,2.44809799005484e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD5L,CD5 antigen-like,39925,-0.0400783766825159,0.00488448691009136,-0.049651971026295,-0.0305047823387369,2.55003209133823e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17A,Interleukin-17A,41877,-0.0357304394006698,0.00435564740073234,-0.0442675083061052,-0.0271933704952344,2.55379074331408e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,-0.0734007896688325,0.00894988281228749,-0.090942559980916,-0.055859019356749,2.64118385049298e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARF1,Scavenger receptor class F member 1,42310,-0.0352567602219818,0.00430550064286321,-0.0436955414819937,-0.0268179789619699,2.87075303381404e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX4,Syntaxin-4,42070,-0.0490057421335185,0.00598484380361784,-0.0607360359886095,-0.0372754482784275,2.88608767207393e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,-0.0376166541206243,0.00460604760035274,-0.0466445074173156,-0.0285888008239329,3.44710336401096e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,-0.102465096515119,0.0125654290848935,-0.12709333752151,-0.0778368555087275,3.81229057230215e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,-0.0356056358452119,0.00436912232147096,-0.044169115595295,-0.0270421560951289,3.98257504916341e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMH,Granzyme H,41900,-0.0650794770188757,0.00798946460608318,-0.0807388276467987,-0.0494201263909527,4.10658513118702e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADD1,Alpha-adducin,39736,-0.0579043299330894,0.00710734787644084,-0.0718347317709134,-0.0439739280952653,4.12536151206416e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,-0.0390678298502005,0.00479684065455937,-0.0484696375331369,-0.0296660221672641,4.1421931151553e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TJAP1,Tight junction-associated protein 1,42181,-0.0685037245467691,0.00841956189927876,-0.0850060658693555,-0.0520013832241827,4.42887050726924e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,-0.052870117759081,0.00650019527462195,-0.06561050049734,-0.040129735020822,4.60061926446736e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARK7,Parkinson disease protein 7,42137,-0.0416361261553394,0.00512238800585094,-0.0516760066468072,-0.0315962456638715,4.73057533827706e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,-0.0409166193099934,0.00503927046679574,-0.0507935894249131,-0.0310396491950738,5.16298499730068e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASS1,Argininosuccinate synthase,39575,-0.0639857998709577,0.00788224888568461,-0.0794350076868995,-0.0485365920550159,5.25816620897927e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,-0.027086781789009,0.00335245794910446,-0.0336575993692537,-0.0205159642087642,7.04336902112458e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,-0.0722193595917525,0.00894425461562478,-0.0897500986383771,-0.054688620545128,7.46808612267518e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,-0.0924146830413901,0.0114648952433239,-0.114885877718305,-0.0699434883644752,8.22166883541125e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.0566996064713136,0.00703636785521217,-0.0704908874675295,-0.0429083254750978,8.52714711093349e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.0195769106004231,0.00243067640176506,0.0148127848529636,0.0243410363478826,8.66826770424687e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,-0.0188006772257648,0.00233581667074471,-0.0233788779004244,-0.0142224765511051,9.18855413277339e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,-0.0848511278598109,0.0105538989076334,-0.105536769718772,-0.0641654860008494,9.74282258818755e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHR,Growth hormone receptor,39736,-0.0231832459017362,0.00288289863089708,-0.0288337272182945,-0.017532764585178,9.76108448719213e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACAN,Aggrecan core protein,41994,0.0222759673255267,0.00277506520344042,0.0168368395267835,0.0277150951242699,1.07999733866229e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,-0.0350744024160832,0.00437217111086177,-0.0436438577933723,-0.0265049470387941,1.14280502270957e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,-0.0498023778364357,0.0062147245856643,-0.0619832380243377,-0.0376215176485337,1.204710552911e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LARP1,La-related protein 1,39919,-0.0508906637594169,0.00635233675751968,-0.0633412438041555,-0.0384400837146783,1.2458984318401e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.0308583962587731,0.00385423527320487,-0.0384126973942546,-0.0233040951232915,1.27737155900838e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY96,Lymphocyte antigen 96,42016,-0.0296204142128123,0.00370124125490033,-0.0368748470724169,-0.0223659813532076,1.31526083232866e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPPB,Natriuretic peptides B,41900,-0.113908703371259,0.0142400883885676,-0.141819276612852,-0.0859981301296669,1.35585076352762e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,-0.100450318389413,0.0125551449649701,-0.125058402520755,-0.075842234258072,1.36040903359105e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAM,Basal cell adhesion molecule,42137,-0.0198619854185318,0.00248450794435591,-0.0247316209894694,-0.0149923498475942,1.40779085251966e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,-0.0690148712492147,0.00863560301659412,-0.0859406531617391,-0.0520890893366902,1.43588847311934e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELP,P-selectin,42217,-0.0451897497435496,0.00565612164480357,-0.0562757481673646,-0.0341037513197346,1.46281826373368e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP9,Matrix metalloproteinase-9,42125,-0.0483368077346578,0.00605540709557716,-0.060205405641989,-0.0364682098273266,1.54998950638309e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL17,C-C motif chemokine 17,42107,-0.0739206303977936,0.00926259130413885,-0.0920753093539057,-0.0557659514416814,1.57363632725982e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A11,Protein S100-A11,42027,-0.0374337694656011,0.00469306072343612,-0.0466321684835359,-0.0282353704476663,1.62789182847423e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,-0.0243678338869118,0.00305906798052013,-0.0303636071287312,-0.0183720606450923,1.7724216104568e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IKBKG,NF-kappa-B essential modulator,42119,-0.0737935950491359,0.00926953827879714,-0.0919618900755782,-0.0556253000226935,1.84389606225667e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN2,CCN family member 2,42146,-0.0455218516854183,0.00572270603043904,-0.0567383555050788,-0.0343053478657578,1.93893329609093e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBI,Acyl-CoA-binding protein,42085,-0.0625400374865732,0.00787287422612057,-0.0779708709697695,-0.0471092040033769,2.1165230122056e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAMBP,STAM-binding protein,41997,-0.0506049145757944,0.00637613355515519,-0.0631021363438986,-0.0381076928076903,2.24211933321193e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,-0.0386804962353201,0.00487354803413371,-0.0482326503822222,-0.029128342088418,2.26954073490735e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,-0.0566916024499088,0.00714330462293937,-0.07069247951087,-0.0426907253889476,2.28380771549521e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,-0.0206546672427957,0.00260333084761218,-0.0257571957041156,-0.0155521387814758,2.32203377999272e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,-0.0179606964134377,0.00226813287407932,-0.0224062368466332,-0.0135151559802422,2.58457292747062e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGN,Secretagogin,41913,-0.0357059498075842,0.00450984211122935,-0.0445452403455937,-0.0268666592695746,2.6177793954776e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RFC4,Replication factor C subunit 4,39919,-0.0178993880282979,0.0022613201877963,-0.0223315755963787,-0.0134672004602172,2.69305272056587e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBS4,Thrombospondin-4,42189,-0.0363899827690741,0.00460937215566011,-0.0454243521941679,-0.0273556133439803,3.13013738401763e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USO1,General vesicular transport factor p115,42070,-0.0712905366712682,0.00903218736310191,-0.0889936239029479,-0.0535874494395884,3.17844697143207e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RALY,RNA-binding protein Raly,39919,-0.0386388966525512,0.00490620736836124,-0.0482550630945392,-0.0290227302105632,3.70332138229217e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,-0.0635097577245534,0.00806595870705594,-0.0793190367903831,-0.0477004786587238,3.70702158141506e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,-0.0614317404104001,0.00780592512300463,-0.0767313536514892,-0.0461321271693111,3.8230018242832e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,-0.0586534765366993,0.00745207246464975,-0.0732595385674129,-0.0440474145059858,3.84551129129279e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,-0.0514791301027952,0.00654664422903948,-0.0643105527917126,-0.0386477074138779,4.07605184138472e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINI2,Serpin I2,39930,-0.0463032126441459,0.00589337006557377,-0.0578542179726705,-0.0347522073156213,4.29558932452295e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EHBP1,EH domain-binding protein 1,39958,-0.0600064115025451,0.00763899696201055,-0.0749788455480858,-0.0450339774570044,4.34808762984995e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,-0.0214685863983219,0.00273738644283898,-0.0268338638262863,-0.0161033089703575,4.81458166929448e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBXN1,UBX domain-containing protein 1,39736,-0.0549995253213159,0.00701916813126866,-0.0687570948586024,-0.0412419557840293,5.08969598530358e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NID1,Nidogen-1,42189,-0.028622451235843,0.0036541802259406,-0.0357846444786866,-0.0214602579929994,5.12385867147339e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA2,GDNF family receptor alpha-2,42070,-0.0165934244562718,0.00211874557751039,-0.0207461657881922,-0.0124406831243514,5.17094382167034e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,-0.0687959526062328,0.00879582070413025,-0.0860357611863281,-0.0515561440261375,5.68591149268956e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,-0.0487582796590161,0.00623899291301149,-0.0609867057685186,-0.0365298535495136,5.89586624921028e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,-0.0841687133385454,0.0107898127674389,-0.105316746362726,-0.0630206803143651,6.60316312380668e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,-0.0302796167154303,0.00388262751757365,-0.0378895666498747,-0.022669666780986,6.71887336836127e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,-0.0248611455318972,0.00319088640067346,-0.0311152828772172,-0.0186070081865772,7.12223955922187e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,-0.07217002904746,0.00926553023945599,-0.0903304683167938,-0.0540095897781263,7.35294146387768e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK4,Kallikrein-4,42262,-0.0494270606520286,0.00634838803628304,-0.0618699012031434,-0.0369842201009139,7.42601402954661e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP10,Caspase-10,41839,-0.0562745489536132,0.00722867498990744,-0.0704427519338317,-0.0421063459733946,7.49300119010159e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,-0.11139782393681,0.0143083201123636,-0.139442131357043,-0.0833535165165775,7.54632508553507e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,-0.0226739201362249,0.00291356577755315,-0.0283845090602291,-0.0169633312122207,7.65161616543332e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEXIM1,Protein HEXIM1,42119,-0.0636862550449882,0.00818801232202248,-0.0797347591961523,-0.0476377508938242,7.9006413549635e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53,Cellular tumor antigen p53,41843,-0.0351401942768512,0.00452181375154945,-0.0440029492298881,-0.0262774393238142,8.3418408206373e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDS,Iduronate 2-sulfatase,42296,0.00724693110319952,0.0009331352972118,0.0054179859206644,0.00907587628573465,8.65888181715636e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,-0.0512148800297243,0.00659755147000329,-0.0641460809109307,-0.0382836791485178,9.04693292426956e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRSF1,G-rich sequence factor 1,39486,-0.0658485723479169,0.00849591877396528,-0.0825005731448889,-0.049196571550945,9.95937322461682e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFD,Complement factor D,39979,-0.0159637400847361,0.00206012936733775,-0.0200015936447181,-0.0119258865247541,1.00566137906598e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF2,TNF receptor-associated factor 2,42119,-0.0544690067827735,0.00703799707497615,-0.0682634810497267,-0.0406745325158202,1.07055986511083e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,-0.0342453549970168,0.00442895823288659,-0.0429261131334745,-0.0255645968605591,1.13326292204803e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXO3,Forkhead box protein O3,41843,-0.0754223123228265,0.00976849001360467,-0.0945685527494917,-0.0562760718961614,1.23699905681329e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD55,Complement decay-accelerating factor,41714,-0.0205800139543008,0.00267463914101775,-0.0258223066706956,-0.015337721237906,1.52172993404952e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,-0.0405582249339446,0.00527634713163503,-0.0508998653119493,-0.03021658455594,1.61463425625943e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,-0.0756559443016662,0.00984423258841672,-0.094950640174963,-0.0563612484283694,1.63222822988259e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,-0.0661269397115041,0.00860902740486823,-0.0830006334250458,-0.0492532459979624,1.70688419542942e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,-0.0515690624691929,0.00673336591638746,-0.0647664596653123,-0.0383716652730735,2.00320235874517e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNRD2,Protein ZNRD2,39930,-0.0544502873956122,0.00711815307644698,-0.0684018674254483,-0.0404987073657761,2.18102543682583e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALB1,Calbindin,42070,-0.0350698602197981,0.0045929529110224,-0.044072047925402,-0.0260676725141942,2.39915191897803e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,-0.0336261954150469,0.00440467722665661,-0.0422593627792939,-0.0249930280508,2.45487931118761e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBLN2,Fibulin-2,39966,-0.0249473644155723,0.00327151938095646,-0.0313595424022469,-0.0185351864288976,2.62212802597422e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CENPF,Centromere protein F,39757,-0.0419683516329095,0.00551108074746452,-0.05277006989794,-0.031166633367879,2.84400426120055e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXO1,Forkhead box protein O1,42119,-0.0668974861910058,0.0087914112409127,-0.0841286522231946,-0.0496663201588169,2.93523835806656e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRIB,Protein scribble homolog,39638,-0.0679813845123564,0.00893473444660645,-0.0854934640277051,-0.0504693049970077,2.99483530108337e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLTA,Clathrin light chain A,41900,-0.0361343883987248,0.00475148564312583,-0.0454473002592515,-0.0268214765381982,3.0431659315696e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0394990902942005,0.00519515960764521,-0.0496816031251851,-0.0293165774632159,3.08402002207557e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,-0.036979797699245,0.00486520186935122,-0.0465155933631734,-0.0274440020353166,3.17324614938117e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,-0.0419194934552705,0.00551667664541789,-0.0527321796802896,-0.0311068072302514,3.23100422318419e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMOX2,Heme oxygenase 2,41839,-0.0367948516177329,0.00484616014036389,-0.0462933254928461,-0.0272963777426196,3.3457147632004e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,-0.0613871600071605,0.00809152838368899,-0.0772465556391909,-0.04552776437513,3.54802687907093e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,-0.0421391022381007,0.00556389456591247,-0.0530443355872892,-0.0312338688889123,3.86705212174629e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,-0.0203395064630001,0.00269456822589546,-0.0256208601857552,-0.015058152740245,4.74475138591719e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.0250462696573541,0.00332144948255573,-0.0315563106431634,-0.0185362286715449,4.96940339541296e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,-0.0280237576270097,0.00371919330831004,-0.0353133765112974,-0.0207341387427221,5.26854528828414e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CETN2,Centrin-2,41839,-0.0519613271645534,0.00690220108109918,-0.0654896412835077,-0.038433013045599,5.47571777123181e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,-0.0474947489441277,0.0063093164343897,-0.0598610091555316,-0.0351284887327239,5.48637818665194e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,-0.0376946950003205,0.00500797247209524,-0.0475103210456272,-0.0278790689550139,5.59821792772905e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AXIN1,Axin-1,42119,-0.0736153466479766,0.00979293056944721,-0.0928094905640932,-0.0544212027318601,5.94823426962733e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,-0.0150631831937654,0.00200643636997345,-0.0189957984789133,-0.0111305679086174,6.48098791863965e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RCOR1,REST corepressor 1,41900,-0.0340206228497132,0.00453317675969761,-0.0429056492987205,-0.0251355964007059,6.5424358584628e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,-0.0601410615257738,0.00802260308588335,-0.0758653635741052,-0.0444167594774425,7.05816456554533e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C3,Complement C3,39445,-0.0351529188614517,0.00469028461385867,-0.0443458767046147,-0.0259599610182887,7.15543986086103e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,-0.0156960889864888,0.00209600481474887,-0.0198042584233966,-0.011587919549581,7.4064372788465e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BID,BH3-interacting domain death agonist,42119,-0.0502981344247829,0.00671983801669398,-0.0634690169375031,-0.0371272519120627,7.59539498249728e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,-0.0478370168686907,0.00639332467526659,-0.0603679332322132,-0.0353061005051682,7.85944649176999e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,-0.0386271621676462,0.00516444128189155,-0.0487494670801536,-0.0285048572551388,8.02905222965307e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKD2,Polycystin-2,39575,-0.0444728445591061,0.0059670373074696,-0.0561682376817465,-0.0327774514364657,9.80432122737738e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX2,Peroxiredoxin-2,39819,-0.0458143978300872,0.00614755162810965,-0.0578635990211821,-0.0337651966389923,9.83510270759098e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,-0.0585346433861407,0.00785554612356095,-0.0739315137883201,-0.0431377729839612,9.9211270669541e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD101,Immunoglobulin superfamily member 2,39930,-0.0328064196555456,0.0044098898364004,-0.0414498037348903,-0.0241630355762008,1.0854942239585e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX1,Peroxiredoxin-1,41742,0.0691206258306621,0.00929630852175825,0.0508998611280159,0.0873413905333082,1.10808433836505e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGCR6,Protein DGCR6,39586,-0.0318026913654195,0.00427997574757372,-0.040191443830664,-0.023413938900175,1.16153471297194e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFB,Complement factor B,39794,-0.0247736186632461,0.00333516623082697,-0.031310544475667,-0.0182366928508252,1.18269439861202e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,-0.0228774469620536,0.00308660585481789,-0.0289271944374966,-0.0168276994866105,1.33647151029058e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITM2A,Integral membrane protein 2A,42119,-0.0466515163769819,0.00629766601598229,-0.0589949417683072,-0.0343080909856567,1.36072250961053e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAN,Brevican core protein,42016,0.0258809117060493,0.00349675198089537,0.0190272778234944,0.0327345455886042,1.42757333027496e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.0281005644373066,0.00379821597500962,-0.0355450677483254,-0.0206560611262877,1.47777849372151e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREH,Trehalase,39966,-0.0567232036215084,0.00766849156379221,-0.0717534470865411,-0.0416929601564756,1.49191874177029e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIF1,Allograft inflammatory factor 1,41843,-0.0392792300622574,0.0053140936020494,-0.0496948535222742,-0.0288636066022406,1.53864179962601e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,-0.065080327090786,0.00880604312206119,-0.0823401716100259,-0.0478204825715461,1.54957668602109e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APRT,Adenine phosphoribosyltransferase,42002,-0.0352185097220143,0.00476734660061458,-0.0445625090592189,-0.0258745103848097,1.58523812715182e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JAM3,Junctional adhesion molecule C,39736,-0.0383129241638067,0.00518636239457533,-0.0484781944571743,-0.028147653870439,1.6062210033377e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,-0.0421397876043174,0.00570664581724794,-0.0533248134061234,-0.0309547618025115,1.64235288378119e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,-0.0231521967939091,0.00313618486206581,-0.0292991191235581,-0.0170052744642602,1.66960598841742e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,-0.0131257514411935,0.00178077580967424,-0.016616072028155,-0.00963543085423202,1.79426298805382e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,-0.0569468455181668,0.00773173635617996,-0.0721010487762795,-0.041792642260054,1.88962594396688e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,-0.0345726861627463,0.00469620178246441,-0.0437772416563765,-0.025368130669116,1.91767922390415e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OLFM4,Olfactomedin-4,39347,-0.0926460258412884,0.0126119121695819,-0.117365373693669,-0.0679266779889079,2.19174165757862e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNLR1,Interferon lambda receptor 1,42119,-0.0271002052654604,0.00369349230496485,-0.0343394501831915,-0.0198609603477293,2.30392578828885e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,-0.018389872904317,0.00250634842575026,-0.0233023158187875,-0.0134774299898465,2.33077004433221e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPSE,Heparanase,39866,-0.0713090063611393,0.00972516781242931,-0.0903703352735008,-0.0522476774487779,2.41529518956713e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,-0.0306854671884017,0.00418553698582163,-0.0388891196806121,-0.0224818146961913,2.43716321477907e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,-0.0398885972229052,0.00544419320670203,-0.0505592159080411,-0.0292179785377692,2.51699095462034e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,-0.0425697079207679,0.00581446677496445,-0.0539660627996982,-0.0311733530418376,2.59603916386328e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,-0.0432637642309897,0.00591360281131356,-0.0548544257411643,-0.0316731027208151,2.72794690346788e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,-0.0472148052848042,0.00645399297354554,-0.0598646315129534,-0.0345649790566549,2.7353643630097e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,-0.0248017233260382,0.00339411636440609,-0.0314541914002742,-0.0181492552518023,2.87907556543644e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,-0.0234575742341519,0.0032138485393085,-0.0297567173711966,-0.0171584310971072,3.06275937541251e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.0442647907989671,0.00607681818434375,0.0323542271576534,0.0561753544402809,3.41707452541562e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,-0.0214859925428205,0.00295283403856849,-0.0272735472584147,-0.0156984378272262,3.62212746457953e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,-0.0429270104157864,0.00590214720460731,-0.0544952189368168,-0.0313588018947561,3.70679752123754e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAA4,Serum amyloid A-4 protein,39979,-0.0243520242553808,0.00335393851787352,-0.0309257437504129,-0.0177783047603487,4.10125850959956e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,-0.0392373978405757,0.00541005683712126,-0.0498411092413334,-0.028633686439818,4.31317062429359e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LBP,Lipopolysaccharide-binding protein,42217,-0.0430931543411827,0.00594721807682932,-0.0547497017717682,-0.0314366069105973,4.52565629538475e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,-0.0425093820233287,0.00586984164235256,-0.0540142716423398,-0.0310044924043177,4.7129001401545e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,-0.0577571798334824,0.00798751450111738,-0.0734127082556725,-0.0421016514112924,5.10574029747798e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCHE,Cholinesterase,39806,-0.0198225242441923,0.00274165565532803,-0.0251961693286353,-0.0144488791597494,5.1395550227542e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA4,Kallistatin,39802,-0.0171574619222217,0.00238495165456679,-0.0218319671651726,-0.0124829566792708,6.6912034048439e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR1,Toll-like receptor 1,39657,-0.0196356364916827,0.00273009934312197,-0.0249866312042017,-0.0142846417791636,6.78367792837222e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDA,Cytidine deaminase,39946,-0.0349328657918869,0.00485900283313867,-0.0444565113448387,-0.0254092202389351,6.92125180604518e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAB2,Disabled homolog 2,42262,-0.0807792337663102,0.0112432226029688,-0.102815950068129,-0.0587425174644914,7.08417777481223e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,-0.0273787288126835,0.00381583607814973,-0.034857767525857,-0.01989969009951,7.69198228536553e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRDL2,Chordin-like protein 2,42145,-0.033268638469274,0.00463798104311226,-0.042359081313774,-0.024178195624774,7.71328620859414e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX9,Sorting nexin-9,42145,-0.0494403866726985,0.00689518213221362,-0.0629549436518372,-0.0359258296935598,7.87245649764302e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,-0.0834951179003868,0.0116499356323384,-0.10632899173977,-0.0606612440610035,8.14258819785329e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AZU1,Azurocidin,41751,-0.0547620020733957,0.00764457453700743,-0.0697453681659302,-0.0397786359808611,8.28216076825899e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASC3,Protein CASC3,39649,-0.0315164412343022,0.0044013119154381,-0.0401430125885609,-0.0228898698800435,8.53707517037371e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCK2,Cytoplasmic protein NCK2,42185,-0.0775725265582269,0.0108364869518573,-0.0988120409838672,-0.0563330121325865,8.57792568075248e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,-0.0484759747249938,0.00677276420699767,-0.0617505925707092,-0.0352013568792784,8.74166674308145e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEPD,Xaa-Pro dipeptidase,39990,0.019224092330632,0.00268917481497948,0.0139533096932722,0.0244948749679917,9.2965072899413e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.0192277318291858,0.00269142028757203,-0.0245029155928269,-0.0139525480655446,9.61255281432016e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,-0.0272653880461406,0.00381804886888329,-0.0347487638291518,-0.0197820122631293,9.72766596048058e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,-0.0521661852180238,0.00730819646765848,-0.0664902502946344,-0.0378421201414132,1.00465641439209e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,-0.0608826925013127,0.00853926390293311,-0.0776196497510616,-0.0441457352515639,1.05807069000031e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTN3,Myeloblastin,41800,-0.0348634271770651,0.00488991556230061,-0.0444476616791743,-0.0252791926749559,1.05853125054037e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARG1,Arginase-1,42015,-0.0365722172507342,0.00512996405199819,-0.0466269467926506,-0.0265174877088177,1.06167027532489e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,-0.0339594097637452,0.00476516919907528,-0.0432991413939327,-0.0246196781335576,1.08220736199194e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,-0.062741939184794,0.00881221952060489,-0.0800138894451796,-0.0454699889244084,1.13465086130588e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL5,Fc receptor-like protein 5,42137,-0.042611841945362,0.00598773803943903,-0.0543478085026625,-0.0308758753880615,1.16258825876784e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,-0.0602063738282333,0.00845972344660465,-0.0767874317835784,-0.0436253158728882,1.17231563385502e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DMD,Dystrophin,39638,-0.0373230961025858,0.00524936949054543,-0.0476118603040548,-0.0270343319011167,1.23201447881461e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP6,Bone morphogenetic protein 6,41886,-0.0289148468181994,0.00406773846964278,-0.0368876142186993,-0.0209420794176996,1.23448788218985e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,-0.0295575640902498,0.00415867879248929,-0.0377085745235288,-0.0214065536569707,1.24163313253161e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,-0.0385327513123378,0.00542170046223017,-0.049159284218309,-0.0279062184063667,1.24438720761103e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,-0.0296656179163072,0.00418203277266396,-0.0378624021507286,-0.0214688336818858,1.37179516294317e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG6,Large proline-rich protein BAG6,41900,-0.0265903794470933,0.00375005673879156,-0.0339404906551247,-0.0192402682390618,1.40213783108062e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMBS,Porphobilinogen deaminase,42262,-0.0288797847524972,0.00407890624832983,-0.0368744409992236,-0.0208851285057707,1.50894106841375e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,-0.0636874203811347,0.00900884399722599,-0.0813447546156977,-0.0460300861465718,1.64715449962001e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSV,Cathepsin L2,42200,0.0286875796695219,0.00405990902656152,0.0207301579774613,0.0366450013615825,1.6714795999476e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,-0.0623423547734106,0.00883788829670189,-0.0796646158349463,-0.0450200937118749,1.82350093282166e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,-0.022359812963259,0.00317515989698819,-0.0285831263613559,-0.0161364995651622,2.00594106047728e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,-0.0404362845540399,0.00575156905631697,-0.0517093599044212,-0.0291632092036586,2.15696145665989e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,-0.0606266456152713,0.00863121126526247,-0.0775438196951857,-0.0437094715353568,2.27764844998951e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10,Interleukin-10,41913,-0.0545657173432118,0.0078119918680776,-0.0698772214046439,-0.0392542132817797,2.98670256523318e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMPR2,GMP reductase 2,39736,-0.0472576068350904,0.00677798417097781,-0.0605424558102069,-0.0339727578599739,3.29632582673291e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,-0.0481246785755748,0.00691575810302708,-0.0616795644575079,-0.0345697926936417,3.62716270885935e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,-0.0258986697060837,0.00372341442465911,-0.0331965619784156,-0.0186007774337518,3.67144186064307e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,-0.0431032856639412,0.00620402024112955,-0.0552631653365551,-0.0309434059913273,3.92492168625397e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX7,Syntaxin-7,39657,-0.0347917379344242,0.0050079814286616,-0.0446073815346009,-0.0249760943342475,3.93385647484254e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMA4,Laminin subunit alpha-4,42185,-0.0240776807985241,0.00346996093153998,-0.0308788042243424,-0.0172765573727057,4.13096305516132e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CMIP,C-Maf-inducing protein,39919,-0.0591599509859578,0.00856462820581219,-0.0759466222693497,-0.0423732797025659,5.1980789054205e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,-0.0538786013115813,0.00780133983915079,-0.0691692273963169,-0.0385879752268458,5.23975207378787e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA12,Serpin A12,41751,-0.075794336293843,0.0109894734111827,-0.0973337041797612,-0.0542549684079248,5.55423929536023e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,-0.0365232211578474,0.00530579154288276,-0.0469225725818976,-0.0261238697337972,6.09649352019085e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,-0.0187444559804233,0.002724479807003,-0.0240844364021492,-0.0134044755586975,6.24820358945392e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,-0.0321373770129345,0.00467203240917548,-0.0412945605349184,-0.0229801934909505,6.30647200157826e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,-0.0343242681738048,0.00499344431049237,-0.0441114190223699,-0.0245371173252398,6.57698026710955e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KEL,Kell blood group glycoprotein,41839,-0.0252286930356471,0.0036732476386779,-0.0324282584074558,-0.0180291276638384,6.79080116438391e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNST,Consortin,42145,-0.0758484479664833,0.0110494299734852,-0.0975053307145143,-0.0541915652184523,6.96450060288538e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,-0.066598160379176,0.00972035977122007,-0.0856500655307673,-0.0475462552275846,7.62912005437644e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.0194076237692904,0.00283445534106824,-0.0249631562377842,-0.0138520913007967,7.86180089020945e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLA2,Src-like-adapter 2,39934,-0.0743279724069202,0.0109000391263217,-0.0956920490945107,-0.0529638957193296,9.63001123833841e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR3,Toll-like receptor 3,42296,-0.0422488710015373,0.00620426485339894,-0.0544092301141993,-0.0300885118888754,1.01914616872724e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,-0.0461513230153757,0.00677836961645654,-0.0594369274636306,-0.0328657185671209,1.026462928065e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,-0.0483544739823776,0.00710426361974237,-0.0622788306770727,-0.0344301172876826,1.04355032143331e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0328682902291459,0.00483104503630451,-0.0423371385003027,-0.0233994419579891,1.07350190286014e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,-0.0207973826507893,0.00305802209698729,-0.0267911059608844,-0.0148036593406943,1.08350937657072e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,-0.0363890042222002,0.00535623097204828,-0.0468872169274149,-0.0258907915169856,1.14861907943044e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,-0.0394315840122796,0.00580865025533326,-0.0508165385127328,-0.0280466295118264,1.19186261075584e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,-0.101053017501357,0.0149042952302952,-0.130265436152736,-0.0718405988499784,1.2603826391653e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,-0.0638740192204878,0.00942945358190126,-0.0823557482410143,-0.0453922901999614,1.30642815313112e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EREG,Proepiregulin,41997,-0.0549353982365507,0.00812434829371643,-0.0708591208922349,-0.0390116755808665,1.41914642559911e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSLN,Mesothelin,42048,-0.0398895048501989,0.00590384706282546,-0.0514610450933368,-0.028317964607061,1.47155263381342e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,-0.0433065618759416,0.00642786842335591,-0.0559051839857191,-0.030707939766164,1.68011103141784e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,-0.0509877518125033,0.00757681344757493,-0.0658383061697501,-0.0361371974552564,1.78747789566901e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASHC3,WASH complex subunit 3,39929,-0.0520940812166526,0.0077458412388425,-0.0672759300447839,-0.0369122323885212,1.83504877948392e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGES2,Prostaglandin E synthase 2,39579,-0.0382636247840713,0.00569066838632144,-0.0494173348212613,-0.0271099147468813,1.85676081462498e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN4B,Sodium channel subunit beta-4,39638,-0.0298481582936889,0.00444056800935477,-0.0385516715920243,-0.0211446449953536,1.88475432078855e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,-0.0364283324697179,0.00542548637329737,-0.0470622857613807,-0.025794379178055,1.96678644283104e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH6,Cadherin-6,42145,-0.0265218011214052,0.00395080947800084,-0.0342653876982868,-0.0187782145445235,1.98248852702955e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,-0.0400240931576506,0.00597347055260061,-0.0517320954407478,-0.0283160908745534,2.16213631466094e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.0393171432997015,0.00587021371022305,-0.0508227621717387,-0.0278115244276643,2.20034837420915e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,-0.0495515173143803,0.00740118139171124,-0.0640578328421343,-0.0350452017866262,2.23991986362812e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,-0.0496135200621501,0.00742111289000605,-0.0641589013265619,-0.0350681387977382,2.40996277612133e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES3,Carboxylesterase 3,42070,-0.0481971899978047,0.00721310462581677,-0.0623348750644056,-0.0340595049312038,2.45147661215586e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBPL,FK506-binding protein-like,39930,-0.0404500804882565,0.00605810963293809,-0.0523239753688152,-0.0285761856076979,2.55260032639232e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,-0.0290779761252461,0.00435748269748714,-0.0376186422123208,-0.0205373100381713,2.60301168062783e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KAZN,Kazrin,39930,-0.0714138015231713,0.0107053908951835,-0.0923963676777309,-0.0504312353686116,2.66214288303278e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIMAP7,GTPase IMAP family member 7,39736,0.0218954183681049,0.00328275333152859,0.0154612218383089,0.0283296148979009,2.68225809362407e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,-0.0213343953763482,0.00319963369398902,-0.0276056774165667,-0.0150631133361298,2.69989156138306e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL5,Insulin-like peptide INSL5,39930,-0.0696856604491213,0.0104522465916544,-0.090172063768764,-0.0491992571294787,2.73122571962412e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANSC1,MANSC domain-containing protein 1,42181,-0.0187739764831008,0.00281843717924364,-0.0242981133544184,-0.0132498396117833,2.82191785231749e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA5,Annexin A5,41780,-0.0205412678189416,0.00308600570938294,-0.0265898390093322,-0.0144926966285511,2.91992159083341e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,-0.0132316617711155,0.00199089203277742,-0.0171338101553593,-0.00932951338687178,3.12372473091861e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,-0.0440700315420336,0.00663505017050352,-0.0570747298762205,-0.0310653332078468,3.21529748811782e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,-0.0274722414546249,0.00414309949990667,-0.035592716474442,-0.0193517664348078,3.48946130843718e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGKA,Diacylglycerol kinase alpha,39657,-0.0374496517032944,0.0056540990405814,-0.048531685822834,-0.0263676175837549,3.67190774784639e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHGB,Secretogranin-1,42210,-0.0283694605439915,0.00428478243803062,-0.0367676341225315,-0.0199712869654515,3.7020611862228e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,-0.0267815709540563,0.00404445745203795,-0.0347087075600506,-0.0188544343480619,3.71162030577664e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,-0.0641104276754987,0.00968382530938942,-0.0830907252819019,-0.0451301300690954,3.71714588374352e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,-0.0357867351666847,0.00540699451278185,-0.0463844444117372,-0.0251890259216323,3.78981999712411e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,0.0282492431558447,0.00427338518277326,0.0198734081976091,0.0366250781140803,3.97310125030904e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,-0.0408063280833284,0.00618190064288674,-0.0529228533433864,-0.0286898028232704,4.24136093730324e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,-0.0373184398982604,0.00565637913239661,-0.0484049429977577,-0.026231936798763,4.36552132763281e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NIT1,Deaminated glutathione amidase,39638,-0.0298886070343972,0.00453352965504416,-0.0387743251582837,-0.0210028889105106,4.51335072655526e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,-0.023550449210691,0.00357429846773065,-0.0305560742074431,-0.0165448242139389,4.59504370599105e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,-0.0285025200687633,0.00432670597181141,-0.0369828637735136,-0.0200221763640129,4.67390307407923e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,-0.0227798086920872,0.00346284536161626,-0.0295669856008551,-0.0159926317833193,4.93496361144399e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA3,GDNF family receptor alpha-3,41989,-0.0185435977447943,0.0028189978428996,-0.0240688335168775,-0.0130183619727111,4.94264478209312e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17D,Interleukin-17D,41913,-0.0227816241760257,0.00346335144017776,-0.0295697929987741,-0.0159934553532773,4.94926292908975e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERI1,3'-5' exoribonuclease 1,39757,-0.0231104433725227,0.00351414977221553,-0.0299981769260651,-0.0162227098189803,5.03525104287783e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,-0.0272922063061828,0.004151224909061,-0.0354286071279423,-0.0191558054844232,5.09639330869989e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,-0.0233044960833578,0.00355671516292809,-0.0302756578026968,-0.0163333343640187,5.92136712201876e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,-0.0505908633498624,0.00772531625775211,-0.0657324832150566,-0.0354492434846683,6.06141458259718e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,-0.0801632111728151,0.0122482225114328,-0.104169727295223,-0.0561566950504068,6.21108145080886e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAS2,Growth arrest-specific protein 2,39757,-0.0348393216215299,0.00533351055968847,-0.0452930023185193,-0.0243856409245405,6.76498914611023e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACHE,Acetylcholinesterase,39736,-0.0228213610983104,0.00349406827065018,-0.0296697349087847,-0.015972987287836,6.79699764335659e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMD,Osteomodulin,42185,0.0271909272674882,0.00416446690497089,0.0190285721337452,0.0353532824012311,6.84403273917123e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH2B3,SH2B adapter protein 3,41843,-0.0654056248335808,0.0100258740482865,-0.0850563379682223,-0.0457549116989394,7.10954257777773e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPOCK1,Testican-1,42016,0.0172668580616224,0.00264688584730794,0.0120789618008988,0.0224547543223459,7.11675149612278e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPHN1,Oligophrenin-1,39929,-0.0721733065505399,0.0110634994129391,-0.0938577653999005,-0.0504888477011793,7.15871866767109e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,-0.0269751842084297,0.00413615629961508,-0.0350820505556753,-0.0188683178611842,7.19038286489068e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,-0.0566619537902284,0.00869300517132172,-0.073700243926019,-0.0396236636544379,7.37128812987374e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH12,Protocadherin-12,39934,-0.0169644232200724,0.00260366302952279,-0.0220676027579371,-0.0118612436822078,7.54685621349131e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCA,Tubulin-specific chaperone A,39736,-0.0558270873544035,0.00857377253167724,-0.0726316815164909,-0.0390224931923161,7.76682435239597e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,-0.0660995057689493,0.0101544269775652,-0.0860021826449771,-0.0461968288929215,7.81000169339562e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,-0.052028558455026,0.00800131691850489,-0.0677111396152955,-0.0363459772947564,8.1794027046377e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLNK,B-cell linker protein,39657,-0.0277693286347774,0.00427119778635443,-0.0361408762960321,-0.0193977809735227,8.29318648558204e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUB1,NEDD8 ultimate buster 1,42119,-0.0555168539730788,0.00854089690451405,-0.0722570119059264,-0.0387766960402313,8.30722343110767e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEC31A,Protein transport protein Sec31A,39638,-0.0513885639851672,0.00790758135792923,-0.0668874234467085,-0.0358897045236259,8.45386574389325e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,-0.0484879360223553,0.00746987006527735,-0.063128881350299,-0.0338469906944117,8.81592598284787e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,-0.0272927975786087,0.00420910520699061,-0.0355426437843103,-0.0190429513729071,9.28965589336385e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,-0.0240258937875111,0.00370679784441476,-0.031291217562564,-0.0167605700124581,9.45451477182573e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATOX1,Copper transport protein ATOX1,42181,-0.0466305737137297,0.00720645694343432,-0.060755229322861,-0.0325059181045985,1.00919118956235e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST5,Cystatin-D,41846,-0.0368625840097131,0.00570013990726972,-0.0480348582279617,-0.0256903097914644,1.03503421352907e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,-0.0677260008071187,0.0104796642445321,-0.0882661427264015,-0.0471858588878359,1.07134190684588e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,0.0302465133635956,0.00468579037180208,0.0210623642348635,0.0394306624923277,1.11927137967402e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK6,Kallikrein-6,42158,-0.0202116018642537,0.00313241251921254,-0.0263511304019103,-0.0140720733265972,1.13827728717897e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSC22D1,TSC22 domain family protein 1,39934,-0.0435165525433971,0.00674403981849112,-0.0567348705876397,-0.0302982344991545,1.14434023374105e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,-0.0328878066139959,0.00510556132828336,-0.0428947068174313,-0.0228809064105606,1.22336323362111e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,-0.0474188778555462,0.00736393102810584,-0.0618521826706336,-0.0329855730404587,1.24931551594635e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF7,SLAM family member 7,42119,-0.0389794669870655,0.00605988184989504,-0.0508568354128598,-0.0271020985612712,1.2984902570608e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO2,Roundabout homolog 2,42249,-0.0147548239714103,0.00229598355363392,-0.0192549517365328,-0.0102546962062879,1.35033488419087e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.0400370766026284,0.00623479112610967,-0.0522572672098033,-0.0278168859954534,1.39431214557404e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAM,Integrin alpha-M,42137,0.0205313847167865,0.00319886573597307,0.0142616078742793,0.0268011615592937,1.42366083924003e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,-0.0175605756395686,0.00273635986483053,-0.0229238409746364,-0.0121973103045007,1.44049581438918e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLPS,Colipase,42115,-0.0479169346389243,0.00746861535078564,-0.0625554207264641,-0.0332784485513844,1.44780217702041e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,-0.0365103171492384,0.0056920464983154,-0.0476667282859366,-0.0253539060125402,1.46164591735149e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,-0.0619389998241635,0.00966228836689759,-0.0808770850232828,-0.0430009146250442,1.50051831780766e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PREB,Prolactin regulatory element-binding protein,41913,-0.0184618151768067,0.00288123445104954,-0.0241090347008638,-0.0128145956527496,1.52799296266454e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.033573864203478,0.00523988127750251,0.023303696899573,0.0438440315073829,1.5390238844207e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,-0.0182820780880233,0.00285442739818103,-0.0238767557884581,-0.0126874003875885,1.56498289000191e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA7,Thyroxine-binding globulin,39979,-0.011970539417737,0.0018695181224139,-0.0156347949376683,-0.00830628389780579,1.58344039402238e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AZI2,5-azacytidine-induced protein 2,39934,-0.0363140167183861,0.00568202725337177,-0.0474507901349947,-0.0251772433017774,1.71236020053082e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,-0.0442302204160714,0.00692838202184808,-0.0578098491788937,-0.0306505916532492,1.78373277145761e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSTN,Growth/differentiation factor 8,41900,-0.0350191285665268,0.00548625403003843,-0.0457721864654021,-0.0242660706676514,1.79337059570808e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,-0.0215793406449224,0.00338248282233537,-0.0282090069766997,-0.0149496743131451,1.83176248152658e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSNAX,Translin-associated protein X,39575,-0.0255555182711184,0.00401108708604015,-0.0334172489597571,-0.0176937875824797,1.95040980126569e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATRN,"Attractin, Isoform 2",39979,-0.010806416791994,0.00169702230687148,-0.0141325805134621,-0.00748025307052595,1.99055619259237e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RWDD1,RWD domain-containing protein 1,42249,-0.0402045846953992,0.00631622980733787,-0.0525843951177814,-0.027824774273017,2.01164282595646e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,-0.0260817313193512,0.00410150934443595,-0.0341206896344457,-0.0180427730042568,2.10807585034434e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,-0.0249708658360414,0.00393193807000768,-0.0326774644532565,-0.0172642672188264,2.22409136275604e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,-0.024973633598263,0.00393409718145721,-0.0326844640739192,-0.0172628031226069,2.26747957119724e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRY2,Protein sprouty homolog 2,41913,-0.059854839044124,0.00943472349624542,-0.078346897096765,-0.041362780991483,2.30968743864093e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFLAM,Pikachurin,39930,-0.020011653273057,0.00315492739893667,-0.0261953109749729,-0.0138279955711411,2.33942203069686e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYDGF,Myeloid-derived growth factor,39958,-0.0642851134395969,0.010154051982177,-0.0841870553246639,-0.04438317155453,2.52794389306481e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YJU2,Splicing factor YJU2,39919,-0.0213074496003773,0.00337768602694294,-0.0279277142131854,-0.0146871849875691,2.92646973873518e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,-0.0699221010490758,0.0110878362500166,-0.0916542600991084,-0.0481899419990432,2.94826020831208e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,-0.0310653031182218,0.00493462706604712,-0.0407371721676741,-0.0213934340687694,3.1797702809511e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,-0.066573713143496,0.0105850100459889,-0.0873203328336343,-0.0458270934533577,3.28473928211649e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,-0.0498797248569987,0.00793614976591593,-0.0654345783981939,-0.0343248713158034,3.39614684980824e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL34,Interleukin-34,41814,-0.0232970262864867,0.00370880016503096,-0.0305662746099474,-0.0160277779630261,3.45716723959278e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,-0.0368124374610184,0.00586277277064084,-0.0483034720914745,-0.0253214028305624,3.51367348143451e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,-0.0324708495217522,0.00517402376872594,-0.0426119361084551,-0.0223297629350494,3.58764935158729e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,-0.0277592329989405,0.00442408760711506,-0.036430444708886,-0.019088021288995,3.61529583391044e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,-0.0188036128891584,0.00300825228775125,-0.0246997873731509,-0.012907438405166,4.21089591968424e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,-0.0357537657445906,0.00572393266894305,-0.046972673775719,-0.0245348577134622,4.35343666899908e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,-0.0424190868163048,0.00680378785857635,-0.0557545110191144,-0.0290836626134951,4.68957282907942e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,-0.044539859614397,0.00714680744886107,-0.0585476022141647,-0.0305321170146293,4.76756695216818e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,-0.0182879109629081,0.00293882716449575,-0.0240480122053198,-0.0125278097204965,5.02511746314628e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISM1,Isthmin-1,42119,-0.024944471237877,0.00400965635505902,-0.0328033976937927,-0.0170855447819614,5.08239933453471e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP1,Caspase-1,41839,-0.043510033170005,0.00699493805511555,-0.0572201117580314,-0.0297999545819785,5.11411917194904e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMOX1,Heme oxygenase 1,42007,0.0310225812803441,0.00499784716233576,0.021226800842166,0.0408183617185221,5.55306030859186e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,-0.0144107940981277,0.00232514440069872,-0.0189680771234972,-0.00985351107275821,5.92453824963596e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,-0.051299805568031,0.00828326309939592,-0.067535001242847,-0.035064609893215,6.10013433138226e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGA4,Pepsin A-4,39990,-0.0473426669029836,0.00764798531725237,-0.0623327181247983,-0.032352615681169,6.21491191451111e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6L,Seizure 6-like protein,42181,-0.017267229207194,0.00279198722619367,-0.0227395241705336,-0.0117949342438545,6.40592279953775e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,-0.0279791665980614,0.00452452554922971,-0.0368472366745517,-0.0191110965215712,6.43356704485573e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,-0.0223350388990131,0.00362467673381347,-0.0294394052972875,-0.0152306725007387,7.39336150222281e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.0329410679433981,0.00534540293386137,-0.0434180576937664,-0.0224640781930298,7.4038285162245e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,-0.0240565654544664,0.00390684485274684,-0.0317139813658502,-0.0163991495430826,7.63894030382827e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,A1BG,Alpha-1B-glycoprotein,39979,-0.0103581674866973,0.00168384323569945,-0.0136585002286682,-0.0070578347447264,7.93294951492838e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,0.0194354874751406,0.00316289569127756,0.0132362119202366,0.0256347630300446,8.25982221463872e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCN2,Ficolin-2,42116,-0.0252864845688437,0.00411665458803631,-0.0333551275613949,-0.0172178415762926,8.35194585875515e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,0.0204568690986465,0.00333895422167682,0.0139125188241599,0.0270012193731331,9.21891187504365e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL22,Interleukin-22,39919,-0.0440016685259406,0.0071865560235701,-0.058087318332138,-0.0299160187197432,9.50072067527228e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,-0.0642476287061774,0.0104985908174497,-0.0848248667083787,-0.043670390703976,9.69674637345624e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,-0.0296653007570787,0.00484965956696916,-0.0391706335083383,-0.0201599680058192,9.85012101988986e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,-0.0142586699157391,0.00233562961033485,-0.0188365039519954,-0.00968083587948275,1.05738884463371e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,0.0265592205171416,0.004365220236657,0.0180033888532939,0.0351150521809893,1.20153323517737e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIAPIN1,Anamorsin,42181,-0.0378087422159732,0.00621743950782178,-0.0499949236513039,-0.0256225607806425,1.2257857105374e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,-0.0466334886625863,0.0076864026678191,-0.0616988378915118,-0.0315681394336609,1.33811485112389e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIF,Leukemia inhibitory factor,41839,-0.0308191320349171,0.00508322175336972,-0.0407822466715217,-0.0208560173983124,1.37314297429203e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,-0.0599993573032512,0.00990515355695868,-0.0794134582748902,-0.0405852563316122,1.42850010120965e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXJ3,Forkhead box protein J3,39657,-0.0279980070501479,0.00462377764545387,-0.0370606112352375,-0.0189354028650583,1.44777644403393e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOK2,Docking protein 2,42145,-0.0754818442567715,0.0124699701715562,-0.0999229857930218,-0.0510407027205213,1.45846931300801e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL2,C-C motif chemokine 2,41992,-0.0318145662513743,0.00525738989881345,-0.0421190504530486,-0.0215100820496999,1.47425079933721e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,-0.0507002538370873,0.00839633636431955,-0.0671570731111536,-0.034243434563021,1.5975114054948e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,-0.0411320294432978,0.00681716294406174,-0.0544936688136588,-0.0277703900729368,1.64528937244752e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,-0.0492726440742304,0.00817684065124199,-0.0652992517506646,-0.0332460363977961,1.72558103507545e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGA,Protein O-GlcNAcase,39930,-0.0438034432337781,0.00729127028413285,-0.0580943329906785,-0.0295125534768777,1.94006343343618e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,-0.0386002817015663,0.0064266665307742,-0.0511965481018837,-0.0260040153012489,1.95859222433062e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,-0.0217008171463333,0.00361338446439271,-0.028783050696543,-0.0146185835961236,1.96386828359523e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.0352056896539949,0.00586967726435529,-0.0467102570921313,-0.0237011222158586,2.04974906410147e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,0.00941881849538288,0.00157022417823619,0.00634117910603994,0.0124964578847258,2.05339774702178e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA4D,Semaphorin-4D,42249,-0.018295460900358,0.00305174293842882,-0.0242768770596784,-0.0123140447410375,2.08509582307135e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACE,Angiotensin-converting enzyme,39990,-0.0165179168533273,0.00275688042372551,-0.0219214024838293,-0.0111144312228253,2.14167122573604e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,-0.0117620765352746,0.0019637298588368,-0.0156109870585947,-0.00791316601195443,2.15630845430407e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,-0.067774921695036,0.0113243222612109,-0.0899705933270094,-0.0455792500630625,2.22054574684501e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH1,Protocadherin-1,42264,-0.0125045106011328,0.00209151631148036,-0.0166038825716343,-0.00840513863063125,2.30559132374496e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,-0.0456636385664637,0.00763738055743865,-0.0606329044590435,-0.030694372673884,2.31309951189378e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MB,Myoglobin,42310,-0.0340171258209149,0.00569232869288754,-0.0451740900589745,-0.0228601615828553,2.3441348075857e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,-0.0337980769249322,0.00565999993682113,-0.0448916768011016,-0.0227044770487628,2.42469485504328e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,-0.0171593982084858,0.00287431084334662,-0.0227930474614452,-0.0115257489555264,2.44718867242028e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MINK1,Misshapen-like kinase 1,39929,-0.0565309738008909,0.00950629341735402,-0.0751633088989047,-0.037898638702877,2.81693466881507e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENAH,Protein enabled homolog,41913,-0.0291064379627886,0.0048967999253837,-0.0387041658165407,-0.0195087101090366,2.85158112161402e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.0230582790761907,0.00388120993012187,-0.0306654505392296,-0.0154511076131519,2.91607163901683e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.0413045870778864,0.00695492300060409,-0.0549362361590704,-0.0276729379967024,2.93931433446726e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,-0.0557425640414951,0.0093981197116253,-0.0741628786762807,-0.0373222494067095,3.09658259940119e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTF2,Transcription termination factor 2,39649,-0.0301053535956616,0.00507933394692979,-0.040060848131644,-0.0201498590596792,3.1768075369251e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFC,Vascular endothelial growth factor C,42181,-0.0332886863820301,0.00561835953214093,-0.0443006710650263,-0.0222767016990339,3.19890991628394e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XRCC4,DNA repair protein XRCC4,41839,-0.0221774301453085,0.00374635900573604,-0.0295202937965512,-0.0148345664940659,3.30455799872394e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,-0.0243237031792571,0.00411032369118549,-0.0323799376139806,-0.0162674687445335,3.35918841934961e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.0164037528553598,0.00277362701019727,0.0109674439153731,0.0218400617953464,3.43114330077435e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,-0.0743028964150779,0.0125757730456868,-0.098951411584624,-0.0496543812455317,3.53972823845996e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,-0.0310837244391274,0.00526439756026592,-0.0414019436572486,-0.0207655052210062,3.64099198314134e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AAMDC,Mth938 domain-containing protein,39638,-0.031940878746634,0.00541084524278068,-0.0425461354224842,-0.0213356220707839,3.67182973204246e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,-0.0217402071575237,0.00369114745226751,-0.028974856163968,-0.0145055581510794,3.97949794254706e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TADA3,Transcriptional adapter 3,39919,-0.024331247759662,0.00413254270098471,-0.032431031453592,-0.016231464065732,4.02681477477038e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0251249201281154,0.00426819486897488,-0.0334905820713061,-0.0167592581849246,4.05727473232791e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IST1,IST1 homolog,39850,-0.0591324377056252,0.0100489731551796,-0.0788284250897773,-0.0394364503214731,4.10824897704281e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL1,Growth-regulated alpha protein,42117,-0.0555574999051846,0.00944293023140099,-0.0740656431587305,-0.0370493566516386,4.11179978430092e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,-0.0284147304190589,0.00483000329426217,-0.0378815368758127,-0.018947923962305,4.14381870511916e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL15,Interleukin-15,42119,-0.0196639142681788,0.00334475598957677,-0.0262196360077493,-0.0131081925286083,4.22417280780731e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,-0.0401511952450595,0.00683922510201834,-0.0535560764450154,-0.0267463140451035,4.46380703713593e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.0114588863319133,0.00195282213158773,-0.0152864177098253,-0.00763135495400138,4.51707446878144e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,-0.0135993077546966,0.0023187353700196,-0.018144029079935,-0.00905458642945818,4.59570171786308e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMS1,PMS1 protein homolog 1,39649,-0.0295436981306674,0.00504176670867877,-0.0394255608796777,-0.019661835381657,4.76684787285094e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM13A,Protein FAM13A,39930,-0.0406134038939913,0.00693839802446921,-0.054212664021951,-0.0270141437660317,4.94895202325417e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,-0.0617572102810232,0.0105520586199712,-0.0824392451761668,-0.0410751753858796,4.95042091293096e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.0169249470556465,0.00289371827634094,-0.0225966348772748,-0.0112532592340183,5.06379186937496e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,-0.0177221469779618,0.00303233354182916,-0.023665520719947,-0.0117787732359766,5.22393666373533e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,-0.0269037138779159,0.0046043974572458,-0.0359283328941177,-0.0178790948617141,5.24593792526208e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGCC,Regulator of cell cycle RGCC,39934,-0.0457280424195612,0.00782542800139535,-0.0610658813022961,-0.0303902035368263,5.25160853931956e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL3,Fc receptor-like protein 3,41913,-0.0317778106206565,0.00544240351087679,-0.042444921501975,-0.021110699739338,5.37625226344947e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNXB,Tenascin-X,42137,0.0154578509589087,0.00264867866149123,0.0102664407823859,0.0206492611354315,5.46725642498434e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,-0.0196918851802113,0.00337490708349752,-0.0263067030638665,-0.0130770672965562,5.50775237248346e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,-0.0178771569860218,0.00306933093677821,-0.0238930456221071,-0.0118612683499365,5.88728109118701e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0185981906035002,0.00319552329143826,-0.0248614162547192,-0.0123349649522813,6.01764133570129e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDHB15,Protocadherin beta-15,39919,-0.0236372427769213,0.00406769357700842,-0.0316099221878578,-0.0156645633659848,6.37868449908339e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MIF,Macrophage migration inhibitory factor,42105,-0.039275458779283,0.00677905213157753,-0.052562400957175,-0.0259885166013911,7.04081427331113e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YWHAQ,14-3-3 protein theta,39736,-0.0437549891489448,0.0075689850058597,-0.0585901997604298,-0.0289197785374598,7.63307937142963e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSMB,Beta-microseminoprotein,42103,-0.0408718629732996,0.00707731760026544,-0.0547434054698199,-0.0270003204767793,7.86240262402444e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARSA,Arylsulfatase A,42137,-0.0263842987503526,0.00457075873613853,-0.0353429858731841,-0.017425611627521,7.9858242691385e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17RA,Interleukin-17 receptor A,42137,-0.0258811556524875,0.00449578598944762,-0.0346928961918049,-0.0170694151131702,8.76040209195409e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS27,Serine protease 27,42107,-0.0234737428355242,0.00407939037821695,-0.0314693479768295,-0.015478137694219,8.89273418903496e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,-0.0519047760182202,0.00902516133040904,-0.0695940922258219,-0.0342154598106185,9.09473968793034e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSHB,Thyrotropin subunit beta,42145,-0.0397100700705514,0.00691372046878689,-0.0532609621893737,-0.0261591779517291,9.46413786983362e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPAG1,Sperm-associated antigen 1,39934,-0.0342826063630563,0.00597028156905767,-0.0459843582384093,-0.0225808544877032,9.58503198410948e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXN,Thioredoxin,39854,-0.0252064605112637,0.00439031066992043,-0.0338114694243078,-0.0166014515982197,9.63345397537034e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL5,C-X-C motif chemokine 5,42101,-0.0655847131011302,0.0114269600513746,-0.0879815548018245,-0.0431878714004359,9.70135792218332e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,-0.0387279835483087,0.00676224742846235,-0.0519819885080949,-0.0254739785885225,1.04767482799209e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRAP,BRCA1-associated protein,39813,-0.0643167401631306,0.0112336631222897,-0.0863347198828185,-0.0422987604434428,1.05866174147311e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARSB,Arylsulfatase B,42070,-0.032210364256226,0.0056403446646061,-0.0432654397988539,-0.021155288713598,1.14883139573662e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,-0.0156858035872102,0.00274789422098847,-0.0210716762603476,-0.0102999309140728,1.16474133501684e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELOB,Elongin-B,39575,-0.0227989428865237,0.00400317235276134,-0.0306451606979359,-0.0149527250751115,1.26380299561077e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFP,Properdin,39979,-0.0137013774692016,0.00241254260707973,-0.0184299609790779,-0.00897279395932532,1.3862042587779e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPI,Glucose-6-phosphate isomerase,39990,-0.0276576706441404,0.00488190494909001,-0.0372262043443568,-0.018089136943924,1.50287738116257e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC3B,Tetranectin,39726,0.0121276718081534,0.00214080779464538,0.00793168853064843,0.0163236550856583,1.50675885020924e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,-0.0235869330343522,0.00416498358836641,-0.0317503008675504,-0.0154235652011541,1.51621188122706e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYAP1,Synapse-associated protein 1,39736,-0.0338532603122509,0.00597936726824465,-0.0455728201580104,-0.0221337004664914,1.53607692259419e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRG2,Bone marrow proteoglycan,39966,-0.0295506245105766,0.00522704463266242,-0.0397956319905949,-0.0193056170305582,1.61086451292916e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,0.016276847575001,0.00288031319216372,0.0106314337183601,0.0219222614316419,1.6262839346256e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAN,Neurocan core protein,42249,0.0214497696001544,0.00380241412794491,0.0139970379093824,0.0289025012909265,1.72331027340772e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,-0.0233497433195125,0.00414170107122515,-0.0314674774191138,-0.0152320092199112,1.75844819960617e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.0418780496695571,0.00742946836247757,-0.0564398076600131,-0.027316291679101,1.76755014440002e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD33,Myeloid cell surface antigen CD33,42181,-0.0453023923897627,0.00806212692593349,-0.0611041611645923,-0.0295006236149331,1.95659286231531e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSB,Cathepsin B,42153,0.0289192320081122,0.00514927969228621,0.0188266438112313,0.0390118202049932,1.99074750081143e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL13,C-C motif chemokine 13,42275,-0.0388243338335716,0.0069136581675012,-0.052375103841874,-0.0252735638252693,1.99697265956099e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,-0.0249667005336787,0.00445217961909606,-0.033692972587107,-0.0162404284802504,2.09899937916642e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,-0.061956882038186,0.011057132817884,-0.0836288623612387,-0.0402849017151333,2.15168175782295e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAU,Urokinase-type plasminogen activator,42137,-0.0162039549393331,0.00289379513863807,-0.0218757934110637,-0.0105321164676025,2.1908860823252e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JUN,Transcription factor AP-1,41913,-0.0274407743069677,0.00490729434047282,-0.0370590712142944,-0.0178224773996409,2.29105831968619e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,-0.0446179894753987,0.00799459182881526,-0.0602873894598766,-0.0289485894909208,2.43805225204055e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL8,C-C motif chemokine 8,42239,-0.0342365393855337,0.00615239846679399,-0.0462952403804499,-0.0221778383906175,2.67480832798539e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,-0.0293415916308815,0.00528910353705343,-0.0397082345635062,-0.0189749486982568,2.95069246029659e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM,Paralemmin-1,39859,-0.0173117809991958,0.0031236404069124,-0.0234341161967441,-0.0111894458016475,3.05449896793239e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNA4,Plexin-A4,42119,-0.0452410076096758,0.00817090208477536,-0.0612559756958354,-0.0292260395235161,3.13712729532271e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAX,Protein max,41839,-0.059628298848652,0.0107748028240605,-0.0807469123838105,-0.0385096853134935,3.18865899114696e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST6,Cystatin-M,41864,-0.027828351483822,0.00505451350771484,-0.0377351979589431,-0.0179215050087009,3.74658713263061e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,0.0248887277677139,0.00453402904669701,0.0160020308361878,0.0337754246992401,4.10751490338638e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR2,Complement factor H-related protein 2,39904,-0.03188681718235,0.00581125897647936,-0.0432768847762496,-0.0204967495884505,4.17450232060092e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP4,Guanylate-binding protein 4,41839,-0.0273008514795852,0.00498042554967335,-0.0370624855569449,-0.0175392174022254,4.29139863175328e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRKL,Crk-like protein,42143,-0.0585809918449986,0.0106987781352924,-0.0795505969901717,-0.0376113866998255,4.44090100232149e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDI2,Protein DDI1 homolog 2,39736,-0.0418403572044417,0.00764566665647737,-0.0568258638511374,-0.0268548505577461,4.53524746100289e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,-0.0189040295564052,0.00346590969886481,-0.0256972125661802,-0.0121108465466302,5.00374046570121e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,-0.0399020794881978,0.00732927543408272,-0.054267459339,-0.0255366996373957,5.31393561635654e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PODXL2,Podocalyxin-like protein 2,42181,-0.0157714320582543,0.00289909730464136,-0.0214536627753514,-0.0100892013411573,5.4167525553181e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,-0.0199648394471354,0.0036779442289169,-0.0271736101358126,-0.0127560687584583,5.80786884357783e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,-0.0137007222776968,0.00252394163770163,-0.018647647887592,-0.00875379666780164,5.80963249274443e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRL,Prolactin,42249,-0.040462095923967,0.00746849532386597,-0.0551003467587443,-0.0258238450891897,6.1393107423234e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,-0.0345462053458469,0.00637644356314596,-0.047044034729613,-0.0220483759620808,6.15758459024121e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.0185236134288178,0.0034209796529134,-0.0252287335485281,-0.0118184933091076,6.24469669648749e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,-0.0294843592627873,0.00544656844519575,-0.0401596334153709,-0.0188090851102036,6.31401613490971e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDGF,Hepatoma-derived growth factor,42243,-0.0500247475154603,0.00927293185476446,-0.0681996939507987,-0.031849801080122,6.97809087994159e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0139738616533694,0.0025917025961481,0.00889412456491908,0.0190535987418196,7.09246473911217e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,-0.0274972384258872,0.00510086954772004,-0.0374949427394185,-0.017499534112356,7.1615403485717e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,-0.0262552873503475,0.00487907302504282,-0.0358182704794314,-0.0166923042212635,7.52424502745597e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,-0.0113365942835926,0.00211175557604434,-0.0154756352126395,-0.00719755335454575,8.07882369458103e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,-0.0482472186892881,0.00899104322563504,-0.0658696634115328,-0.0306247739670434,8.2063236572096e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSPN,Persephin,42119,-0.0468628209180376,0.00878013636340066,-0.0640718881903029,-0.0296537536457723,9.58287509238226e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAFB2,Scaffold attachment factor B2,39934,-0.0148509564350755,0.00278414189138113,-0.0203078745421825,-0.00939403832796846,9.78550201120907e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK8,Kallikrein-8,41668,-0.0198617001432433,0.00372458407721325,-0.0271618849345813,-0.0125615153519053,9.84315123494758e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN2L,Ataxin-2-like protein,39934,-0.026220644939591,0.00491711842896207,-0.0358581970603567,-0.0165830928188254,9.87197238603833e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,-0.0263513145465816,0.00494615639144246,-0.0360457810738088,-0.0166568480193544,1.01088744203576e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,-0.036567617772642,0.00686401002217451,-0.050021077416104,-0.02311415812918,1.01575977406697e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRP2,Neuropilin-2,42137,-0.0151800781692415,0.00284998199322546,-0.0207660428759634,-0.00959411346251957,1.01794471800094e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSNK1D,Casein kinase I isoform delta,39657,-0.0349902002902259,0.00657208390437436,-0.0478714847427997,-0.0221089158376522,1.03461388552943e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,-0.0135318241283058,0.00254481689089667,-0.0185196652344632,-0.00854398302214829,1.06925045489386e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,-0.0495973817068369,0.00932912007119988,-0.0678824570463887,-0.0313123063672851,1.07843795998399e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,-0.0110722291146239,0.0020838739657918,-0.0151566220875758,-0.00698783614167199,1.09755055436014e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,-0.0155879404918003,0.00293448190584748,-0.0213395250272614,-0.00983635595633925,1.10483158915025e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,-0.0481178068745888,0.00906554080955595,-0.0658862668613185,-0.0303493468878592,1.13070171596534e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MITD1,MIT domain-containing protein 1,42016,-0.0519375499201449,0.00979583663998835,-0.0711373897345221,-0.0327377101057678,1.16356098333216e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,-0.0282244252993542,0.00532439698569362,-0.0386602433913137,-0.0177886072073947,1.17360808001197e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,-0.0458927811249162,0.00868772570146337,-0.0629207234997844,-0.028864838750048,1.2986827927676e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,-0.0130692134867831,0.00247710309900528,-0.0179243355608334,-0.00821409141273275,1.3405835572364e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,-0.0232320664241982,0.00441115369353928,-0.0318779276635352,-0.0145862051848613,1.4153778061596e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAP3,Cytosol aminopeptidase,41913,-0.0256768285606868,0.00487998231808734,-0.0352415939041379,-0.0161120632172356,1.44972373584244e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,-0.0150829960774398,0.0028764735423708,-0.0207208842204866,-0.00944510793439304,1.59867021139932e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,-0.0217001563181778,0.00414359091955972,-0.0298215945205148,-0.0135787181158407,1.66095864478365e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,-0.0276361709875103,0.00527846115694505,-0.0379819548551226,-0.017290387119898,1.66921497777823e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA4C,Semaphorin-4C,42070,-0.0148097332163025,0.00282972679952724,-0.0203559977433759,-0.00926346868922909,1.68712512518216e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,-0.0643972555691107,0.012309128752149,-0.0885231479233228,-0.0402713632148987,1.7108504713971e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,-0.0220676267157104,0.00421914404049979,-0.03033714903509,-0.0137981043963308,1.71762887413416e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,-0.0377205924255444,0.00721219200491342,-0.0518564887551747,-0.0235846960959141,1.72472361795973e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0252502386702501,0.00482876071723593,-0.0347146096760326,-0.0157858676644677,1.72843615552125e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,-0.0322564768952095,0.00617270519602365,-0.0443549790794159,-0.0201579747110032,1.76101749921977e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,-0.0211508938335762,0.00404923123082112,-0.0290873870459856,-0.0132144006211668,1.78298518796401e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCC,Tubulin-specific chaperone C,42016,-0.0425800996000539,0.00815215285857588,-0.0585583192028626,-0.0266018799972451,1.78515215966744e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,-0.0494681694713852,0.00948880578173197,-0.0680662288035799,-0.0308701101391906,1.88246858327423e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,-0.029362168144962,0.00563494928581683,-0.0404066687451629,-0.018317667544761,1.91517966875925e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNGR2,Interferon gamma receptor 2,42016,-0.0278884270425463,0.00535318277981187,-0.0383806652909775,-0.017396188794115,1.91957557529584e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRAS,Ras-related protein R-Ras,39649,-0.0699255400482682,0.0134258985423205,-0.0962403011912163,-0.04361077890532,1.94051359495177e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,-0.0169097692334471,0.00324704219573487,-0.0232739719370875,-0.0105455665298067,1.94606256083357e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN9,Septin-9,42070,-0.0152148114624603,0.00292214690171288,-0.0209422193898175,-0.00948740353510306,1.95033323163622e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,-0.0174418132235721,0.00334980129382896,-0.0240074237594769,-0.0108762026876674,1.95559764715122e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.0415107773261049,0.00797426835367701,-0.0571403432993119,-0.025881211352898,1.96273751330725e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTF1,Cardiotrophin-1,41900,-0.0447138050743271,0.00859322654321901,-0.0615565290990364,-0.0278710810496179,1.98608891025024e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,-0.0154664933115147,0.00297545532366528,-0.0212983857458986,-0.00963460087713073,2.0492107279605e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,-0.0177410522243416,0.00341706310075306,-0.0244384959018176,-0.0110436085468656,2.11765176340102e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,-0.0205127687324151,0.00395270907644634,-0.0282600785222499,-0.0127654589425803,2.14549926631961e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,-0.0282239811945739,0.00544407416917676,-0.0388943665661604,-0.0175535958229874,2.19864135663268e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPLAH,5-oxoprolinase,39638,-0.0366723784859499,0.00709230100559716,-0.0505732884569204,-0.0227714685149795,2.37262950799984e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASPN,Asporin,39958,0.0146410905850224,0.00284075936748936,0.00907320222474323,0.0202089789453015,2.59360270750298e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,-0.0532344156058071,0.0103376661871438,-0.0734962413326089,-0.0329725898790053,2.6476905815349e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMNB1,Lamin-B1,39908,-0.0320620590987159,0.00623931841898042,-0.0442911231999175,-0.0198329949975142,2.81242161758467e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB44,Ras-related protein Rab-44,39919,-0.0235342063489063,0.00458315259739957,-0.0325171854398095,-0.0145512272580032,2.86925793673787e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN6,Dynactin subunit 6,41839,-0.0376294832598204,0.00733195273190648,-0.0520001106143571,-0.0232588559052837,2.90339178829599e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PADI4,Protein-arginine deiminase type-4,41814,-0.0380660658305277,0.00742069856161249,-0.0526106350112882,-0.0235214966497672,2.94291457194034e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMOTL2,Angiomotin-like protein 2,39882,-0.0255842130439265,0.00498932237463375,-0.0353632848982087,-0.0158051411896444,2.98018809698195e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSR,Insulin receptor,39657,-0.00896495730936727,0.00175026425673169,-0.0123954752525614,-0.00553443936617315,3.07307962149961e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,-0.0255876251428058,0.00500721310871984,-0.0354017628358967,-0.0157734874497149,3.27141489738421e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,-0.0529037811741038,0.0103538736717644,-0.0731973735707621,-0.0326101887774456,3.27342085798234e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD109,CD109 antigen,42137,-0.0176418722250838,0.00345809291061086,-0.0244197343298811,-0.0108640101202865,3.41316947234217e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,-0.0236397536457794,0.00464528667482579,-0.0327445155284379,-0.0145349917631208,3.65789885402224e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,-0.0537910301526784,0.0105920080049317,-0.0745513658423445,-0.0330306944630124,3.85582925639498e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THPO,Thrombopoietin,41900,0.0201230332129854,0.00396315750509172,0.0123552445030056,0.0278908219229652,3.87552944604661e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,-0.0325752494390451,0.00643236027911668,-0.0451826755861138,-0.0199678232919764,4.15467820234604e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DXO,Decapping and exoribonuclease protein,39929,-0.0234233941519311,0.0046253811515641,-0.0324891412089967,-0.0143576470948654,4.16787001751866e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP2,Guanylate-binding protein 2,41913,-0.0312022203550472,0.00616580634978617,-0.0432872008006281,-0.0191172399094663,4.23677612554631e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.0153734589897607,0.0030438735519925,0.00940746682785538,0.021339451151666,4.46079105355047e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,-0.0466388350652519,0.009237013163989,-0.0647433808666703,-0.0285342892638335,4.5090938610945e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK24,Serine/threonine-protein kinase 24,41839,-0.0318299679072832,0.00631178026744022,-0.044201057231466,-0.0194588785831004,4.64482908257405e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,-0.048523429810402,0.0096486567133693,-0.0674347969686058,-0.0296120626521981,5.00498129645018e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,-0.027494864107674,0.00546760064764938,-0.0382113613770668,-0.0167783668382812,5.01402180880948e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G1B,Phospholipase A2,42299,-0.0227130018851836,0.00452232392203976,-0.0315767567723816,-0.0138492469979857,5.16669407146163e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UROS,Uroporphyrinogen-III synthase,39649,-0.0338759438061297,0.00674558713011624,-0.0470972945811575,-0.0206545930311019,5.19504055532625e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOBR,Apolipoprotein B receptor,39638,0.0220178986497416,0.00438566242482864,0.0134220002970774,0.0306137970024057,5.23615269147701e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,-0.0443552916363739,0.00883987391876195,-0.0616814445171474,-0.0270291387556005,5.31039096909491e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TK1,"Thymidine kinase, cytosolic",39757,-0.0242134743666376,0.00482969894653441,-0.0336796843018451,-0.0147472644314302,5.42826590646344e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,-0.014590770993005,0.0029130408164144,-0.0203003309931772,-0.00888121099283275,5.56004733282949e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST1,Cystatin-SN,38503,-0.0547848311548754,0.0109375681700089,-0.0762224647680929,-0.0333471975416579,5.56960399231348e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,-0.0368478405040514,0.0073590552147003,-0.051271588724864,-0.0224240922832388,5.59425996040477e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX16,Syntaxin-16,41843,-0.0290828255693575,0.00580948814142958,-0.0404694223265595,-0.0176962288121555,5.6260553365448e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MBL2,Mannose-binding protein C,39826,0.0562309803062254,0.0112362732366621,0.0342078847623676,0.0782540758500832,5.6881115821401e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_A,,39934,-0.0167545334664142,0.0033538252975688,-0.0233280310496491,-0.0101810358831794,5.95126369354975e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,-0.0461570887724355,0.00924104714788949,-0.0642695411822989,-0.0280446363625721,5.97778464143429e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C8B,Complement component C8 beta chain,39979,0.0153644615248995,0.00308114323188414,0.00932542079040654,0.0214035022593924,6.23539509111587e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,-0.0351790060332052,0.00705884865600639,-0.0490143493989777,-0.0213436626674327,6.33398865173757e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,-0.0455334377779817,0.00914665337890939,-0.0634608784006441,-0.0276059971553193,6.51362353391523e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,-0.0183923066606484,0.00369643333404961,-0.0256373159953857,-0.0111472973259112,6.59955932685653e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,0.0184049595074379,0.00370602621190993,0.0111411481320944,0.0256687708827813,6.9108534968765e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,-0.0201017617950766,0.00405347727343264,-0.0280465772510046,-0.0121569463391486,7.18334214268194e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDC,Nuclear migration protein nudC,42296,-0.0319425354770653,0.00644829964319803,-0.0445812027777335,-0.0193038681763972,7.37080119378582e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,-0.0633722591884698,0.0128042504769799,-0.0884685901233504,-0.0382759282535893,7.55734944641784e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPD52L2,Tumor protein D54,39736,-0.0549625010774674,0.0111169096211464,-0.0767516439349144,-0.0331733582200203,7.76335636440275e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0191366214764646,0.00387138900542463,0.0115486990258323,0.0267245439270969,7.78353252486455e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMP,Cartilage oligomeric matrix protein,42042,0.0167209204397703,0.00338300006984245,0.0100902403028791,0.0233516005766615,7.80042753936574e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL4,Early placenta insulin-like peptide,39919,-0.0242452803739871,0.00491618298191115,-0.033880999018533,-0.0146095617294412,8.26627530239666e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RCC1,Regulator of chromosome condensation,39919,-0.0262407473593858,0.00532451819503391,-0.0366768030216522,-0.0158046916971193,8.41292719986424e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1S,Complement C1s subcomponent,39979,-0.0105976804688967,0.0021505236201934,-0.0148127067644757,-0.00638265417331761,8.42658803156859e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRG,Histidine-rich glycoprotein,39925,-0.0156307395953365,0.00317231972073993,-0.0218484862479868,-0.00941299294268627,8.45846340277177e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINE2,Glia-derived nexin,39958,-0.0326141664933449,0.00662345043982203,-0.0455961293553961,-0.0196322036312938,8.59661203501547e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,-0.0383009820424923,0.00778407163915677,-0.0535577624552395,-0.023044201629745,8.73697026486086e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEXN,Nexilin,39990,-0.0350205316468253,0.00712261317982677,-0.0489808534792858,-0.0210602098143649,8.91932094448204e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX6,Syntaxin-6,41843,-0.0328198271522217,0.00667806147968243,-0.0459088276523993,-0.0197308266520442,9.00405355774704e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMMD1,COMM domain-containing protein 1,39638,-0.030579792533513,0.0062348096963078,-0.0428000195382763,-0.0183595655287497,9.49106474796293e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB7,Integrin beta-7,42262,-0.0229651251251388,0.00468484598075758,-0.0321474232474236,-0.0137828270028539,9.59542466180142e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA2,Integrin alpha-2,39736,0.0173096063002776,0.00353428196425524,0.0103824136503373,0.0242367989502179,9.8362677394082e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBNL,Drebrin-like protein,42185,-0.0460169805751214,0.0094099435561142,-0.0644604699451053,-0.0275734912051376,1.01860156061215e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F2R,Proteinase-activated receptor 1,42166,-0.028344651393986,0.00581640977969997,-0.039744814562198,-0.0169444882257741,1.11034432546311e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THTPA,Thiamine-triphosphatase,39897,-0.0436587222485425,0.0089620826606791,-0.0612244042634736,-0.0260930402336115,1.12261081480704e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRP1,Neuropilin-1,42230,-0.0135005492688218,0.00277353320488103,-0.0189366743503886,-0.00806442418725497,1.14206472043108e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAGED1,Melanoma-associated antigen D1,41843,-0.0238972049159627,0.0049123173664409,-0.0335253469541869,-0.0142690628777385,1.15918955070467e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,-0.0173588700587478,0.00357504480318438,-0.0243659578729892,-0.0103517822445064,1.21407772901956e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,-0.0294504471405499,0.00607320937374827,-0.0413539375130965,-0.0175469567680033,1.25582472854901e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYMP,Thymidine phosphorylase,42070,-0.0327409084482046,0.00675286912804421,-0.0459765319391712,-0.0195052849572379,1.25822773262868e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCN15,Lipocalin-15,39934,-0.0300374740040503,0.00619791444047512,-0.0421853863073816,-0.0178895617007191,1.2739884639568e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PZP,Pregnancy zone protein,39979,-0.0163722546877038,0.0033825193153705,-0.02300199254583,-0.00974251682957758,1.31376800471291e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,-0.028434545469713,0.0058797616155942,-0.0399588782362776,-0.0169102127031483,1.33946121499514e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD93,Complement component C1q receptor,41654,-0.0154638401372681,0.00319854617823775,-0.0217329906466141,-0.00919468962792214,1.34902356300757e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,-0.0332521944771824,0.00687964899343215,-0.0467363065043094,-0.0197680824500554,1.36032336257509e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,-0.0323556995133565,0.00669864602984161,-0.0454850457318461,-0.019226353294867,1.38250062110976e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,-0.0152646526423418,0.00316081342923573,-0.0214598469636438,-0.00906945832103974,1.38771825911553e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX3,Syntaxin-3,39929,-0.0187678762528619,0.00389069905927405,-0.0263936464090391,-0.0111421060966848,1.42697592750932e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMT,Catechol O-methyltransferase,41740,-0.0409109387506049,0.00848580743300327,-0.0575431213192913,-0.0242787561819185,1.44366445226345e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.0166972791561932,0.00347942188221587,-0.0235169460453363,-0.00987761226705007,1.61278593029318e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RSPO1,R-spondin-1,42016,-0.0165782968221858,0.00345658115312822,-0.0233531958823171,-0.0098033977620545,1.63479233093045e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCTN3,Tectonic-3,39958,-0.0148841431309925,0.00310478152832307,-0.0209695149265057,-0.00879877133547924,1.65609705878566e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP1,Retinol-binding protein 1,39649,-0.0343533978828081,0.00716812146945396,-0.0484029159629378,-0.0203038798026783,1.66840901224331e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,-0.0441094398461344,0.00923007340597381,-0.0622003837218431,-0.0260184959704257,1.78164903531125e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYO9B,Unconventional myosin-IXb,41913,-0.0319543720612068,0.00670343006364333,-0.0450930949859477,-0.0188156491364659,1.89090550386885e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICA1,Islet cell autoantigen 1,41913,-0.0387515917886395,0.0081295456350185,-0.0546855012332757,-0.0228176823440032,1.89192666642728e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDK1,Cyclin-dependent kinase 1,39560,-0.0177640752220732,0.00373247036848593,-0.0250797171443056,-0.0104484332998408,1.96715301842381e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1,Integrin beta-1,42167,0.0101908190482892,0.00214160038409593,0.00599328229546121,0.0143883558011173,1.97041618752098e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMCN2,Hemicentin-2,39721,-0.0281812413781553,0.00592391400500845,-0.0397921128279718,-0.0165703699283387,1.98765699933173e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,-0.0319847906709643,0.0067263195926718,-0.0451683770726011,-0.0188012042693276,2.00722326711953e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNB3,Plexin-B3,42099,-0.0231958860873304,0.00488009895566142,-0.0327608800404267,-0.013630892134234,2.02329042965909e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.0145579324569533,0.00306727842387058,-0.0205697981677397,-0.00854606674616697,2.09803215594224e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPH1,Neurexophilin-1,41839,-0.0187012144383009,0.0039436927765804,-0.0264308522803985,-0.0109715765962033,2.13765351506573e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0166522076925942,0.00351753976302423,-0.0235465856281217,-0.00975782975706671,2.22353257864221e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHAD,Chondroadherin,39736,0.0226635742805888,0.00478914154458566,0.0132768568532009,0.0320502917079766,2.24740563894798e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,-0.0320572521457956,0.00678704510500483,-0.0453598605516051,-0.0187546437399861,2.34832981434709e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,-0.0490324084353093,0.0103941316172664,-0.0694049064051514,-0.0286599104654671,2.41350579525185e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,-0.0161640589313814,0.00343373641976575,-0.0228941823141222,-0.0094339355486405,2.53361495590691e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.0169021129684572,0.00359592319791096,-0.0239501224363627,-0.00985410350055177,2.62269929444585e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,-0.0269223550340993,0.00572729212319952,-0.0381478475955704,-0.0156968624726283,2.62345574643645e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABHD14B,Protein ABHD14B,41976,-0.0266349106831385,0.0056683571473048,-0.037744890691856,-0.0155249306744211,2.64202434513317e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,-0.0356884619454133,0.00759820307230718,-0.0505809399671353,-0.0207959839236912,2.67212286289944e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,-0.0341689883331434,0.00729303528241521,-0.0484633374866772,-0.0198746391796096,2.82438655742586e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LACTB2,Endoribonuclease LACTB2,42145,-0.0313547096048103,0.00669358163390269,-0.0444741296072596,-0.018235289602361,2.83656010108643e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR1,Cadherin-related family member 1,41839,-0.0196813655487089,0.00420190281189245,-0.0279170950600181,-0.0114456360373997,2.84241710901467e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPART,Spartin,39736,-0.0371912196843572,0.0079444381174986,-0.0527623183946545,-0.02162012097406,2.88263153987627e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,-0.04115404940242,0.00879704693083682,-0.0583962613868602,-0.0239118374179798,2.92866295747578e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN5,Contactin-5,42170,0.0175790011190365,0.00376052317253835,0.0102083757008613,0.0249496265372116,2.97338964919946e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,-0.0187940960949466,0.00402207604835951,-0.0266773651497312,-0.010910827040162,3.00638685701509e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C4BPB,C4b-binding protein beta chain,42181,-0.018110805299764,0.00387704432217717,-0.0257098121712313,-0.0105117984282968,3.02182016669872e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,-0.0422940218828082,0.00905511769500693,-0.0600420525650218,-0.0245459912005946,3.03572036382436e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLGN,Calmegin,39649,-0.0217720461707524,0.00466189668592534,-0.0309093636751661,-0.0126347286663387,3.04435862733207e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS1BP3,HCLS1-binding protein 3,39638,-0.0435065409809466,0.00933003601348442,-0.061793411567376,-0.0252196703945171,3.15192567010381e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APP,Amyloid-beta precursor protein,42112,-0.0312118091656225,0.00670629764783863,-0.0443561525553862,-0.0180674657758587,3.28484483675176e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,-0.141372962707121,0.0303925162204897,-0.20094229449928,-0.0818036309149609,3.32536639560122e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,-0.0249288736277333,0.0053637985923716,-0.0354419188687817,-0.014415828386685,3.39572924175684e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,-0.0283912461817822,0.00611596471030903,-0.0403785370139879,-0.0164039553495765,3.47998376794679e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,0.0369655319061275,0.00797404997153296,0.0213363939619229,0.0525946698503321,3.58998296883127e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,-0.0396557053387101,0.00857946381072545,-0.056471454407732,-0.0228399562696883,3.83340448654752e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,-0.0330356654067049,0.00715350833279909,-0.0470565417389912,-0.0190147890744187,3.91518381997286e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX2,Sorting nexin-2,39919,-0.040186276398206,0.00872739223276801,-0.0572919651744314,-0.0230805876219807,4.17732983687026e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,-0.0393119107636796,0.00853863265396838,-0.0560476307654577,-0.0225761907619016,4.18280273437648e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,-0.0188154785049418,0.00409443442958318,-0.0268405699869248,-0.0107903870229588,4.35900741783777e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RP2,Protein XRP2,42070,-0.0198794561566665,0.00432836077797132,-0.0283630432814903,-0.0113958690318427,4.41221697609667e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,0.0277883027616762,0.00605338928402014,0.0159236597649967,0.0396529457583557,4.46864961427271e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCP1,Plastin-2,39966,-0.0224134018174283,0.00488491269420771,-0.0319878306980754,-0.0128389729367812,4.51671960311733e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB27B,Ras-related protein Rab-27B,39958,-0.0386269659261031,0.00842740803554525,-0.0551446856757718,-0.0221092461764344,4.6214998830275e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,-0.010860689514752,0.00237012125259636,-0.0155061271698409,-0.00621525185966315,4.63869217330196e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NID2,Nidogen-2,42137,-0.0338398749498253,0.00738985294965002,-0.0483239867311393,-0.0193557631685112,4.70838346399428e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA11,Annexin A11,42087,-0.0307988069642846,0.00673111666548236,-0.04399179562863,-0.0176058182999392,4.79122671635046e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,-0.018055341548622,0.00394616277671914,-0.0257898205909915,-0.0103208625062525,4.80320114890916e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,-0.0332001234477915,0.00726002057257524,-0.0474297637700389,-0.018970483125544,4.85950026909368e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FXN,"Frataxin, mitochondrial",42262,-0.0337499145817962,0.0073812885179486,-0.0482172400769754,-0.0192825890866169,4.86493584814368e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,-0.0320483036361174,0.0070089349826767,-0.0457858162021638,-0.0183107910700711,4.87142126943758e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TST,Thiosulfate sulfurtransferase,41809,-0.0350380846473015,0.00766684953600176,-0.050065109737865,-0.020011059556738,4.9196682039355e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPT1,Angiopoietin-1,42085,-0.0387351784628641,0.00848366478620713,-0.05536316144383,-0.0221071954818981,5.01864833864393e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLG4,Disks large homolog 4,39929,-0.033599704845343,0.00736368935608609,-0.0480325359832717,-0.0191668737074143,5.09845597804578e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD2,T-cell surface antigen CD2,39575,-0.0181297668259472,0.00397328427275601,-0.025917404000549,-0.0103421296513455,5.09951696815151e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,-0.021843905162929,0.00478811310373407,-0.0312286068462478,-0.0124592034796102,5.10965685053546e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,-0.0124533595974429,0.00272961754243782,-0.0178034099806211,-0.00710330921426481,5.11227003119991e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,-0.0311593561098042,0.00683962478505259,-0.0445650206885072,-0.0177536915311011,5.26749371085575e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,0.0197577748080156,0.00434182142852845,0.0112478048080999,0.0282677448079314,5.39678168547131e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,-0.0145978448397354,0.00321436048568461,-0.0208979913916772,-0.00829769828779357,5.64616345277456e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDC4,Syndecan-4,42145,0.0218200338374036,0.00480937793344299,0.0123936530878553,0.0312464145869519,5.75570096565481e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0357023894247739,0.00787017597537207,-0.0511279343365031,-0.0202768445130446,5.78049566277098e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,-0.0221840123456521,0.00489688909832733,-0.0317819149783736,-0.0125861097129305,5.95228997929392e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,-0.0378955225175991,0.00837850939029946,-0.0543174009225861,-0.0214736441126122,6.15035795414575e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,-0.0351903746866023,0.0077840766105334,-0.0504471648432477,-0.0199335845299568,6.22477916454071e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDHB,Succinate dehydrogenase,39930,-0.0303034916041514,0.0067063978639971,-0.0434480314175857,-0.0171589517907171,6.2881698488277e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,-0.0527188574137589,0.0117135805313022,-0.0756774752551112,-0.0297602395724065,6.84177632410274e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR1,TGF-beta receptor type-1,39657,-0.0101064870333357,0.00224568702998291,-0.0145080336121022,-0.00570494045456923,6.85189115037579e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,-0.0296026753860948,0.00658062075546759,-0.0425006920668113,-0.0167046587053783,6.91277787079981e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRAP2,GRB2-related adapter protein 2,42145,-0.0589552597179385,0.0131116622082913,-0.0846541176461895,-0.0332564017896875,6.96880184864296e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,-0.0397181128319258,0.00883921184172913,-0.0570429680417149,-0.0223932576221368,7.0814415149421e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP10,Bone morphogenetic protein 10,39736,0.0129661011407499,0.00288745391156666,0.00730669147407929,0.0186255108074206,7.17719645181203e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PF4,Platelet factor 4,39914,-0.044614737735172,0.00993979319084596,-0.0640967323892301,-0.0251327430811139,7.2435928435316e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0217300794253754,0.00484282990858524,-0.0312220260462025,-0.0122381328045483,7.28012903483788e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CETN3,Centrin-3,39930,-0.0360621853061651,0.00803808049399518,-0.0518168230743957,-0.0203075475379346,7.31440883507787e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL24,C-C motif chemokine 24,42166,-0.0375007611370214,0.008360305791889,-0.0538869604891238,-0.0211145617849189,7.33156185713873e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMS,Spermine synthase,39586,-0.0294862310419998,0.00657925213506941,-0.0423815652267358,-0.0165908968572637,7.48001668447229e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROCR,Endothelial protein C receptor,39575,0.0158304091417827,0.00353647087086467,0.00889892623488793,0.0227618920486775,7.67027617652771e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0168338296288975,0.0037626193973848,0.00945909561002334,0.0242085636477717,7.7530361855263e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0312904542906701,0.0069966939674092,0.017576934114548,0.0450039744667921,7.80605356267973e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,-0.0220956956999196,0.0049442461677344,-0.031786418188679,-0.0124049732111602,7.9359895973287e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BGN,Biglycan,41820,0.0536950016936674,0.0120233032000695,0.0301293274215312,0.0772606759658037,8.03896519180134e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,-0.0490781077264543,0.0109984462314783,-0.0706350623401518,-0.0275211531127569,8.18738700394903e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,-0.02008894800062,0.00450857688947252,-0.0289257587039861,-0.0112521372972538,8.44409145604362e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGA,Glycoprotein hormones alpha chain,42137,-0.0278930492626726,0.00627134495155335,-0.0401848853677171,-0.015601213157628,8.74870266729906e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR15L,Protein GPR15L,39930,-0.0283374792508578,0.00637094992924415,-0.0408245411121763,-0.0158504173895392,8.75317340295303e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYBB1,Beta-crystallin B1,39958,-0.0300036256983561,0.00675541568387713,-0.0432442404387552,-0.0167630109579569,9.02126106244259e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSF,Cathepsin F,42181,-0.018164498701318,0.00409198220419632,-0.0261847838215428,-0.0101442135810932,9.10707089332018e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD36,Platelet glycoprotein 4,39657,-0.0210441126412278,0.00475771052000266,-0.030369225260433,-0.0117190000220226,9.81975006483461e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPARC,SPARC,42181,-0.0313725688881213,0.00709434190257201,-0.0452774790171625,-0.0174676587590802,9.84619664508978e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,-0.019753991695745,0.00447180979488434,-0.0285187388937183,-0.0109892444977717,1.0079947555116e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGN,Cingulin,39649,-0.0168538890509218,0.00382024314090497,-0.0243415656070955,-0.00936621249474801,1.03518100741528e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,-0.0353818931960629,0.00804708744781539,-0.0511541845937811,-0.0196096017983448,1.10674664905566e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CERT,Ceramide transfer protein,41839,-0.0272581376989228,0.00623302197846043,-0.0394748607767052,-0.0150414146211404,1.23383949277936e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,0.0119363181936287,0.00273131413106718,0.00658294249673702,0.0172896938905204,1.25072361264626e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,-0.0319783164152726,0.00732013189918905,-0.0463257749376831,-0.0176308578928621,1.26029199509044e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBN2,Fibrillin-2,39649,-0.0267749825764722,0.00613205295850531,-0.0387938063751426,-0.0147561587778018,1.27462096680616e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,-0.0189565300351515,0.00434544358440007,-0.0274735994605756,-0.0104394606097273,1.29813920777423e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPI,Mannose-6-phosphate isomerase,42070,-0.0376515949504543,0.0086520883165548,-0.0546096880509017,-0.0206935018500069,1.36059434725457e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARD3,Partitioning defective 3 homolog,39757,-0.0330390629726003,0.007598743825807,-0.047932600871182,-0.0181455250740185,1.38625973983759e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPXM1,Probable carboxypeptidase X1,42181,-0.0303246772487471,0.00698165692623661,-0.0440087248241708,-0.0166406296733233,1.41261375704776e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAX,Apoptosis regulator BAX,41814,-0.0404691856261389,0.00932149713593455,-0.0587393200125707,-0.0221990512397072,1.42572993812891e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A14,Protein S100-A14,39934,-0.0229374865620572,0.00529390945164896,-0.0333135490872891,-0.0125614240368252,1.48488532426174e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,0.0265487396401737,0.00613413727398141,0.0145258305831701,0.0385716486971773,1.51516094617946e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCB,Tubulin-folding cofactor B,42016,-0.0438853680518654,0.0101447356083061,-0.0637690498441452,-0.0240016862595855,1.52991066546054e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,-0.021660979254915,0.00501249847200646,-0.0314854762600476,-0.0118364822497823,1.56152554584421e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYZL2,Lysozyme-like protein 2,39560,-0.0160558014890598,0.00372133473583833,-0.0233496175713029,-0.00876198540681663,1.6134665072312e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD4,Sushi domain-containing protein 4,39919,-0.0169805949255182,0.00393649875878671,-0.0246961324927401,-0.00926505735829627,1.6195835980535e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELENOP,Selenoprotein P,39979,0.00993405061733531,0.00230518819003279,0.00541588176487103,0.0144522194697996,1.65050317384796e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,-0.0344499710726763,0.00800238742344644,-0.0501346504226313,-0.0187652917227213,1.68418312161161e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRNN,Cornulin,41749,0.0294228693666923,0.00684048276237361,0.01601552315244,0.0428302155809446,1.71035714951375e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPEP1,Dipeptidase 1,41997,0.0200193209659018,0.00465684760720671,0.0108918996557767,0.029146742276027,1.72861406831425e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTF3,Neurotrophin-3,42119,-0.0150302711236274,0.00349768108042821,-0.0218857260412667,-0.00817481620598811,1.7417080993121e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPP1,Osteopontin,42286,-0.0191295396648284,0.00446392348453272,-0.0278788296945125,-0.0103802496351442,1.8368691204456e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0477525887577302,0.0111438513027655,0.0259106402043099,0.0695945373111504,1.83909747380366e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,-0.0465622327818813,0.0108896105270634,-0.0679058694149256,-0.025218596148837,1.91977257491267e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0177984065700571,0.00416533926507041,-0.0259624715295951,-0.0096343416105191,1.94449777366375e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,-0.0259863277893186,0.00608182328962346,-0.0379067014369806,-0.0140659541416566,1.94650615688337e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C5,Complement C5,39979,-0.00653778827674018,0.00153185074904699,-0.00954021574487227,-0.00353536080860808,1.9891839251904e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.0212352217793318,0.00498269488761681,-0.0310013037590608,-0.0114691397996029,2.04195216214791e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELAVL4,ELAV-like protein 4,39586,-0.0356977195253666,0.00839321701128563,-0.0521484248674864,-0.0192470141832468,2.1251714979426e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,-0.0315224788940356,0.00741869051016173,-0.0460631122939525,-0.0169818454941186,2.1637971893428e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F3,Tissue factor,42174,0.0112794840432101,0.00265606010588712,0.00607360623567137,0.0164853618507489,2.18388908524626e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA4,Carbonic anhydrase 4,42310,-0.0104535521679746,0.00246328468755582,-0.015281590155584,-0.0056255141803652,2.21265291311643e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STXBP3,Syntaxin-binding protein 3,41843,-0.0187709947337187,0.00442591325983336,-0.0274457847229921,-0.0100962047444453,2.23880253095799e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRZB,Secreted frizzled-related protein 3,41973,-0.0106197653723906,0.00250448051690949,-0.0155285471855332,-0.00571098355924799,2.24714581375896e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JCHAIN,Immunoglobulin J chain,41913,-0.0264200362137605,0.0062327455131626,-0.0386362174195592,-0.0142038550079618,2.26123673957783e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB5,Integrin beta-5,42181,0.0165278879136963,0.00390085789295296,0.00888220644350853,0.0241735693838841,2.28032710729905e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,-0.0252374832284244,0.00596428351488357,-0.0369274789175962,-0.0135474875392526,2.3407731272783e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF22,Kinesin-like protein KIF22,39575,-0.053636130834995,0.0126887765177627,-0.0785061328098099,-0.0287661288601801,2.3868858843006e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,-0.0162973543449625,0.00385906447367677,-0.023861120713369,-0.00873358797655607,2.42808784888817e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIT,Vitrin,39958,-0.0165668765702277,0.00392566529149486,-0.0242611805415576,-0.00887257259889775,2.46042927203871e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,-0.0358133403159226,0.00849181573173654,-0.0524572991501262,-0.019169381481719,2.48742714086048e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,-0.0167600398860291,0.00397707872901258,-0.0245551141948938,-0.00896496557716443,2.52372851748761e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCN1,Transcobalamin-1,39806,-0.0153419886269425,0.00364049196316239,-0.0224773528747407,-0.00820662437914418,2.52559527845429e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,-0.0109735770490054,0.00260597018397616,-0.0160812786095986,-0.00586587548841209,2.55956458926522e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR4,Complement factor H-related protein 4,39945,0.0313275602133659,0.00745332936807428,0.0167190346519404,0.0459360857747915,2.6522750282452e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,-0.0347242726780587,0.00826378397012166,-0.0509212892594972,-0.0185272560966203,2.66667711070924e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PADI2,Protein-arginine deiminase type-2,41913,-0.0243436957862764,0.00579868737192902,-0.0357091230352573,-0.0129782685372955,2.7086600520424e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,-0.0157513674849686,0.00375511021131348,-0.023111383499143,-0.00839135147079418,2.75412190110257e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACRBP,Acrosin-binding protein,39919,-0.0170631096973064,0.00408006841774778,-0.0250600437960921,-0.00906617559852077,2.91050334616732e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKB,Creatine kinase B-type,39966,0.0244897725624513,0.00585891862019678,0.0130062920668656,0.035973253058037,2.9380387248815e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDHD2,Phospholipase DDHD2,39934,-0.0282761396993732,0.00678442269439143,-0.0415736081803804,-0.014978671218366,3.09833229853276e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MATN3,Matrilin-3,41992,0.0139435015204202,0.00334794407723679,0.00738153112903613,0.0205054719118043,3.1358475549808e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYTL1,Cytokine-like protein 1,39966,-0.0108339406900801,0.00260374604614592,-0.0159372829405261,-0.00573059843963409,3.19321386812827e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TWF2,Twinfilin-2,39966,-0.0361578355356831,0.00869071924527052,-0.0531916452564133,-0.0191240258149528,3.19871954098689e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,-0.0376216655952102,0.0090705034540482,-0.0553998523651447,-0.0198434788252757,3.37898065261917e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,-0.0311896068330082,0.00754038397116055,-0.0459687594164829,-0.0164104542495335,3.55472949760542e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCN,Decorin,41900,-0.00962800377010076,0.00233974612859919,-0.0142139061821552,-0.00504210135804636,3.89550029114721e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHNAK2,Protein AHNAK2,39638,-0.0130663647979375,0.00318219073816434,-0.0193034586447396,-0.00682927095113544,4.05310517260619e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.0265426995320509,0.00646655531054196,-0.0392171479407131,-0.0138682511233886,4.07354321937741e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,-0.025610180171209,0.00625298191781321,-0.0378660247301229,-0.0133543356122951,4.2385753539851e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BGLAP,Osteocalcin,39966,-0.0350482632044581,0.00859101740721809,-0.0518866573226056,-0.0182098690863107,4.54133226475084e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.0132862389521398,0.00325827817001753,-0.0196724641653741,-0.00690001373890539,4.57448085765851e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTG,Protogenin,42262,-0.0101757418649378,0.00249564755826496,-0.0150672110791371,-0.0052842726507385,4.5801031440635e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CABP2,Calcium-binding protein 2,39649,-0.0272299191811872,0.00667981339150304,-0.0403223534285332,-0.0141374849338413,4.60488788023645e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHGA,Chromogranin-A,39966,-0.035292446689777,0.0086733821125416,-0.0522922756303585,-0.0182926177491955,4.75238212075371e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSC,Dipeptidyl peptidase 1,42123,-0.0183127042930346,0.00450282592195672,-0.0271382431000698,-0.00948716548599947,4.79053520498023e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX6,Peroxiredoxin-6,42262,0.0247863287615997,0.00609923620003599,0.0128318258095292,0.0367408317136703,4.85416693739847e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB6,Serpin B6,42216,-0.0240633586836986,0.00594569130985317,-0.0357169136510109,-0.0124098037163864,5.21220189595742e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,-0.0366410399979427,0.0090582312437391,-0.0543951732356714,-0.0188869067602141,5.26663713195429e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.0158593869864775,0.00392365725650558,-0.0235497552092284,-0.00816901876372656,5.32907293937368e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,-0.0260101553715721,0.00645702983052467,-0.0386659338394005,-0.0133543769037438,5.65799805828222e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,-0.0380546387901979,0.00947231440690529,-0.0566203750277323,-0.0194889025526635,5.92088906360575e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,-0.0164892004978128,0.00410460841525407,-0.0245342329917108,-0.00844416800391488,5.92629386400185e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,-0.013754269573634,0.00342536949102108,-0.0204679937760353,-0.00704054537123269,5.97237442218518e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD226,CD226 antigen,39657,-0.0174477564162631,0.00435298178609907,-0.0259796007170173,-0.00891591211550891,6.15767579746867e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0230141781840417,0.00575170242480715,0.0117408414314197,0.0342875149366637,6.33374887732349e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC2,Mucin-2,39966,-0.0378018006562868,0.0094628199981545,-0.0563489278526696,-0.019254673459904,6.51649267933836e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTF4,Neurotrophin-4,41843,-0.0153868131817471,0.00385672151835511,-0.0229459873577232,-0.00782763900577112,6.65382942941003e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,-0.0290188286919038,0.00729457791120181,-0.0433162013978593,-0.0147214559859482,6.9817921381384e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAPK2,Death-associated protein kinase 2,39657,-0.0224747692257235,0.00565972299238964,-0.0335678262908072,-0.0113817121606398,7.20244598542368e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNPY4,Protein canopy homolog 4,42070,-0.0302468516515423,0.00763789273534579,-0.0452171214128201,-0.0152765818902646,7.53024064347779e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0131171313410428,0.00332078856629275,0.006608385751109,0.0196258769309766,7.86347623408432e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,-0.0268886756137822,0.0068350289130946,-0.0402853322834476,-0.0134920189441168,8.40667337074339e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,-0.0364873277166465,0.00928047640110779,-0.0546770614628178,-0.0182975939704753,8.48901144996853e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,-0.0446957465857331,0.0113839250551859,-0.0670082396938975,-0.0223832534775686,8.6727900213218e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.0237107591114722,0.00604438361243623,-0.0355577509918472,-0.0118637672310972,8.806812668252e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1B,Interleukin-1 beta,41825,-0.0224860345756085,0.00573469685382938,-0.0337260404091141,-0.0112460287421029,8.86087734773473e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,-0.0155024750276081,0.00396066939188695,-0.0232653870357065,-0.00773956301950969,9.12853756441559e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D23,TBC1 domain family member 23,42070,-0.0357538097363677,0.0091546528555076,-0.0536969293331626,-0.0178106901395728,9.44763236554625e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,-0.045634320996986,0.011684695535152,-0.0685363242458839,-0.0227323177480882,9.45849346525152e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0551893016148726,0.0141411144629566,-0.0829058859622675,-0.0274727172674777,9.56528353570554e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,-0.0141750306164618,0.00363493450034454,-0.0212995022371371,-0.00705055899578649,9.68819317132256e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,-0.0221946993103156,0.0056998064886172,-0.0333663200280053,-0.0110230785926259,9.9111032223912e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCG3,Secretogranin-3,42144,-0.0131362583042453,0.00337774300160983,-0.0197566345874006,-0.00651588202109002,0.000101112337884239
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,-0.0290846035374886,0.00747958248523778,-0.0437445852085547,-0.0144246218664226,0.000101328106422159
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,0.0209715607736732,0.0053942805470052,0.010398770901543,0.0315443506458034,0.000101660422158288
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPARCL1,SPARC-like protein 1,42169,0.0107828944828673,0.00277599310196513,0.00534194800301563,0.0162238409627189,0.0001030962408278
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP3,Stromelysin-1,42137,0.0195358456906693,0.00503804362301644,0.00966128018955712,0.0294104111917816,0.000105962265511023
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,-0.0230211075870139,0.00596739964059993,-0.0347172108825898,-0.0113250042914381,0.000115040116026986
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.0298697682209101,0.00775510576258944,-0.0450697755155854,-0.0146697609262348,0.000118002506921032
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0350954225804715,0.00911261308037559,-0.0529561442180077,-0.0172347009429354,0.000118139088713316
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,-0.0340164901219778,0.00888485739010606,-0.0514308106065857,-0.01660216963737,0.000129584633201325
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.012464297065713,0.00325697807463566,-0.0188479740919989,-0.00608062003942709,0.000130316186127557
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEO1,Neogenin,39934,-0.00883671922952552,0.00230959540191018,-0.0133635262172695,-0.00430991224178156,0.000130893808598523
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRUNE2,Protein prune homolog 2,39757,-0.0113088816981962,0.00295744311474711,-0.0171054702031006,-0.00551229319329189,0.00013208745516568
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPB1,Heat shock protein beta-1,41949,-0.0269109281352097,0.00711387590917955,-0.0408541249172016,-0.0129677313532178,0.000155701912965439
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX1B,Syntaxin-1B,39649,-0.0155010311747178,0.00409932316695416,-0.023535704581948,-0.00746635776748768,0.000156793406920856
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM3,Paralemmin-3,39575,-0.0292303008471241,0.00774563440794164,-0.0444117442866897,-0.0140488574075585,0.000161640572798326
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,-0.0121063533486313,0.00321139677300652,-0.0184006910237241,-0.00581201567353857,0.000164201727336818
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,-0.0197214847672477,0.00523234298286181,-0.0299768770136568,-0.00946609252083853,0.000164512533867744
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,0.0178994556974549,0.00475585999587185,0.00857797010554603,0.0272209412893637,0.000168314818228604
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,-0.0220566320991185,0.00586773404050775,-0.0335573908185137,-0.0105558733797233,0.000171485188323839
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRTN,Neurturin,41913,-0.0189200194356495,0.00504006322818139,-0.028798543362885,-0.00904149550841401,0.00017482729923411
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK13,Kallikrein-13,41839,-0.0171040369440623,0.00455800269500534,-0.0260377222262727,-0.0081703516618518,0.000175807221878938
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,-0.0321090435334622,0.00856897449438782,-0.0489042335424623,-0.0153138535244621,0.000179759709425229
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2orf69,UPF0565 protein C2orf69,39649,-0.0225554393787681,0.00602095730265596,-0.0343565156919738,-0.0107543630655624,0.000180478884533581
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA4,Carboxypeptidase A4,39518,-0.0168300732720767,0.0044972186604183,-0.0256446218464965,-0.0080155246976568,0.000183257148031773
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNU13,NHP2-like protein 1,39575,-0.0240829513729639,0.00644325992081952,-0.0367117408177701,-0.0114541619281576,0.000186656596759375
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHRL,Appetite-regulating hormone,42145,-0.0315070311301505,0.00844023740066835,-0.0480498964354604,-0.0149641658248405,0.00019002048879311
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNC79,Protein unc-79 homolog,39560,-0.0213011642563945,0.00571021390233327,-0.0324931835049677,-0.0101091450078213,0.000192169800839881
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM3,Myomesin-3,39736,0.0369221284903166,0.00990772216055594,0.0175029930556269,0.0563412639250062,0.000195039436515464
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.0172904490334644,0.00464275805399357,0.00819064324763704,0.0263902548192918,0.000196746801513187
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTR,Transthyretin,39862,-0.00942342285592358,0.00253269796731684,-0.0143875108718646,-0.00445933483998257,0.000199633245042811
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF2,Fibroblast growth factor 2,42119,-0.0260653005327734,0.00702182840307264,-0.0398280842027958,-0.0123025168627511,0.000206421732453155
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.0100650433142901,0.00272012845861739,0.00473359153539997,0.0153964950931802,0.000216279764769421
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,-0.0558845651747306,0.0151155284733927,-0.0855110009825802,-0.026258129366881,0.000218903206082298
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.0563487853541075,0.0152457120130824,-0.086230380899749,-0.0264671898084661,0.000219852123518052
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_DRA,,42060,-0.01365412971975,0.00370122145277932,-0.0209085237671974,-0.0063997356723025,0.000225946412078788
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,-0.0394676584487831,0.0107035578051197,-0.0604466317468177,-0.0184886851507486,0.000227687716967172
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPP,Lipoma-preferred partner,39575,-0.0248216175609656,0.00674843554581373,-0.0380485512307606,-0.0115946838911707,0.000236073805195091
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,-0.0187558120520705,0.00510155172133545,-0.028754853425888,-0.00875677067825301,0.000237398336411901
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,-0.0208850323746395,0.00568087196217095,-0.0320195414204946,-0.00975052332878448,0.000237662180215991
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTP1,Glutathione S-transferase P,41759,0.0260976229049978,0.00710128057023888,0.0121791129873296,0.040016132822666,0.000238739324409037
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,-0.0277703522793709,0.00755909182320374,-0.0425861722528502,-0.0129545323058916,0.000239941521964894
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLC,Galectin-10,42119,-0.0250252235633294,0.00682461449543579,-0.0384014679743836,-0.0116489791522753,0.000246443782597465
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCT,Secretin,39649,-0.0179775537467958,0.00491601349570913,-0.0276129401983857,-0.00834216729520586,0.000256432269710018
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN2,Ataxin-2,39586,-0.0395755225368033,0.0108556847170783,-0.0608526645822767,-0.0182983804913299,0.000267996778753587
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACYBP,Calcyclin-binding protein,39713,-0.0386420904791618,0.010603636072771,-0.059425217181793,-0.0178589637765307,0.000269415816160365
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB33A,Ras-related protein Rab-33A,39575,-0.0247462135225278,0.0067923918171551,-0.0380593014841518,-0.0114331255609038,0.000270484438333123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDRG1,Protein NDRG1,41839,-0.0244413080934153,0.00670929948986468,-0.0375915350935501,-0.0112910810932805,0.000270613263301205
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.00986366782404206,0.00271351522697756,-0.0151821576689181,-0.00454517797916604,0.000279190409203934
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,-0.00864237559516792,0.0023876321295106,-0.0133221345690087,-0.00396261662132714,0.000296086972707059
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBQLN3,Ubiquilin-3,39575,-0.0207799115768838,0.00574349643000942,-0.0320371645797022,-0.00952265857406532,0.000298233794537195
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MKI67,Proliferation marker protein Ki-67,39657,-0.0150292333309874,0.00415903774853481,-0.0231809473181156,-0.00687751934385917,0.000303277323827083
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPS10,40S ribosomal protein S10,39575,0.0153920484724251,0.00426464344049661,0.00703334732905174,0.0237507496157984,0.00030848282938122
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA3,Annexin A3,42224,-0.0254278356037708,0.00705648204194367,-0.0392585404059804,-0.0115971308015612,0.000315113497227909
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP7,Caspase-7,39929,-0.0311067923916187,0.00863257551470476,-0.04802664040044,-0.0141869443827974,0.000315403963234463
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,-0.0209493320965531,0.00581421993598703,-0.0323452031710877,-0.0095534610220185,0.000315812970382836
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FZD8,Frizzled-8,39586,-0.0158740715762754,0.00441030504085615,-0.0245182694563535,-0.00722987369619737,0.000320462352281435
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,-0.0172912412518883,0.00480793884344157,-0.0267148013850338,-0.00786768111874279,0.000324067025506224
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,-0.0206108487697874,0.00573127271649224,-0.0318441432941122,-0.00937755424546263,0.000324307652501831
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.0117687181109529,0.0032756135288266,-0.0181889206274531,-0.00534851559445277,0.000328267256720423
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFIC,Nuclear factor 1 C-type,39934,-0.0167970254407261,0.00467696454369893,-0.025963875946376,-0.00763017493507618,0.000330250619711106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,-0.0212142223912814,0.0059079020824962,-0.032793710472974,-0.00963473430958891,0.000330829914596395
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN2,Contactin-2,42262,-0.0160439512852691,0.00447151485429988,-0.0248081203996969,-0.00727978217084135,0.000334344825071941
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPBP,Platelet basic protein,39908,-0.0313605328540975,0.0087413696463216,-0.0484936173608879,-0.0142274483473072,0.000335146160285855
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,-0.025975889604469,0.00725632017413114,-0.040198277145766,-0.011753502063172,0.000345343487039916
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,-0.0132691655867294,0.00370946117738636,-0.0205397094944067,-0.00599862167905217,0.000348893096311092
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,0.0125844902691749,0.00352340045624106,0.00567862537494243,0.0194903551634074,0.00035591843060107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARTN,Artemin,41913,-0.0164141457273919,0.00459788580741506,-0.0254260019099254,-0.00740228954485834,0.000358329500783053
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0320663598596947,0.00899008489715464,-0.0496869262581178,-0.0144457934612716,0.000362816428755464
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,0.00672744753022274,0.00188836014192205,0.00302626165205553,0.0104286334083899,0.000368722189366411
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D5,TBC1 domain family member 5,42119,-0.0282134643132928,0.00792518983901311,-0.0437468363977585,-0.0126800922288271,0.000372165239240397
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,-0.0274323636032526,0.00774847927296906,-0.042619382978272,-0.0122453442282333,0.000401243152007259
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0175183065938148,0.00495257742308436,-0.0272253583430601,-0.00781125484456942,0.000405726805773034
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,-0.0194899159411912,0.00551101509131036,-0.0302915055201596,-0.00868832636222293,0.000407029101381952
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA1,Annexin A1,39699,-0.0160185295044096,0.00453722124652216,-0.024911483147593,-0.00712557586122618,0.000416501108536867
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB2A2,Mammaglobin-A,39575,0.0112161280158136,0.00318046965341122,0.00498240749512758,0.0174498485364996,0.000422708595344891
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STXBP1,Syntaxin-binding protein 1,39934,-0.0280451973802086,0.00797657673488252,-0.0436792877805784,-0.0124111069798389,0.000439905734228509
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MICALL2,MICAL-like protein 2,39649,-0.0245382150668856,0.00699758116178973,-0.0382534741439935,-0.0108229559897777,0.000455550871460211
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDF2,Growth/differentiation factor 2,42145,0.0125861035198059,0.00359082118559035,0.00554809399604882,0.019624113043563,0.000457951021688285
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNL1,Thioredoxin-like protein 1,39570,-0.036498427762303,0.0104179346471199,-0.056917579670658,-0.016079275853948,0.000461150136981126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,-0.0201580839737806,0.00577611358208344,-0.0314792665946641,-0.00883690135289701,0.000485177933185932
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DENR,Density-regulated protein,39657,-0.0205080618185897,0.00587777050981892,-0.0320284920178348,-0.00898763161934461,0.00048655726576535
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRAL,GDNF family receptor alpha-like,39574,0.0224849152442936,0.00644907720663118,0.00984472391929647,0.0351251065692907,0.000491240515961146
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,-0.0309057162264948,0.0088707000280398,-0.0482922882814528,-0.0135191441715368,0.000495804850295296
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,-0.0175378376101669,0.00503790881706412,-0.0274121388916126,-0.00766353632872127,0.000501100714624362
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEDD9,Enhancer of filamentation 1,39657,-0.012027245702565,0.0034601459327674,-0.0188091317307891,-0.00524535967434086,0.000511027785718371
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WIF1,Wnt inhibitory factor 1,42262,0.0118809283212948,0.00341903599027932,0.00517961778034734,0.0185822388622423,0.000512562112304439
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,-0.0200600230918543,0.00577379102150089,-0.0313766534939961,-0.00874339268971257,0.000513751897359832
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,-0.0103556717094744,0.00298078909016937,-0.0161980183262063,-0.00451332509274242,0.000514425517455312
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,-0.0097186256733873,0.00279768868153738,-0.0152020954892006,-0.00423515585757404,0.000515097634548302
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,-0.0170655586208775,0.00491368411700265,-0.0266963794902027,-0.00743473775155233,0.000516191573938747
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,-0.0348986750258163,0.010065470516103,-0.0546269972373781,-0.0151703528142545,0.000527920319971552
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRG3,Proteoglycan 3,39966,0.0175679871947732,0.00507653836773766,0.00761797199400743,0.027518002395539,0.000540905656009833
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,-0.0114424257248247,0.00330812151498354,-0.0179263438941925,-0.004958507555457,0.000544397871088632
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,-0.0170750807985963,0.00493977953328101,-0.0267570486838271,-0.00739311291336549,0.000548946584821315
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0173444930981393,0.00501809449697473,0.00750902788406887,0.0271799583122098,0.000549509207254626
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP4,Dipeptidyl peptidase 4,41948,0.00979518035153985,0.00283629081849644,0.00423605034728682,0.0153543103557929,0.000555043130724661
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIM,Vimentin,41900,-0.0403037029565859,0.0116828228760055,-0.0632020357935566,-0.0174053701196152,0.000562688536404675
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL26,C-C motif chemokine 26,42119,-0.0314496348583807,0.00912580959363564,-0.0493362216619066,-0.0135630480548549,0.000570195209043984
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,-0.0339709583526597,0.00985838856424876,-0.0532933999385873,-0.0146485167667322,0.000571238393848009
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,-0.0343250660277113,0.00997649808240531,-0.0538790022692257,-0.0147711297861969,0.000582602296572611
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,-0.00760395157581618,0.00221477100228993,-0.0119449027403044,-0.00326300041132792,0.000598425340271381
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,-0.0214492806715318,0.0062503818296046,-0.0337000290575568,-0.00919853228550681,0.000602062018345225
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,-0.0255479043509676,0.0074450877115841,-0.0401402762656724,-0.0109555324362627,0.000602425164713324
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,-0.0218396996622946,0.0063729865015758,-0.0343307532053832,-0.00934864611920602,0.000612698215648555
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOSB,Protein fosB,41839,-0.0133869113317069,0.00390929106846575,-0.0210491218258998,-0.00572470083751405,0.000618064223939897
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,-0.00957891583231775,0.00279754442917934,-0.0150621029135093,-0.00409572875112624,0.000619150957465344
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,0.0177152643184958,0.00519721972557304,0.00752871365637268,0.027901814980619,0.000654859063454293
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,-0.0247659453594259,0.00729387637931734,-0.0390619430628878,-0.0104699476559639,0.0006875892848233
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EHD3,EH domain-containing protein 3,39638,-0.040932045239856,0.0120734427607972,-0.0645959930510185,-0.0172680974286936,0.000700723754005162
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,-0.0370297104450845,0.0109376684778791,-0.0584675406617275,-0.0155918802284414,0.00071284420716781
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTB,Lymphotoxin-beta,39919,-0.0118747420977083,0.00351607119647521,-0.0187662416427997,-0.00498324255261686,0.000734541801302793
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRADD,Death domain-containing protein CRADD,41997,-0.0255174594130645,0.00756981733924942,-0.0403543013979934,-0.0106806174281356,0.000751216938307923
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBN1,Drebrin,39657,-0.0175803625784132,0.00521680321986197,-0.0278052968893426,-0.00735542826748369,0.000754391453582752
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VGF,Neurosecretory protein VGF,39934,-0.0103905685747818,0.00308644910427307,-0.016440008819157,-0.00434112833040662,0.000763782506385403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.0312962567682955,0.00930753792282726,0.013053482439554,0.0495390310970369,0.000774646111457486
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.0115762126890495,0.00344628267710203,-0.0183309267361695,-0.00482149864192949,0.000784775764562695
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,-0.041087413207959,0.0122366831144788,-0.0650713121123374,-0.0171035143035806,0.000788501385519734
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TG,Thyroglobulin,39919,-0.0359359568279784,0.0107048127621458,-0.0569173898417841,-0.0149545238141727,0.000790552807860771
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,-0.0432540859000776,0.0129037808517248,-0.0685454963694583,-0.0179626754306969,0.000804833396445333
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,-0.0219098274989193,0.00654021188189549,-0.0347286427874345,-0.00909101221040419,0.000810320689263249
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREML1,Trem-like transcript 1 protein,39990,0.0181308484334352,0.00541404594760151,0.00751931837613626,0.0287423784907342,0.00081409806402486
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRN1,Secernin-1,42119,-0.0188316060828155,0.00562584404750448,-0.0298582604159243,-0.00780495174970669,0.000818139892669083
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,-0.00733958945519407,0.00221151133334557,-0.0116741516685514,-0.00300502724183674,0.000906416610108085
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROC,Vitamin K-dependent protein C,42199,-0.00865132479049419,0.00260718424050644,-0.0137614059018868,-0.00354124367910157,0.000908167358755146
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,-0.0289125331687293,0.00871363373637458,-0.0459912552920235,-0.0118338110454352,0.000909240473885007
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,-0.015027034238487,0.0045291209926167,-0.0239041113840157,-0.00614995709295823,0.000909995345573412
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRR4,Proline-rich protein 4,39652,-0.0240680121723706,0.00726428882229229,-0.0383060182640635,-0.00983000608067773,0.000925326726474689
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,0.00703856907758358,0.00212669376399464,0.00287024930015409,0.0112068888550131,0.000937204738145747
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSH,Pro-cathepsin H,41865,-0.0251337661377225,0.00759675391594093,-0.0400234038129667,-0.0102441284624783,0.000940510630753498
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,-0.0195906464607746,0.0059267898515153,-0.0312071545697446,-0.00797413835180465,0.000951221117303319
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIFBP,KIF-binding protein,42070,-0.0277250119673254,0.00839241361408745,-0.0441741426509368,-0.011275881283714,0.000957075328863338
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.0081498063399919,0.00246968095787127,-0.0129903810174196,-0.00330923166256421,0.00097002958135112
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,0.00992316122554062,0.00301450426179841,0.00401473287241575,0.0158315895786655,0.00099800535591973
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1R,Complement C1r subcomponent,39979,-0.00630583141329666,0.00191758723315897,-0.0100643023902882,-0.00254736043630508,0.00101057318828236
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,-0.0323295802346594,0.00983608502070158,-0.0516083068752345,-0.0130508535940843,0.00101636909692093
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.0191182090737762,0.00583544642606258,-0.0305556840688589,-0.00768073407869357,0.00105530488692103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.0394711608038378,0.0120558253655383,-0.0631005785202929,-0.0158417430873827,0.00106342353877852
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,-0.013347142075189,0.00407907268295422,-0.0213421245337793,-0.00535215961659872,0.00107078598294955
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.0144960732108547,0.0044382446766433,0.0057971136446338,0.0231950327770755,0.00109281967744788
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP8,Caspase-8,42224,-0.0202325258233376,0.00621000884415627,-0.0324041431578839,-0.00806090848879128,0.00112454929665319
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,-0.0220372542456399,0.00677722109654439,-0.0353206075948669,-0.00875390089641286,0.00115018515964723
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACRV1,Acrosomal protein SP-10,39657,-0.0352847973781919,0.0108628964679212,-0.0565760744553173,-0.0139935203010664,0.00116486553346122
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,-0.019412963825233,0.00598903469359245,-0.0311514718246742,-0.00767445582579182,0.00119288917238626
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSD1,Tryptase delta,39934,-0.0120814732098852,0.00373905321359425,-0.01941001750853,-0.0047529289112405,0.00123641605556115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,0.00864085651418153,0.00267934055007997,0.0033893490360248,0.0138923639923383,0.00126338929076097
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC51B,Organic solute transporter subunit beta,39575,-0.0238798889675766,0.0074113303902853,-0.0384060965325358,-0.00935368140261738,0.0012763559883978
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,-0.0344519542724281,0.0106945415193313,-0.0554132556503176,-0.0134906528945387,0.00127911898303635
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,-0.0163394309474398,0.00507608670539315,-0.0262885608900104,-0.00639030100486926,0.00129053359191783
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.0132499507308519,0.00412002466336146,-0.0213251990710404,-0.00517470239066344,0.00130366731538823
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNW1,Interferon omega-1,39575,0.0114832179396833,0.00360437362956353,0.00441864562573879,0.0185477902536278,0.0014470228703692
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,-0.0238044857246353,0.007477507261344,-0.0384603999568695,-0.00914857149240106,0.00145853443883367
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLN4,Cerebellin-4,42262,-0.0102425518231504,0.00322456859213082,-0.0165627062637268,-0.003922397382574,0.00149441629767826
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,-0.0145137881762007,0.00457657379712667,-0.0234838728185689,-0.00554370353383238,0.00152151878421153
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MGLL,Monoglyceride lipase,42166,-0.0280754848281806,0.0088596403725892,-0.0454403799584554,-0.0107105896979058,0.00153346577310951
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,-0.00933570040906363,0.0029587579763307,-0.0151348660426718,-0.00353653477545546,0.00160765858238754
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,-0.0167616835483245,0.00531432438054363,-0.02717775933419,-0.00634560776245897,0.00161438592181647
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,-0.013056495315688,0.0041422554090972,-0.0211753159175186,-0.00493767471385753,0.0016257511414914
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL33,Interleukin-33,41913,-0.0126380257086103,0.00401268898792639,-0.020502896124946,-0.00477315529227459,0.00163903189424561
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPC1,Glypican-1,42262,-0.00945694887734195,0.00300268651578653,-0.0153422144482836,-0.00357168330640036,0.00163904865441754
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAP,Cartilage-associated protein,39649,-0.0158576620186975,0.00503711977298546,-0.025730416773749,-0.00598490726364599,0.00164738590484829
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,-0.00730847648587163,0.00232191716852281,-0.0118594341361763,-0.00275751883556692,0.00164971020509377
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MESD,LRP chaperone MESD,42137,-0.0388874922593048,0.0123547003353263,-0.0631027049165443,-0.0146722796020652,0.00164981448317453
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM106A,Transmembrane protein 106A,39919,-0.0229824958407136,0.00732958270450071,-0.037348477941535,-0.00861651373989226,0.00171953389266408
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,-0.00879335384328226,0.0028054145917518,-0.0142919664431158,-0.00329474124344873,0.00172567417248922
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,-0.013989936412047,0.00446614405855187,-0.0227435787668086,-0.00523629405728531,0.00173814718901143
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM171B,Protein FAM171B,39919,-0.00849581585963487,0.00271360487419668,-0.0138144814130604,-0.00317715030620938,0.0017476100910803
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNB2,Ephrin-B2,39649,-0.0184714864689788,0.00590723639666267,-0.0300496698064377,-0.00689330313151998,0.00177103334997515
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,-0.00881230261933643,0.00282331949260214,-0.0143460088248366,-0.00327859641383624,0.00180468919675877
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,-0.020739265761015,0.00666569508894255,-0.0338040281353424,-0.0076745033866876,0.00186701549382387
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,-0.0236490677444761,0.00760567965144191,-0.0385561998613022,-0.00874193562764995,0.0018794246466248
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD2,Sushi domain-containing protein 2,42137,0.00893664014418388,0.00287553102506214,0.00330059933506209,0.0145726809533057,0.00188861530394903
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,0.00864558806175555,0.00278374372198845,0.00318945036665818,0.0141017257568529,0.00190272900958821
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,0.00750318165439362,0.00242575589699895,0.00274870009627567,0.0122576632125116,0.00198459343239214
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMVK,Phosphomevalonate kinase,41832,-0.0340563076071176,0.011040050863917,-0.055694807300395,-0.0124178079138402,0.0020411159742849
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,-0.01590086973608,0.00517994518473883,-0.0260535622981681,-0.00574817717399191,0.00214798193326674
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,-0.00769856190819069,0.00251440862392776,-0.0126268028110891,-0.00277032100529228,0.00220541802614294
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMTN,Smoothelin,39897,-0.0289546390077223,0.00945873062391887,-0.0474937510306033,-0.0104155269848414,0.00221002735357879
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPEP2,Dipeptidase 2,42070,-0.00935368108495304,0.00305892720427773,-0.0153491784053374,-0.0033581837645687,0.00223382832681058
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMOD1,Leiomodin-1,39934,-0.0108379134049506,0.00354774049396527,-0.0177914847731225,-0.00388434203677866,0.00225675274409825
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,-0.0362502086239842,0.0118781420896208,-0.0595313671196411,-0.0129690501283274,0.00227884921111462
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,-0.0150806186588765,0.00494139701793701,-0.024765756814033,-0.00539548050371996,0.00227946126206349
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,-0.0200837187968219,0.0065913273005936,-0.0330027203059853,-0.00716471728765842,0.00231689352715483
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN10,Ataxin-10,41839,-0.0227105673319043,0.00745525938216822,-0.0373228757209541,-0.00809825894285462,0.00232172784790919
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,-0.036803661583868,0.0121411041103131,-0.0606002256400816,-0.0130070975276544,0.00244030833022896
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,-0.0307285062059161,0.0101405584257565,-0.0506040007203989,-0.0108530116914333,0.00244913538621822
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANPEP,Aminopeptidase N,42187,-0.00839179777032646,0.00277285057704576,-0.0138265849013362,-0.00295701063931676,0.00247935345754956
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,-0.0301105695979535,0.00995732960909322,-0.0496269356317762,-0.0105942035641308,0.0024996696549758
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,-0.0256479870850161,0.00849412291882812,-0.0422964680059192,-0.00899950616411297,0.00253767567992463
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,0.00965482896977251,0.00319965323889215,0.00338350862154391,0.0159261493180011,0.00255486307069057
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,-0.018258373659319,0.00605213804074724,-0.0301205642191836,-0.0063961830994544,0.00255888896114281
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,-0.0320088306966417,0.0106308746152601,-0.0528453449425515,-0.011172316450732,0.00261021896534543
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FIS1,Mitochondrial fission 1 protein,42125,-0.0234367972177357,0.00779064959069871,-0.0387064704155052,-0.00816712401996621,0.00263176362631419
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,-0.0262995734949905,0.00874777814060467,-0.0434452186505757,-0.00915392833940538,0.00264929876821977
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLNS1A,Methylosome subunit pICln,39649,-0.0103101987094231,0.00342999495578962,-0.0170329888227708,-0.00358740859607546,0.00265396659004633
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB37,Ras-related protein Rab-37,41913,-0.0247129200279623,0.00826140865109372,-0.040905280984106,-0.00852055907181859,0.00278238412612405
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRH,Corticoliberin,41830,0.0260986555913955,0.00873129554685815,0.00898531631955354,0.0432119948632375,0.00280320968641152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,-0.0231307401546682,0.00775331917345842,-0.0383272457346467,-0.00793423457468966,0.0028564645589039
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0124282168490446,0.00417247344255622,0.00425016890163443,0.0206062647964548,0.00290162724650382
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RALB,Ras-related protein Ral-B,39657,-0.00901395226669092,0.00303087206895305,-0.0149544615218389,-0.00307344301154294,0.00294535674187406
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIP1,Huntingtin-interacting protein 1,39575,-0.0100019163581497,0.00336564757153374,-0.0165985855983558,-0.00340524711794357,0.0029673460446578
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM17,Splicing factor 45,39934,-0.0232749768072744,0.00786527425603658,-0.0386909143491061,-0.00785903926544268,0.00309069363421389
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,-0.0113105837241096,0.0038353680369749,-0.0188279050765804,-0.00379326237163883,0.00319451319292775
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,-0.0147448702879599,0.00500001516301643,-0.0245449000074721,-0.00494484056844768,0.00319508473993538
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG3,Desmoglein-3,42196,-0.0104974595855905,0.003567921988215,-0.0174905866824919,-0.00350433248868911,0.00326463202583275
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SATB1,DNA-binding protein SATB1,39934,-0.00880154424131016,0.00299348376547894,-0.0146687724216489,-0.00293431606097144,0.0032862641515398
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLMH,Bleomycin hydrolase,42310,-0.00921768256603667,0.00313877932693293,-0.0153696900468252,-0.00306567508524813,0.00332266320241218
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,-0.0169194192683688,0.00576204559617527,-0.0282130286368723,-0.00562580989986527,0.00332760413766589
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD6,Programmed cell death protein 6,42145,0.0210418077342049,0.00717235176425242,0.00698399827627019,0.0350996171921397,0.00335467243866464
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOP56,Nucleolar protein 56,39575,-0.0335325483889499,0.0114435332004263,-0.0559618734617855,-0.0111032233161143,0.00339374346479565
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GASK1A,Golgi-associated kinase 1A,39575,-0.0127866571182191,0.00436913794983286,-0.0213501674998915,-0.00422314673654672,0.00343407863478932
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,-0.0169419285193294,0.00579576556642718,-0.0283016290295266,-0.00558222800913208,0.00347088980082918
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,-0.0142565835629211,0.00488060612532078,-0.0238225715685498,-0.00469059555729239,0.00349521779743863
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,-0.017160148709249,0.00588082776660485,-0.0286865711317945,-0.00563372628670346,0.00353015803333283
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDZD2,PDZ domain-containing protein 2,39575,-0.0174778100875403,0.00602013056352813,-0.0292772659920554,-0.00567835418302518,0.00370073731613546
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.010563778313162,0.00364439420690915,-0.0177067909587039,-0.00342076566762005,0.00375386010164569
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,-0.0183956511426176,0.00635735042052848,-0.0308560579668535,-0.00593524431838183,0.00381478608374894
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,-0.0104729772301883,0.00361960237957596,-0.0175673978941572,-0.00337855656621944,0.00381826689542111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEP1B,Meprin A subunit beta,42145,0.0336697089530038,0.0116501380414663,0.01083543839173,0.0565039795142777,0.00385768117883799
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB2,Integrin beta-2,42079,-0.00843410071146475,0.00292142113413886,-0.0141600861343769,-0.00270811528855258,0.00389570184744345
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,-0.010219451747926,0.0035398285837365,-0.0171575157720496,-0.00328138772380251,0.00389682032062404
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,0.0109215393076611,0.00379695787963519,0.00347950186357615,0.0183635767517461,0.00403024602444716
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS53,Serine protease 53,39929,0.0112086489712269,0.00389944091403499,0.00356574477971833,0.0188515531627355,0.00405517768868704
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,0.00907791656555445,0.00319280359007075,0.00282002152901578,0.0153358116020931,0.00447395948496003
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGFAC,Hepatocyte growth factor activator,39897,0.00785328192476494,0.00276627425949218,0.00243138437616026,0.0132751794733696,0.00453446804062784
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,0.0115698145838308,0.00408007168216366,0.00357287408679003,0.0195667550808716,0.00458101107979592
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53BP1,TP53-binding protein 1,39657,-0.0248641492151288,0.00878918008074933,-0.0420909421733975,-0.00763735625686012,0.00467850905481809
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL3,C-X-C motif chemokine 3,42129,-0.0273500407530705,0.00968248970028765,-0.0463277205656343,-0.00837236094050667,0.00473954857389191
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPQ,Carboxypeptidase Q,39960,-0.0107896038530211,0.00381976902616761,-0.0182763511443096,-0.00330285656173258,0.00474111517856353
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,-0.0109865100512009,0.00389039391166792,-0.01861168211807,-0.00336133798433178,0.00475117884742992
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLB1,Beta-galactosidase,42016,-0.0123387223079032,0.00437376790908422,-0.0209113074097083,-0.00376613720609814,0.00479334731783679
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VNN1,Pantetheinase,39990,-0.0210869050224324,0.00747803886966338,-0.0357438612069727,-0.00642994883789222,0.00481299482224878
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTX3,Pentraxin-related protein PTX3,42119,-0.0142520643675227,0.00505439239026036,-0.024158673452433,-0.00434545528261236,0.00481327394714709
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,-0.024876108579938,0.00883209436213279,-0.0421870135297182,-0.00756520363015771,0.00486272372928458
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,-0.0180216252401922,0.00639935717348275,-0.0305643653002184,-0.00547888518016597,0.00486872484231515
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB5,Serpin B5,41900,-0.0139414788923921,0.00495404635084179,-0.0236514097400421,-0.00423154804474222,0.00489766945043892
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,-0.0159127168801145,0.00566255401229277,-0.0270113227442083,-0.00481411101602068,0.00496030263427094
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,-0.0283385487502312,0.0101070596686656,-0.0481483857008158,-0.00852871179964657,0.00505843196204094
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,-0.0102218811978714,0.00367382503219972,-0.0174225782609828,-0.00302118413475991,0.00540421470854024
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDSN,Corneodesmosin,42246,-0.0123714623681857,0.00445111773670014,-0.0210956531321179,-0.00364727160425338,0.00545329660005458
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,-0.0120700241851147,0.00434781020693971,-0.0205917321907166,-0.00354831617951291,0.00551058307575242
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,-0.0270217173320265,0.00973519776453873,-0.0461027049505224,-0.00794072971353063,0.00551632438360084
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.028442663527649,0.010248333774435,-0.0485293977255416,-0.00835592932975649,0.00552336439595559
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,-0.0111004266465242,0.00401181660653636,-0.0189635871953355,-0.00323726609771295,0.00566805286949543
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,-0.0161826487291339,0.00585706850402213,-0.0276625029970173,-0.00470279446125057,0.00573805549391384
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,-0.0107305940625734,0.00388591658762776,-0.0183469905743238,-0.00311419755082297,0.00576336857753057
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,-0.0135805471044679,0.00491857492548588,-0.0232209539584202,-0.00394014025051555,0.00576894046836961
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,-0.0227866071470434,0.00826417188632105,-0.0389843840442326,-0.00658883024985413,0.0058380678301282
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX18,Sorting nexin-18,39930,-0.0122618231230104,0.00447073916869307,-0.0210244718936488,-0.003499174352372,0.0061035106338394
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEX101,Testis-expressed protein 101,39649,-0.0172290784165161,0.00629004770224924,-0.0295575719129246,-0.00490058492010756,0.00617061566713865
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP9,Caspase-9,39657,-0.0178274455599356,0.00652799730046748,-0.0306223202688518,-0.0050325708510193,0.00632577064162683
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,-0.0103960848427872,0.00381530781273378,-0.0178740881557454,-0.00291808152982902,0.00644322920235403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,-0.0242822280866676,0.00892359093753381,-0.0417724663242338,-0.00679198984910129,0.00651605723720834
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,-0.0324499988723815,0.0119274159809646,-0.0558277341950721,-0.009072263549691,0.00652433891627026
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,-0.0292178880913589,0.0107781240042593,-0.0503430111397072,-0.00809276504301064,0.00672144555228617
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOX9,Transcription factor SOX-9,39649,-0.00763008113225415,0.00282215448181047,-0.0131615039166027,-0.00209865834790562,0.00686901253862853
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL6B,Myosin light chain 6B,39649,-0.0251703431457149,0.00931907292561162,-0.0434357260799137,-0.00690496021151617,0.0069247306674759
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,0.0127706936421316,0.00472984843823021,0.00350019070320037,0.0220411965810628,0.00694412414656047
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,-0.0217395286206953,0.00805473637662932,-0.0375268119188888,-0.00595224532250187,0.00696593682149893
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,-0.0148567366525063,0.00551163300738853,-0.0256595373469878,-0.00405393595802474,0.00703844904849894
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.0404747178842886,0.0150206418437222,-0.0699151758979842,-0.0110342598705931,0.00705792318623962
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,-0.0121357928441416,0.00451090687826175,-0.0209771703255346,-0.00329441536274858,0.00714721221988327
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPB41L5,Band 4.1-like protein 5,39649,-0.0170503140938272,0.00635084083247901,-0.0294979621254861,-0.00460266606216834,0.00726960071686676
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GC,Vitamin D-binding protein,39979,-0.00702474433056173,0.00263412289388002,-0.0121876252025666,-0.00186186345855688,0.00766798862588347
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L1,Bcl-2-like protein 1,39929,-0.0271408098540643,0.0101806979726735,-0.0470949778805045,-0.00718664182762418,0.00768895302273574
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,0.00884972804317874,0.00332142663590175,0.00233973183681131,0.0153597242495462,0.00772302137583392
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNLZ,DNL-type zinc finger protein,39586,0.0230469264028016,0.00865254666866648,0.00608793493221529,0.0400059178733879,0.00774221304873032
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRAS,GTPase Hras,39750,-0.0269175361248848,0.0101533691894517,-0.0468181397362101,-0.00701693251355954,0.00803449082219731
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD69,Early activation antigen CD69,42082,-0.0235857141851265,0.00890251290437201,-0.0410346394776956,-0.00613678889255737,0.00807450556108849
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,-0.0222069072997207,0.0084122487893645,-0.0386949149268751,-0.00571889967256627,0.00830428364395853
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED8,Protein TMED8,39930,-0.0278465278480598,0.0105651396751891,-0.0485542016114304,-0.00713885408468912,0.00840785661981162
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,-0.00805524795321119,0.00305676980654624,-0.0140465167740418,-0.00206397913238055,0.0084200285227665
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRING1,SREBP regulating gene protein,39560,-0.0166492679284082,0.00635509190568901,-0.0291052480635587,-0.00419328779325774,0.00880945585307972
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.00705823129490547,0.00269629441611643,0.00177349423931728,0.0123429683504937,0.00886085764392905
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,-0.0149558803149674,0.00571448808321802,-0.0261562769580748,-0.00375548367186012,0.00887757108803814
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00800888965481431,0.00307522971974548,-0.0140363399055155,-0.00198143940411316,0.00921759859003744
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,-0.0122667760587046,0.00471174738087318,-0.021501800925216,-0.00303175119219317,0.00923949666831105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,0.00459699093935147,0.00176857736427813,0.00113057930536634,0.0080634025733366,0.00935268459066066
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.00849564556999599,0.00327295944972695,0.00208064504853117,0.0149106460914608,0.00944976900082578
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NINJ1,Ninjurin-1,41843,-0.0143557334519331,0.0055351186902532,-0.0252045660848294,-0.00350690081903686,0.00950889424819609
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,-0.0152306202417094,0.00588134661650572,-0.0267580596100606,-0.0037031808733582,0.00961791391308323
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,-0.0225904443844291,0.00872517255960073,-0.0396917826012465,-0.00548910616761163,0.00963499922290718
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR3,Folate receptor gamma,42132,-0.0499303499343782,0.01949674464288,-0.0881439694344231,-0.0117167304343334,0.010449135515455
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,-0.0247418922204903,0.00968395355909814,-0.0437224411963227,-0.00576134324465797,0.0106336631138552
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,-0.00516675556858416,0.00202650666192109,-0.00913870862594949,-0.00119480251121883,0.0107960319729789
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,-0.0275556218360362,0.010808888148584,-0.0487410426072608,-0.00637020106481159,0.0108057036945436
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX5,Sorting nexin-5,39638,-0.00776068969560333,0.00304525502484763,-0.0137293895443047,-0.00179198984690197,0.0108336051519638
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP2,Caspase-2,42119,-0.0177004640324013,0.00694588564744787,-0.0313143999013992,-0.00408652816340351,0.0108347164886164
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,0.0149963199831887,0.00588582488576038,0.0034601032070983,0.026532536759279,0.0108517652608441
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GTPBP2,GTP-binding protein 2,39649,-0.0213769715219411,0.00839092077682026,-0.0378231762445088,-0.00493076679937339,0.0108591318061521
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCND2,G1/S-specific cyclin-D2,39757,0.00966362256817946,0.00380379841532026,0.00220817767415174,0.0171190674622072,0.0110822395866485
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,-0.0136496363250239,0.00537958487525554,-0.0241936226805248,-0.00310564996952307,0.0111845236614444
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,0.0108715724093456,0.00428842660566524,0.00246625626224175,0.0192768885564495,0.0112549873264497
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,-0.0291758734792598,0.0115495436689422,-0.0518129790703865,-0.00653876788813313,0.0115432934709994
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,0.014789184360134,0.00585730972560181,0.00330885729795442,0.0262695114223135,0.0115867387511522
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLKB1,Plasma kallikrein,39759,0.00630713578395154,0.00249870467575935,0.00140967461946321,0.0112045969484399,0.0116111978540631
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGF,Pro-epidermal growth factor,42081,-0.0266979891177075,0.0105835762162656,-0.047441798501588,-0.005954179733827,0.0116609333317549
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FMR1,Synaptic functional regulator FMR1,41843,-0.00926736706798308,0.00368105641124582,-0.0164822376340249,-0.00205249650194128,0.0118279950928137
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC16,Mucin-16,42070,-0.0487729134151337,0.0194143033968018,-0.0868249480728653,-0.0107208787574021,0.0120091732804692
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,0.00811327609685077,0.00324069487897901,0.00176151413405191,0.0144650380596496,0.0123094658470025
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,-0.0101920543230684,0.00409089875029243,-0.0182102158736415,-0.00217389277249522,0.0127363157741128
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,0.00671297442666836,0.00269858312715696,0.00142375149744072,0.012002197355896,0.0128758409661134
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK3,Dickkopf-related protein 3,42310,-0.00744523323133967,0.00299477656018855,-0.0133149952893092,-0.00157547117337011,0.0129279625085454
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,-0.0164605686522621,0.00662301988787695,-0.0294416876325009,-0.00347944967202329,0.01295433959711
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLASP1,CLIP-associating protein 1,39560,-0.0190790228921867,0.00769278109208443,-0.0341568738326722,-0.00400117195170125,0.013148709545257
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPH3,Neurexophilin-3,39657,-0.00760702710007757,0.00306737629667068,-0.0136190846415521,-0.00159496955860304,0.0131538095168839
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB118,Beta-defensin 118,39586,-0.0144595373528123,0.00583800493953562,-0.0259020270343021,-0.00301704767132244,0.0132717661410156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,-0.0252363897505458,0.0101956322991915,-0.0452198290569612,-0.00525295044413046,0.0133305561778542
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,-0.0221688599582103,0.00896158831849249,-0.0397335730624556,-0.00460414685396499,0.0133819059222992
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,-0.0223541321811163,0.00904997537788444,-0.0400920839217698,-0.0046161804404628,0.0135208662658058
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD99L2,CD99 antigen-like protein 2,42137,0.00615921407420915,0.00249402247251366,0.00127093002808238,0.0110474981203359,0.0135390248970029
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,-0.0194461882758057,0.00787768921021447,-0.034886459127826,-0.00400591742378532,0.0135825466426074
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,-0.0184723994967896,0.00748908492939122,-0.0331510059583964,-0.00379379303518286,0.0136557771487731
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,-0.0221669667616999,0.00898820579940266,-0.0397838501285291,-0.00455008339487066,0.0136691263814658
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,-0.0230400445946514,0.00936384750582945,-0.0413931857060771,-0.00468690348322565,0.0138883033415681
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,-0.00910402470131141,0.00371306976271052,-0.016381641436224,-0.00182640796639878,0.0142263116629674
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RYR1,Ryanodine receptor 1,39575,0.00845531139419267,0.0034494118282412,0.00169446421083992,0.0152161585775454,0.0142522668129152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,-0.0250447336875278,0.0102397416718411,-0.0451146273643363,-0.00497484001071928,0.0144667535320959
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,0.00583128773251112,0.00238515754052748,0.00115637895307726,0.010506196511945,0.0145048294361464
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGF,Beta-nerve growth factor,42016,0.00302071548805058,0.0012360983239177,0.000597962773171889,0.00544346820292927,0.0145482805210706
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COPB2,Coatomer subunit beta',39575,-0.0107257329541793,0.00439657672586354,-0.0193430233368719,-0.0021084425714868,0.0147206985350796
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP3,Caspase-3,42310,-0.0218103438842273,0.00894082230472549,-0.0393343556014892,-0.00428633216696531,0.0147237999405777
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAND5,DAN domain family member 5,39657,0.0136111213119523,0.00559015728667718,0.00265441303006501,0.0245678295938395,0.0149142096851801
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKAP12,A-kinase anchor protein 12,39736,0.00528084565205569,0.00217189072696353,0.00102393982720717,0.00953775147690421,0.0150541517586254
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,-0.0299612971513002,0.0123602512519998,-0.0541873896052198,-0.00573520469738061,0.0153634709305998
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,-0.0205689853733492,0.00850844298440587,-0.0372455336227847,-0.00389243712391375,0.0156414712522952
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,-0.0171109358807806,0.00708827133662109,-0.031003947700558,-0.00321792406100327,0.0157953816507752
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWF,von Willebrand factor,42310,-0.0181550889202263,0.00752181257060066,-0.0328978415586036,-0.00341233628184896,0.0158062673852059
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,-0.0113420900686197,0.00471742192041344,-0.02058823703263,-0.00209594310460934,0.0162195043235586
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO4,Roundabout homolog 4,39638,-0.00448156319318253,0.00186458081762982,-0.00813614159573698,-0.000826984790628078,0.016254325213229
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUGT1,Protein SGT1 homolog,41843,-0.0195390189507791,0.00813612349688168,-0.0354858210046672,-0.00359221689689102,0.0163410530817891
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPMT,Thiopurine S-methyltransferase,41843,-0.0174500982203426,0.00728752723684431,-0.0317336516045574,-0.00316654483612771,0.0166561475222136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSTN,Osteocrin,39649,-0.00983283566601789,0.00413232845395098,-0.0179321994357618,-0.00173347189627398,0.017353471665596
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,0.00634169053098681,0.00266989811630907,0.00110869022302103,0.0115746908389526,0.0175539015824816
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SULT1A1,Sulfotransferase 1A1,42249,0.0309705455921295,0.0130553659521753,0.00538202832586587,0.0565590628583931,0.0176940759604384
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,-0.0089336181509491,0.00376627974457524,-0.0163155264503166,-0.00155170985158163,0.0177061928045001
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,-0.00906715430358569,0.00382461373097924,-0.016563397216305,-0.00157091139086639,0.0177692969916043
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMFG,Glia maturation factor gamma,39958,-0.0173088383603878,0.00735904452141679,-0.0317325656223647,-0.00288511109841089,0.0186872576184226
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.0126581143281206,0.00538371645355802,-0.0232101985770943,-0.00210603007914693,0.0187279788204268
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL12,Stromal cell-derived factor 1,41913,-0.00944026093800384,0.00401762460850395,-0.0173148051706716,-0.0015657167053361,0.018802463675127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL36G,Interleukin-36 gamma,39624,-0.016127200890314,0.00686863774784747,-0.029589730876095,-0.00266467090453293,0.0188947591887427
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMBN,Ameloblastin,41913,0.00652283402377505,0.00278337966912617,0.00106740987228776,0.0119782581752623,0.0191186938536746
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCAN,Versican core protein,42249,-0.00715757032658775,0.00305608011006258,-0.0131474873423104,-0.00116765331086509,0.0191911324923455
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,-0.0104896297174299,0.00448591419943382,-0.0192820215483202,-0.00169723788653959,0.0193865057299784
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDNRB,Endothelin receptor type B,39657,-0.0104719076961094,0.00447968710231576,-0.0192520944166483,-0.00169172097557056,0.0194235349186899
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,-0.0142027915579021,0.00608106540517996,-0.0261216797520548,-0.00228390336374935,0.0195306550980073
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,-0.0165000344355802,0.00706737447792349,-0.0303520884123103,-0.00264798045885018,0.0195749905719921
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,-0.0144688603002574,0.0062018574225667,-0.0266245008484881,-0.00231321975202668,0.0196635947713581
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,-0.0113300962400512,0.00486623392550234,-0.0208679147340358,-0.00179227774606665,0.0199106147811562
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTF,Ciliary neurotrophic factor,39586,0.00823032579465049,0.00353993081660334,0.00129206139410794,0.015168590195193,0.0200902866579511
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA7,Carbonic anhydrase 7,39757,0.0079919263449056,0.00343784236791664,0.001253755303789,0.0147300973860222,0.0201062622265166
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,-0.012035179941572,0.0051937456658542,-0.0222149214466462,-0.00185543843649772,0.0205087096397987
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,-0.0108442522066064,0.00470145363244616,-0.0200591013262009,-0.00162940308701191,0.0210937234803994
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCP2,Non-specific lipid-transfer protein,41843,-0.0174390623832146,0.00756253820722733,-0.0322616372693802,-0.00261648749704908,0.0211271153533885
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTN,Titin,39575,-0.0162576346807257,0.00707566117623614,-0.0301259305861486,-0.0023893387753029,0.0215984926481923
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHIT1,Chitotriosidase-1,42207,-0.0364700670052228,0.0159007492917079,-0.0676355356169702,-0.00530459839347533,0.0218282627507423
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOC,Myocilin,42137,-0.0103928807540685,0.00453616363584194,-0.0192837614803187,-0.00150200002781829,0.0219719492663471
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FN1,Fibronectin,39979,-0.00636579459592113,0.00278007725201036,-0.0118147460098614,-0.000916843181980829,0.0220516794963007
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,0.0118287073754041,0.00516737405133195,0.00170065423479348,0.0219567605160147,0.0220913709285565
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEPACAM2,HEPACAM family member 2,39929,0.0101826812861298,0.00446085089037013,0.00143941354100434,0.0189259490312552,0.0224678511806003
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYT1,Synaptotagmin-1,39929,-0.00932626854300445,0.00409008989638969,-0.0173428447399282,-0.00130969234608066,0.0226136631939291
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERVV_1,,39575,0.0101474996492559,0.00445267458127201,0.00142025746996275,0.018874741828549,0.0226881278648316
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,-0.00645002383651312,0.00283074897686866,-0.0119982918311757,-0.000901755841850542,0.0227124093028965
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,0.00993557192921142,0.00436150474695673,0.00138702262517622,0.0184841212332466,0.0227448389324572
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,-0.0175175364365178,0.00769128508620326,-0.0325924552054761,-0.00244261766755936,0.0227673349328225
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTX1,Neuronal pentraxin-1,42137,-0.00963787744897169,0.00423551477906665,-0.0179394864159423,-0.00133626848200106,0.022892026153383
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBZ,Hemoglobin subunit zeta,39958,-0.0249235275050889,0.0109719664041609,-0.0464285816572442,-0.00341847335293358,0.0231314606275456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.0130171947592894,0.00573768811422414,-0.0242630634631687,-0.00177132605541007,0.0233047003138081
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,0.00545236308752091,0.00241340990260024,0.000722079678424446,0.0101826464966174,0.0238906925572962
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,0.0107987186712159,0.00479433712992692,0.00140181789655913,0.0201956194458727,0.0243173185614094
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GKN1,Gastrokine-1,41538,-0.00650034671536794,0.00288637788174456,-0.0121576473635873,-0.0008430460671486,0.0243340705278257
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEB,Nebulin,39575,-0.00915699309574591,0.00406681817903923,-0.0171279567266628,-0.00118602946482903,0.0243649938142755
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD3,Extracellular superoxide dismutase,39990,0.0139585603407258,0.00620533708664607,0.00179609965089952,0.0261210210305521,0.024503259711027
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,-0.00697797988925027,0.00310533953753908,-0.0130644453828269,-0.000891514395673663,0.02465339257401
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,-0.0171694776020435,0.00765583966758959,-0.0321749233505191,-0.00216403185356788,0.0249383366843221
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB10,Ras-related protein Rab-10,39958,-0.0122493311803241,0.00546285497406866,-0.0229565269294987,-0.00154213543114952,0.0249615442854286
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,-0.0119824843487481,0.00535909132274393,-0.0224863033413262,-0.00147866535616998,0.0253769285947752
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,0.00852336338510711,0.0038367973246751,0.00100324062874391,0.0160434861414703,0.0263388600746786
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LXN,Latexin,41960,0.0154401163477027,0.0069609474087992,0.00179665942645631,0.0290835732689492,0.0265643852713859
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCUN1D1,DCN1-like protein 1,39586,-0.0170972838765666,0.00772409410633577,-0.0322365083249847,-0.00195805942814851,0.0268836462253815
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,-0.0210580226086171,0.00953600873563076,-0.0397485997304533,-0.00236744548678077,0.0272426719357742
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.007399350523776,0.0033514114848873,-0.0139681170341551,-0.000830584013396885,0.0272766536636444
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,-0.00823588345000675,0.00374227477057721,-0.0155707420003381,-0.000901024899675415,0.0277689872237999
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF5,Fibroblast growth factor 5,41913,-0.00761834001077992,0.00346874709556172,-0.0144170843180809,-0.000819595703478945,0.0280890876955649
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F12,Coagulation factor XII,39979,-0.00922559174122575,0.00420854585182369,-0.0174743416108002,-0.000976841871651327,0.028391813889107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSLP,Thymic stromal lymphopoietin,41900,-0.0134261040367685,0.00612812661368203,-0.0254372321995853,-0.00141497587395176,0.0284764210813127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHPK,Sedoheptulokinase,39757,-0.00895455819683283,0.00409512951437826,-0.0169810120450142,-0.000928104348651451,0.0287897942907246
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES2,Cocaine esterase,42070,-0.0123591782450996,0.00566048909023157,-0.0234537368619535,-0.0012646196282457,0.0290227001638181
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,-0.0156589772952536,0.00717492083635039,-0.0297218221345003,-0.0015961324560068,0.0290961032195979
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,-0.0198823165051095,0.00911950361885455,-0.0377565435980644,-0.00200808941215459,0.029263711190708
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NENF,Neudesin,39919,-0.0250256435533381,0.0114895395004492,-0.0475451409742186,-0.00250614613245759,0.0294173642031711
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIPF,Gastric triacylglycerol lipase,39638,0.0139689321454631,0.00642540573383309,0.00137513690715024,0.0265627273837759,0.0297251420454826
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA11,Serpin A11,42310,-0.00922289759774524,0.00424330354770195,-0.0175397725512411,-0.000906022644249417,0.0297583927786735
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,-0.0188485861887148,0.00868018416161897,-0.0358617471454879,-0.00183542523194159,0.0299148638312058
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,0.0110577325248679,0.00513905672414464,0.000985181345544402,0.0211302837041914,0.0314416866881084
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLHL41,Kelch-like protein 41,39934,-0.0115276121856834,0.00536482698465394,-0.0220426730756051,-0.00101255129576167,0.0316762242325112
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX5,Syntaxin-5,39657,-0.00870761966031261,0.00406621963329343,-0.0166774101415677,-0.000737829179057486,0.0322592873472809
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.0220807701451947,0.0103403110429542,-0.0423477797893849,-0.00181376050100456,0.0327498725034156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRR1B,Cornifin-B,39757,-0.018901968917593,0.00885228898108507,-0.0362524553205197,-0.00155148251466623,0.0327612149926067
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.0105090324223426,0.00493576169311476,0.000834939503837616,0.0201831253408475,0.0332631514333899
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.00787338473599903,0.00370257654758766,-0.0151304347692709,-0.000616334702727215,0.0334832337186526
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CORO6,Coronin-6,39586,-0.00847102119124448,0.00400018040922221,-0.01631137479332,-0.000630667589168942,0.0342262920418994
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,-0.00998454666054557,0.00471729467227287,-0.0192304442182004,-0.000738649102890744,0.0343176817173943
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,-0.0109060753515019,0.00515833822263788,-0.0210164182678721,-0.000795732435131608,0.0345152873388757
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,-0.0128771296346892,0.00609198541728854,-0.0248174210525748,-0.000936838216803716,0.0345564140109058
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTD,Biotinidase,39979,-0.00441095409586047,0.00209300539968794,-0.00851324467924882,-0.000308663512472112,0.0350983471816544
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSP90B1,Endoplasmin,41774,-0.0135935425922787,0.00645857937184788,-0.0262523581611006,-0.000934727023456872,0.0353340202097416
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.00888346963536851,0.00423677983141293,0.000579381165799175,0.0171875581049378,0.0360384865050613
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00659031443816953,0.00314469105166069,0.000426719976914579,0.0127539088994245,0.0361280605917823
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,-0.0130847027554826,0.00625172534420465,-0.0253380844301237,-0.000831321080841526,0.0363741874124456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POMC,Pro-opiomelanocortin,39638,-0.0157025867372584,0.00750767356853173,-0.0304176269315805,-0.000987546542936184,0.0365026362855902
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,0.00694428307815411,0.00332620440271372,0.000424922448835214,0.013463643707473,0.0368389351232974
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP9,Fatty acid-binding protein 9,42119,-0.011835974512974,0.00573051527553342,-0.0230677844530195,-0.000604164572928535,0.0389014077661548
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,-0.011262877786902,0.00547203632150329,-0.0219880689770485,-0.000537686596755569,0.0395846708407083
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPN3,Calpain-3,39919,0.00819478402549026,0.0039880443047182,0.000378217188242587,0.0160113508627379,0.0399175793486135
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,0.00698491173942883,0.00340676200887186,0.000307658202039992,0.0136621652768177,0.0403580538304195
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,0.008194430912288,0.00399903910732638,0.000356314261928291,0.0160325475626477,0.0404760979690532
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,-0.0227875021059706,0.011131506740781,-0.0446052553179014,-0.000969748894039876,0.0406702878991551
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,-0.0133450768287078,0.00656370401081391,-0.026209936689903,-0.000480216967512534,0.0420592969837585
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.00504626663213525,0.002489925673331,-0.009926520951864,-0.000166012312406499,0.0427151205771467
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA6C,Semaphorin-6C,39657,-0.00533299067698716,0.00263816034818835,-0.0105037849594363,-0.000162196394538004,0.0432540539921345
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC4A1,Band 3 anion transport protein,39966,-0.00976984691666313,0.00486060487303871,-0.019296632467819,-0.000243061365507266,0.0444540957721812
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK4,Serine/threonine-protein kinase 4,42145,-0.0178535758612298,0.00888312443493643,-0.0352644997537052,-0.000442651968754391,0.0444689072574184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAS6,Growth arrest-specific protein 6,42236,-0.00513540843740335,0.00255977244721091,-0.0101525624339367,-0.000118254440869962,0.0448549191170403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,-0.00751980483474677,0.00374858852254362,-0.0148670383389323,-0.00017257133056128,0.0448766998711382
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00573802012204133,0.00286113443194329,0.000130196635432471,0.0113458436086502,0.0449333815870001
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH4,Myosin-4,39575,0.00938075890682753,0.00468203582073753,0.000203968698181964,0.0185575491154731,0.045141311037043
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,-0.0244882810656731,0.0122330952926031,-0.0484651478391751,-0.000511414292171039,0.0453254693880521
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,-0.0167605415118337,0.00838769166573262,-0.0332004171766697,-0.000320665846997789,0.045716137516981
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARFIP1,Arfaptin-1,39934,-0.0140851697407777,0.00708428478375767,-0.0279703679169427,-0.000199971564612674,0.046810549882509
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PER3,Period circadian protein homolog 3,39657,-0.0249597505048074,0.0125668317301662,-0.0495907406959332,-0.000328760313681706,0.0470401047790689
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,-0.00528295805127542,0.00267458168358502,-0.0105251381511021,-4.07779514487779e-05,0.0482644165838296
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,-0.0093680675470383,0.00474707025353953,-0.0186723252439758,-6.38098501008315e-05,0.0484702794589308
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMM2,Phosphomannomutase 2,39575,-0.0119610078732807,0.00613235468074251,-0.023980423047536,5.84073009745889e-05,0.0511448838132684
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.00497404621836494,0.00256289940301602,-4.92366115464474e-05,0.00999732904827633,0.0523046311164469
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOK1,Docking protein 1,39929,-0.0271618406356173,0.0140215617327546,-0.0546441016318164,0.000320420360581764,0.0527520790218307
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBX2,Chromobox protein homolog 2,39575,0.00780153948251166,0.0040333382756889,-0.00010380353783859,0.0157068825028619,0.0531063972615523
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPLX2,Complexin-2,39560,0.00606824035144999,0.00313878036488487,-8.37691637243579e-05,0.0122202498666243,0.0532235520756387
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,0.0105845823778292,0.00549001788107548,-0.000175852669078696,0.0213450174247372,0.053884406567184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,-0.00834643994541424,0.00433604405355451,-0.0168450862903811,0.000152206399552593,0.0542634771476709
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,-0.00930252804149394,0.00483335408496359,-0.0187759020480226,0.000170845965034708,0.0542942183581401
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,-0.0152198026733427,0.00790917030285807,-0.0307217764669445,0.000282171120259099,0.0543396926234107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSLNL,Mesothelin-like protein,39649,0.00745253198901934,0.00387316177602929,-0.000138865091998078,0.0150439290700368,0.0543618351853381
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCC,Netrin receptor DCC,39649,-0.00438425066921629,0.00228342817950206,-0.00885976990104033,9.12685626077488e-05,0.0548798231172038
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHD,SH2 domain-containing adapter protein D,39554,-0.016179507726907,0.00842786963670698,-0.0326981322148527,0.000339116761038698,0.0549138544263591
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAP,Prolyl endopeptidase FAP,42310,0.00536016820854315,0.00279567543001169,-0.000119355634279769,0.0108396920513661,0.0552196925241404
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,-0.0150007881977705,0.00782536720618981,-0.0303385079219026,0.0003369315263615,0.0552708751885295
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHCY,Adenosylhomocysteinase,42145,-0.0129667709894446,0.00683628599651451,-0.026365891542613,0.000432349563723834,0.057881315492938
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.00374660319670609,0.0019754381596017,-0.00761846198952541,0.000125255596113238,0.057906909139858
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,-0.0146304811432414,0.00773202134191204,-0.029785242973389,0.00052428068690623,0.0584864665902604
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,-0.0464833743486123,0.0246377571935768,-0.0947733784480229,0.00180662975079833,0.0592299627362314
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,-0.0110513221699241,0.00587902268165336,-0.0225742066259647,0.000471562286116462,0.0601633445837526
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.0049356497952624,0.00262654430404598,-0.000212377040667723,0.0100836766311925,0.0602507409401296
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENG,Endoglin,42310,-0.00329638948488189,0.00175548329254937,-0.00673713673827865,0.000144357768514877,0.060434187344827
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEG1,Protein LEG1 homolog,39398,-0.0135271384247087,0.00720619930010278,-0.0276512890529102,0.000597012203492708,0.0605240698082958
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.00414177925105834,0.00220981919734254,-0.000189466375733047,0.00847302487784972,0.0609207703105621
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,0.00768035661454354,0.00409966549890453,-0.000354987763309331,0.0157157009923964,0.0610373732630101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0102924361463624,0.00551645163821887,-0.000519809064546585,0.0211046813572714,0.0620954864655667
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL25,Interleukin-25,39510,0.00655091743722096,0.00351650875360064,-0.000341439719836308,0.0134432745942782,0.0625026595139996
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRX,Cone-rod homeobox protein,41900,-0.0203366350417013,0.0109431975231318,-0.0417853021870396,0.00111203210363698,0.0631369448789546
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,-0.00913460516928355,0.00492389757138676,-0.0187854444092016,0.000516234070634506,0.0635997048296419
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.00497723721010751,0.00268615857607066,-0.000287633598990976,0.010242108019206,0.0639206366637973
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVPL,Envoplakin,39757,0.00630833028227683,0.00342140456200689,-0.000397622659256679,0.0130142832238103,0.065241156104078
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.00681973373076809,0.00369915502220982,-0.000430610112763145,0.0140700775742993,0.0652693671038024
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,0.00620730043002265,0.00336718376734162,-0.000392379753966937,0.0128069806140122,0.0652865142832247
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F11,Coagulation factor XI,39822,0.00591274151588742,0.00320927694147676,-0.000377441289407023,0.0122029243211819,0.0654444068487763
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,0.0083308681603089,0.00453314332630433,-0.000554092759247579,0.0172158290798654,0.0661184511361846
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,0.00512980771316919,0.00280213754525888,-0.000362381875538218,0.0106219973018766,0.0671754819394759
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,0.00738258361827381,0.00403511879311993,-0.000526249216241259,0.0152914164527889,0.06733947315015
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUK1,Guanylate kinase,39575,0.00751330826886872,0.00411280295668203,-0.000547785526228062,0.0155744020639655,0.0677555359939151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGMA,Repulsive guidance molecule A,42249,-0.0059393224549122,0.00326739628872278,-0.0123434191808088,0.000464774270984443,0.0691236638133382
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,-0.00248324147203945,0.00136674247912925,-0.00516205673113277,0.000195573787053868,0.069258383441242
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,-0.00869526981245572,0.00479547732036679,-0.0180944053603746,0.000703865735463176,0.0698238720101207
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL21R,Interleukin-21 receptor,39657,-0.0100130683941929,0.00553500169207083,-0.0208616717106517,0.000835534922265927,0.0704711258728333
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0104314809028511,0.00578603411999274,-0.0217721077780369,0.00090914597233469,0.0714305250215212
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,-0.0151552892639877,0.00843115057186943,-0.0316803443848517,0.00136976585687644,0.072278157941089
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK7,Kallikrein-7,39475,-0.00726436632771735,0.0040529501332905,-0.0152081485889667,0.000679415933532024,0.073102289193228
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BIN2,Bridging integrator 2,42137,-0.0162086558001186,0.009050017882133,-0.0339466908490993,0.00152937924886211,0.0733143204510531
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BDNF,Brain-derived neurotrophic factor,39966,-0.015308122582495,0.00857196310770943,-0.0321091702736055,0.00149292510861552,0.0741524244069092
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.015906717455935,0.00893255868091386,-0.00160109755865618,0.0334145324705261,0.0749795852113888
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK15,Kallikrein-15,39900,-0.00957240882034322,0.00537550071141208,-0.0201083902147109,0.000963572574024452,0.0749805862817553
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANSC4,MANSC domain-containing protein 4,39575,-0.0123607988425727,0.00694474949888924,-0.0259725078603956,0.00125091017525025,0.0751237791654801
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,-0.00436394179910342,0.00246064247824243,-0.00918680105645858,0.000458917458251738,0.076168995250256
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,-0.00744684107045937,0.00420765938131807,-0.0156938534578428,0.000800171316924054,0.0767828015464419
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMP,Olfactory marker protein,39586,-0.00868000419044007,0.00491271380966758,-0.0183089232573885,0.00094891487650838,0.0772819394089068
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPHS1,Nephrin,39657,0.00599524414052525,0.00340458947610447,-0.000677751232639513,0.01266823951369,0.0782778705604308
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,-0.0058516527214938,0.00333502133567983,-0.0123882945394263,0.00068498909643866,0.0793544081466039
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,-0.021398209784477,0.0122056713370734,-0.0453213256051409,0.00252490603618691,0.0796012166026998
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB9,Serpin B9,42016,-0.00580945413479381,0.00333159100408913,-0.0123393725028085,0.000720464233220883,0.0812259992390253
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,-0.00778413373198009,0.00446760600883994,-0.0165406415093064,0.000972374045346188,0.0814752527973318
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,-0.00543866883381524,0.00312632587768214,-0.0115662675540722,0.000688929886441749,0.0819501235370044
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,-0.0219323722689756,0.0126121841576594,-0.0466522532179879,0.00278750868003677,0.0820610125710482
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,-0.00487970345066419,0.00280620947595443,-0.0103798740235349,0.000620467122206499,0.0820759045769213
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00531025113003585,0.00305391206606323,-0.000675416519448071,0.0112959187795198,0.0820915110228144
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMMD9,COMM domain-containing protein 9,39919,0.00704140038379041,0.00407508891837568,-0.000945773896225927,0.0150285746638067,0.0840310425064254
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD177,CD177 antigen,42123,-0.0225553110200202,0.0130588736269052,-0.0481507033287543,0.003040081288714,0.0841542483365673
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,-0.0129795029299503,0.00751895713255827,-0.0277166589097645,0.00175765304986392,0.0843327443853107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP29,Dual specificity phosphatase 29,39649,-0.0118559820015034,0.00687896246696565,-0.0253387484367561,0.00162678443374928,0.0848237519858643
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOX2,Transcription factor SOX-2,39915,0.00432611871823864,0.00251109659287338,-0.000595630603793187,0.00924786804027046,0.0849519135193551
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,0.00516756543387801,0.00301378881864306,-0.000739460650662386,0.0110745915184184,0.0864392967306114
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF16,Fibroblast growth factor 16,39657,-0.00812376327758101,0.00475423076537671,-0.0174420555777194,0.00119452902255734,0.0875264449806413
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.0103963046086027,0.00608790028328699,-0.0015359799466398,0.0223285891638452,0.0877201967054083
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MST1,Hepatocyte growth factor-like protein,39854,-0.0117460048015271,0.00688702445057911,-0.0252445727246622,0.00175256312160792,0.088123812787487
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,0.00441855674099845,0.00260186613711297,-0.000681100887742964,0.00951821436973987,0.0894934990717585
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,-0.0151700848963174,0.00893880825257237,-0.0326901490713592,0.00234997927872448,0.0897049936873254
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,-0.0221393396715218,0.0130758004057631,-0.0477679084668175,0.00348922912377382,0.09045369812621
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,-0.00839564929426999,0.00496950521462178,-0.0181358795149287,0.0013445809263887,0.0911647333284299
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPB2,Carboxypeptidase B2,39959,0.00387453762363269,0.00229410998799255,-0.00062191795283271,0.00837099320009808,0.0912647662223439
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR4,Toll-like receptor 4,39657,-0.00489792618921007,0.00290221279119552,-0.0105862632599533,0.00079041088153314,0.0915061906008129
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLN1,Cerebellin-1,39586,0.0160124011973106,0.009493096519018,-0.00259406797996471,0.0346188703745858,0.0916814330137302
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HCG22,Protein PBMUCL2,39575,0.0100094767620803,0.00593502244628826,-0.00162316723264465,0.0216421207568053,0.0917259653977269
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GH2,Growth hormone variant,41843,-0.0278466603412255,0.016517647446279,-0.0602212493359323,0.00452792865348127,0.0918437682963251
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN3B,Sodium channel subunit beta-3,39586,0.00803630612258785,0.00477326477234218,-0.00131929283120283,0.0173919050763785,0.0922858879259967
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,-0.0130700173380119,0.00777765368793467,-0.0283142185663638,0.00217418389034008,0.0928967443176817
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1F,Protein phosphatase 1F,39958,-0.00914089856543081,0.00545227585730403,-0.0198273592457467,0.0015455621148851,0.0936621417998598
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,-0.00863137458379594,0.0051508677702036,-0.018727075413395,0.00146432624580312,0.0938227736710186
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,-0.0162568323415301,0.00974519114468124,-0.0353574069851054,0.0028437423020451,0.095306541702261
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL14,C-X-C motif chemokine 14,41913,-0.00968237842534321,0.00581673807619296,-0.0210831850546814,0.001718428203995,0.0960217389811357
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,-0.00689829605736003,0.00417012185793934,-0.0150717348989211,0.00127514278420107,0.0981113473862609
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A16,Protein S100-A16,41814,0.0102327989535291,0.00618815027729124,-0.00189597558996175,0.0223615734970199,0.0982301461764006
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,-0.00863560143835448,0.00523050775360725,-0.0188873966354247,0.00161619375871572,0.0987657009874457
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,-0.00896356092584022,0.00543413166986346,-0.0196144589987726,0.00168733714709215,0.0990748735522701
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYB5A,Cytochrome b5,39560,-0.0120223547097019,0.00728926976080607,-0.0263093234408818,0.00226461402147796,0.099110294415303
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00505415346691185,0.00308076199214193,-0.000984140037686325,0.01109244697151,0.100913977500967
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,-0.00399141971428646,0.00243894518253919,-0.00877175227206326,0.000788912843490347,0.101751215052617
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTD,Deoxycytidylate deaminase,39736,-0.0160139323749286,0.00979154653303662,-0.0352053635796804,0.00317749882982318,0.101975573795987
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.00846579668050939,0.00518926504784295,-0.00170516281326279,0.0186367561742816,0.102833430505905
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTXR,Neuronal pentraxin receptor,42145,-0.00565940682244348,0.0034707311720697,-0.0124620399197001,0.00114322627481313,0.102996017785423
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APCS,Serum amyloid P-component,39870,-0.00540758511460384,0.00332284953761649,-0.0119203702083322,0.00110519997912448,0.10368141787474
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF12,Fibroblast growth factor 12,39657,-0.00753867716395701,0.004634893535803,-0.0166230684941309,0.00154571416621686,0.10387078260991
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAEP,Glycodelin,42016,-0.017266696116672,0.0106291701394961,-0.0380998695900844,0.00356647735674044,0.104300471827567
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,-0.00809360527905499,0.00499039978022847,-0.0178747888483028,0.00168757829019281,0.104867395887479
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXK,Tyrosine-protein kinase TXK,39757,-0.0121492370636022,0.00750310955444898,-0.0268553317903222,0.00255685766311776,0.105426709386856
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,-0.0066400028873747,0.00411850187694921,-0.0147122665661951,0.00143226079144575,0.106933846643911
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PODXL,Podocalyxin,42070,0.00247845335944621,0.00153933353176176,-0.000538640362806837,0.00549554708169926,0.107403367262541
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,-0.00849937447195558,0.00528287954472867,-0.0188538183796238,0.00185506943571262,0.107676869979393
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NME1,Nucleoside diphosphate kinase A,39657,0.0035995949446662,0.00224302052320058,-0.000796725280806936,0.00799591517013934,0.108566816004842
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.00758637021991175,0.00473288813621594,-0.016862830966895,0.00169009052707149,0.108978761322182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.0088301886263647,0.00553879455502152,-0.0196862259542069,0.00202584870147749,0.11091003174478
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP2BP,LRP2-binding protein,39649,-0.0126344151457637,0.0079369040488231,-0.028190747081457,0.00292191678992956,0.111445477866156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMB,Granzyme B,42119,-0.0109662993694031,0.00689664838267982,-0.0244837301994555,0.00255113146064937,0.111837649522215
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD84,SLAM family member 5,42119,-0.00512582482611366,0.00323964038433018,-0.0114755199794008,0.0012238703271735,0.11362267714934
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP10,Stromelysin-2,42124,-0.00924164492445258,0.00584939525715611,-0.0207064596284786,0.0022231697795734,0.114145897737657
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG4,Desmoglein-4,42018,0.00769251575424431,0.00487346196334701,-0.00185946969391583,0.0172445012024044,0.114485852102393
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,-0.00748201802285363,0.00474551740959676,-0.0167832321456633,0.00181919609995603,0.114900063994821
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPN1,Epsin-1,39757,-0.00697221582992821,0.00443266337404451,-0.0156602360430554,0.00171580438319903,0.115766171227019
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCLRE1C,Protein artemis,39560,0.00490135210828447,0.00311729063312702,-0.00120853753264448,0.0110112417492134,0.115907178134733
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVI2B,Protein EVI2B,39560,0.0064288117582883,0.00409151140634931,-0.00159055059815634,0.0144481741147329,0.116152068447838
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,0.00555666946179677,0.00353693768580858,-0.00137572840238805,0.0124890673259816,0.116202229682555
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.0124112481660347,0.00790069699764463,-0.0278966142814182,0.00307411794934879,0.116233473468054
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BEX3,Protein BEX3,39560,0.00751890491631896,0.00478957449689912,-0.00186866109760332,0.0169064709302412,0.116479297848514
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,0.0134167470005294,0.00856149180261785,-0.0033637769326016,0.0301972709336604,0.117119243003287
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FADD,FAS-associated death domain protein,42145,-0.0121508235559352,0.00775569221989509,-0.0273519803069295,0.0030503331950592,0.117208777214877
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCIN,Adseverin,39586,-0.0118178314996592,0.00756045214102024,-0.0266363176960589,0.00300065469674043,0.118055118036712
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD40LG,CD40 ligand,42296,-0.0125365198267765,0.00805501320532887,-0.0283243457092211,0.00325130605566805,0.119645042280221
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGR,Progesterone receptor,39657,-0.0159430522603339,0.0102457445088447,-0.0360247114976695,0.00413860697700162,0.119721075169955
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,-0.0061280189550304,0.00396159685305679,-0.0138927487870217,0.00163671087696091,0.121926861271122
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRK1,Protein BRICK1,41839,-0.00708585809833191,0.00461778646913488,-0.0161367195778363,0.00196500338117245,0.12493778865457
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.00529489470688033,0.00345835268965611,-0.0120732659786063,0.00148347656484565,0.125786849157043
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,-0.0105506833966093,0.00689287726379277,-0.0240607228336431,0.00295935604042451,0.125880209181645
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK3,Prostate-specific antigen,39966,0.0178858420154554,0.0116874944476617,-0.00502164710196147,0.0407933311328723,0.125960384363567
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RELB,Transcription factor RelB,39657,-0.00733127811580189,0.00479563327423429,-0.0167307193333011,0.00206816310169733,0.12635742918241
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTC,Probetacellulin,41843,-0.0114114448274201,0.00747426719168352,-0.0260610085231198,0.00323811886827963,0.126843496440989
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.00919321288741807,0.00602761806232653,-0.0210073442895781,0.00262091851474194,0.127242564301512
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL28,C-C motif chemokine 28,42075,-0.00912630331745628,0.00599093626405807,-0.0208685383950101,0.00261593176009753,0.127694189977713
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD2,Bromodomain-containing protein 2,39586,-0.00543438125386923,0.00358939468285541,-0.0124695948322658,0.00160083232452737,0.130051942746117
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QL2,Complement C1q-like protein 2,39657,-0.00665848799493868,0.00440265538447903,-0.0152876925485176,0.00197071655864023,0.130465796809177
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.00863531999407849,0.00572410569462574,-0.00258392716738796,0.0198545671555449,0.131432732509655
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,-0.00453827157379499,0.00302086771574863,-0.0104591722966623,0.00138262914907233,0.133046325572663
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY2A,Pancreatic alpha-amylase,41665,-0.00745948004419936,0.00497645444287595,-0.0172133307522362,0.0022943706638375,0.133909531477241
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDAN1,Codanin-1,39929,0.00334341589014741,0.00223233847444933,-0.00103196751977327,0.0077187993000681,0.134234116809393
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTN4,Alpha-actinin-4,41913,-0.00479820297055524,0.00321002489231333,-0.0110898517594894,0.00149344581837888,0.135001916016874
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESR1,Estrogen receptor,39657,-0.00873237382628711,0.00584327060387234,-0.0201851842098769,0.00272043655730267,0.135091133974652
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,-0.0067709631088145,0.00453706942683065,-0.0156636191854026,0.00212169296777358,0.13563225809273
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FST,Follistatin,42166,0.00738055354879721,0.00494957426340249,-0.00232061200747166,0.0170817191050661,0.135945586695573
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN2B,Sodium channel subunit beta-2,39649,0.00429269655831066,0.00288145112357036,-0.00135494764388725,0.00994034076050856,0.136313528235883
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100G,Protein S100-G,39934,0.00741464001587555,0.00500392364722279,-0.00239305033268112,0.0172223303644322,0.138430577161793
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,-0.0103388538012757,0.0069793267519196,-0.0240183342350381,0.00334062663248676,0.138536057084941
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,0.00814494780677102,0.00550634183090262,-0.0026474821817981,0.0189373777953402,0.139117267357181
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00571147171395045,0.00386721730713232,-0.0132912176359298,0.0018682742080289,0.139732668845839
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.00593885836364149,0.00402510177818565,-0.0138280578488854,0.00195034112160238,0.140118823422499
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,-0.00905117206390764,0.00613948400655205,-0.0210845607167497,0.00298221658893438,0.140440447039314
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,0.00809426511311645,0.00549715779632246,-0.00268016416767558,0.0188686943939085,0.140929267819885
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,-0.00521231935811686,0.00354685868095266,-0.0121641623727841,0.00173952365655036,0.141708890985741
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,-0.00787637348281604,0.00540941897783093,-0.0184788346793647,0.00272608771373259,0.145402667726744
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFP,Alpha-fetoprotein,41976,0.00958821977239277,0.00661677098732207,-0.00338065136275848,0.022557090907544,0.147339137947282
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.00439127782183327,0.00303258575197954,-0.00155259025204662,0.0103351458957132,0.147637018669747
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRXN3,Neurexin-3,39649,-0.00530096668548232,0.00367346217942249,-0.0125009525571504,0.00189901918618575,0.149036492283676
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRDT,Bromodomain testis-specific protein,39575,-0.00538937247914297,0.00373854721030727,-0.0127169250113452,0.00193818005305927,0.149452627755766
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,-0.0070889722357093,0.00492984561526158,-0.016751469641622,0.0025735251702034,0.150465590241215
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,0.0052540627826792,0.00365414218957563,-0.00190805590888905,0.0124161814742474,0.150508669197793
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.00760847041408092,0.00529307138751644,-0.0179828903336131,0.00276594950545131,0.150622267532761
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,-0.0084975960918126,0.00591704256028055,-0.0200949995099625,0.00309980732633728,0.150991290008084
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,-0.0149488041159974,0.0104204533012566,-0.0353728925864603,0.00547528435446544,0.151439793200397
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDAC8,Histone deacetylase 8,39657,-0.00879563775551031,0.00615550937711445,-0.0208604361346546,0.00326916062363402,0.153059806200845
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL5,Interleukin-5,41913,-0.0200840884510752,0.0140569113251092,-0.0476356346482893,0.0074674577461389,0.153093908983235
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,-0.00676028548705629,0.00474365961270062,-0.0160578583279495,0.00253728735383693,0.154145302841855
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,-0.00701864600543888,0.00493317347553812,-0.0166876660174936,0.00265037400661583,0.15483859513014
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PI16,Peptidase inhibitor 16,39990,0.00350979000879143,0.00246698271547678,-0.00132549611354306,0.00834507613112592,0.154848916340977
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,-0.0161065173704386,0.0113331644575132,-0.0383195197071644,0.00610648496628735,0.155286690502045
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,-0.00913602125975617,0.00643219471821054,-0.0217431229074488,0.0034710803879365,0.155530821244532
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CORO1A,Coronin-1A,41883,-0.012806338571329,0.00901922221176499,-0.0304840141063884,0.00487133696373036,0.155662041666263
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OBP2B,Odorant-binding protein 2b,41979,0.00825495230460057,0.0058160495706617,-0.00314450485389636,0.0196544094630975,0.155823187653436
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,-0.0100183585435038,0.00706022825617925,-0.0238564059256151,0.00381968883860757,0.155931574290289
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,-0.00647791225796311,0.00457127064405851,-0.0154376027203178,0.00248177820439156,0.156483877228423
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGS8,Regulator of G-protein signaling 8,41913,0.00919489649510274,0.00650223416786084,-0.00354948247390451,0.02193927546411,0.157351992536444
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EP300,Histone acetyltransferase p300,39657,-0.00442493691442227,0.00314793751887182,-0.010594894451411,0.0017450206225665,0.159852541468522
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAD2,Glutamate decarboxylase 2,39657,0.0065090193229989,0.00463185274961983,-0.00256941206625596,0.0155874507122538,0.159968098990905
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY2B,Alpha-amylase 2B,41300,-0.00715428007773142,0.00509527829767106,-0.0171410255411667,0.00283246538570385,0.160313537385824
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUCL3,Mucin-like protein 3,39560,0.00611225292460672,0.00436350639521623,-0.00244021961001709,0.0146647254592305,0.161312265542856
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.00871730867514413,0.00623414282213655,-0.0035016112562435,0.0209362286065318,0.162040794800423
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,-0.00795924033427169,0.00572261746965309,-0.0191755705747918,0.00325708990624837,0.164297481011322
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,-0.00443535284926583,0.00319474864862254,-0.010697060200566,0.00182635450203435,0.165065992252578
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.00423031947314909,0.00305084913500522,-0.0102099837777593,0.00174934483146115,0.165585107766278
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,-0.00210379725588783,0.00151737868038205,-0.00507785946943664,0.00087026495766099,0.165631220482596
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,-0.0109503283046249,0.00790144476547013,-0.0264371600449463,0.0045365034356966,0.165816415122019
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,-0.00672914123325387,0.00489373229842128,-0.0163208565381596,0.00286257407165184,0.169143085600808
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,0.00866712139088051,0.00635036587405741,-0.00377959572227202,0.021113838504033,0.172336837825964
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,-0.0151574689364325,0.0111310929848535,-0.0369744111867453,0.00665947331388035,0.173307929164652
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.00519285975104226,0.0038149790469415,-0.00228449918096309,0.0126702186830476,0.17348546705677
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,0.0103797688838749,0.00763605498698949,-0.0045868988906245,0.0253464366583743,0.17407618188212
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD99,CD99 antigen,42137,0.00274806494923881,0.00202177688488272,-0.00121461774513132,0.00671074764360894,0.174095552745367
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.0104840634294596,0.00772853556503304,-0.00466386627800513,0.0256319931369244,0.174954645553611
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,0.0109450582180116,0.00812992163786083,-0.0049895881921956,0.0268797046282189,0.178238437620019
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,-0.00661633601796721,0.00491699641001864,-0.0162536489816037,0.00302097694566932,0.178457212958174
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO2,Gamma-enolase,42249,-0.00888813183906673,0.00661347979253493,-0.0218505522324352,0.00407428855430172,0.178989551335367
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,0.00570727869191147,0.00428596149142722,-0.00269320583128588,0.0141077632151088,0.183012029663767
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLB,Beta-klotho,41839,0.0101029265217725,0.00759506068545111,-0.00478339242171171,0.0249892454652566,0.183476304189651
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,0.00429592328995195,0.00323027317208218,-0.00203541212732913,0.010627258707233,0.183580565379259
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTN,Neuroplastin,41843,-0.0105802901090639,0.00798005935146843,-0.026221206437942,0.00506062621981425,0.184915227630677
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RILPL2,RILP-like protein 2,39958,-0.0133872537077882,0.0101012966337475,-0.0331857951099333,0.00641128769435696,0.185098153650646
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDAC9,Histone deacetylase 9,39586,-0.00905603746059946,0.00683624348918276,-0.0224550746993977,0.00434299977819874,0.185295038053931
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,-0.00678886951611559,0.00513014390321724,-0.0168439515664214,0.0032662125341902,0.185753445736373
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2,Interleukin-2,41913,0.00429528210005258,0.00325418098863588,-0.00208291263767374,0.0106734768377789,0.186882009996587
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNPY2,Protein canopy homolog 2,41900,-0.00815394560977351,0.00619703322390533,-0.020300130728628,0.00399223950908095,0.188269856099022
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP6,Guanylate-binding protein 6,39575,0.00600759103515599,0.00456930647532447,-0.00294824965647997,0.0149634317267919,0.188614393521448
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.00739655569296304,0.00562618445913099,-0.0184238772328598,0.0036307658469337,0.188649485650673
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTX2,Neuronal pentraxin-2,39966,0.00459259559094749,0.00349396364960181,-0.00225557316227205,0.011440764344167,0.18872566201003
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A3,Protein S100-A3,39919,-0.00572839297180021,0.00436424775151455,-0.0142823185647687,0.00282553262116831,0.189353547016972
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,0.00560505806781761,0.0043013810973623,-0.0028256488830125,0.0140357650186477,0.192573200798595
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD1,Sushi domain-containing protein 1,41900,-0.00644064527768434,0.00495206109243434,-0.0161466850188556,0.00326539446348696,0.193418313658221
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM1,Myomesin-1,39586,-0.00651418316819068,0.00501771534318438,-0.0163489052408321,0.00332053890445071,0.194233197698741
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.00359618041142837,0.00277542705360684,-0.00184365661364103,0.00903601743649777,0.195097849816072
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00394029162881071,0.00304122482048973,-0.00202050901934916,0.00990109227697057,0.195127391779153
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTKN2,Rhotekin-2,39575,0.00670936988120559,0.00520383445904219,-0.00349014565851711,0.0169088854209283,0.19731656750286
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,-0.00917462530361569,0.00712023952982578,-0.0231302947820742,0.00478104417484283,0.19758410372831
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.00368580445413883,0.00286676985894498,-0.00930467337767099,0.00193306446939334,0.198574249481013
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.00396981574815525,0.00308857914929701,-0.0100234308807774,0.00208379938446689,0.198706311499882
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCLN,Nicalin,41913,-0.00668269891256626,0.00521105474079831,-0.0168963662045309,0.00353096837939843,0.199721845962232
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR2,Toll-like receptor 2,39757,-0.00303662121073535,0.00237178652847032,-0.00768532280653718,0.00161208038506647,0.200462867834714
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.0099283221054009,0.00781432187914818,-0.0252443929885313,0.00538774877772954,0.203922773001353
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,0.00799414553288279,0.00630460495291594,-0.00436288017483246,0.020351171240598,0.204830120803911
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TUBB3,Tubulin beta-3 chain,39586,0.00371671413765217,0.00293289707619081,-0.00203176413168181,0.00946519240698616,0.205092735472426
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLINT1,Clathrin interactor 1,39560,0.00647914579905129,0.00511736950064143,-0.00355089842220592,0.0165091900203085,0.205501095649974
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,0.00432591037761018,0.00342267159564127,-0.00238252594984671,0.0110343467050671,0.206293248256498
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00451995699167772,0.0035982076496346,-0.00253253000160609,0.0115724439849615,0.209076854331362
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,-0.00667473536416322,0.00533446236074204,-0.0171302815912176,0.00378081086289117,0.210866120099579
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,0.00669436394384554,0.00535415392858514,-0.00379977775618134,0.0171885056438724,0.211207617921844
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,0.006472188441148,0.00517794536593996,-0.00367658447609433,0.0166209613583903,0.211338804626138
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,-0.0107110221226137,0.00857472687479248,-0.027517486797207,0.00609544255197954,0.211641070575546
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSB,Lupus La protein,41839,-0.00747399892134992,0.00598571986433935,-0.0192060098554551,0.00425801201275521,0.211819486043551
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRMD7,FERM domain-containing protein 7,39649,0.00432156783441145,0.00347185601172575,-0.00248326994857102,0.0111264056173939,0.213252702248845
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,0.00704691685261075,0.00566136261847837,-0.00404935387960685,0.0181431875848284,0.213254413307226
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.00515373771197176,0.00414247103095934,-0.0132729809326521,0.00296550550870855,0.213481380192411
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRGN,Neurogranin,39990,-0.0117368868929066,0.00944409058825193,-0.0302473044458804,0.00677353066006714,0.213976059341652
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,0.00512319246363563,0.00412588629759695,-0.00296354467965439,0.0132099296069256,0.214366698381419
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM25,RNA-binding protein 25,39560,0.00592587580550952,0.00479456978061428,-0.00347148096449446,0.0153232325755135,0.216501522759421
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00334922462128806,0.00272224542840956,-0.00198637641839468,0.00868482566097081,0.218604900621198
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FZD10,Frizzled-10,39649,-0.00748418545648323,0.0060932752866411,-0.0194270050182998,0.00445863410533333,0.219371901068078
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1A,Protein phosphatase 1A,41843,-0.00391539779169302,0.00319499400675464,-0.0101775860449321,0.00234679046154608,0.220416623046587
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,0.00381816719782764,0.00311831571704635,-0.00229373160758321,0.0099300660032385,0.220815422211
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP1,DNA topoisomerase 1,39930,-0.0150600477137113,0.0123323907393273,-0.0392315335627928,0.00911143813537028,0.222043936554845
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELL,L-selectin,39979,-0.00289165643915907,0.00237607000673149,-0.00754875365235279,0.00176544077403465,0.223632779546414
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTOA,Otoancorin,39586,0.00652383015990834,0.00538408284390805,-0.00402897221415143,0.0170766325339681,0.22565778216593
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,-0.00966495665045787,0.00801130736587053,-0.0253671190875641,0.00603720578664837,0.227682923226972
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,-0.00373661131769601,0.00311000600240575,-0.00983222308241129,0.00235900044701927,0.229586383454
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTPN,Myotrophin,41900,0.00396014208013736,0.00330681415146949,-0.00252121365674284,0.0104414978170176,0.231105726198741
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REST,RE1-silencing transcription factor,39560,0.00417631696606244,0.0035052891174554,-0.00269404970415015,0.011046683636275,0.233509462299444
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,-0.00560446538486943,0.00471791347926972,-0.0148515758042381,0.00364264503449921,0.23488944019103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPK3A,Uroplakin-3a,39586,0.0058780935609156,0.00496368552233876,-0.00385073006286837,0.0156069171846996,0.236351775315103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0102308484062469,0.00864430364952064,-0.00671198674681353,0.0271736835593074,0.236617862543071
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,-0.00809151397131438,0.00687375433082254,-0.0215640724597266,0.0053810445170978,0.239151871441162
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.00650418852109602,0.00552587570730764,-0.017334904907419,0.00432652786522696,0.239204045469407
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3GL3,Endophilin-A3,39690,-0.0102420116484128,0.00872534065953954,-0.0273436793411103,0.00685965604428472,0.240490856817396
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,-0.00674748733620711,0.00575037923280582,-0.0180182306325065,0.0045232559600923,0.240661470056067
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RUVBL1,RuvB-like 1,41843,-0.0118276143664557,0.0100853987316012,-0.0315949958803941,0.00793976714748258,0.240918639902027
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSPN,Claspin,41820,-0.00422917045136662,0.00361180686762042,-0.0113083119119026,0.00284997100916941,0.24164830588646
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP5,Platelet glycoprotein V,39736,0.00435737387762023,0.00373924669134453,-0.00297154963741506,0.0116862973926555,0.24391932405546
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,0.0042381788331047,0.00366122260223244,-0.00293781746727088,0.0114141751334803,0.247058181282515
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,-0.00667918655028957,0.00580048771811979,-0.0180481424778044,0.00468976937722522,0.249556856600602
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAG,S-arrestin,39586,0.0061617610947623,0.00535757036103768,-0.00433907681287154,0.0166625990023961,0.25012622787963
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,-0.0053031560812755,0.00462421751347335,-0.0143666224076833,0.00376031024513227,0.251479635635403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,-0.00551359068187571,0.00481871574958864,-0.0149582735510694,0.00393109218731802,0.252563511644083
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAT1,Diamine acetyltransferase 1,39575,0.00564474148211465,0.00494307998842623,-0.00404369529520076,0.0153331782594301,0.25350044947367
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHP1,Calcineurin B homologous protein 1,39586,-0.0086096022189121,0.00756271751948374,-0.0234325285571002,0.00621332411927604,0.25496702762978
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAX,Integrin alpha-X,39757,-0.00598833798047181,0.00529209332600652,-0.0163608408994446,0.00438416493850097,0.257842445757311
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MELTF,Melanotransferrin,39958,-0.00347462620286486,0.00307382494893442,-0.00949932310277632,0.0025500706970466,0.258335080297244
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH23,Cadherin-23,39929,0.00308304019542195,0.0027328157163484,-0.00227327860862092,0.00843935899946482,0.259278280878752
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,-0.0100638814170829,0.00892106010740292,-0.0275491592275926,0.00742139639342685,0.259300763089156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF9,Fibroblast growth factor 9,39539,0.00475492169037884,0.00421961756224292,-0.0035155287316173,0.013025372112375,0.25982605064745
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN2,Dynactin subunit 2,42070,-0.0108292837780455,0.00964985087287388,-0.0297429914888783,0.00808442393278732,0.261787675061952
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,-0.0123281974130519,0.0110734860219815,-0.0340322300161358,0.00937583519003188,0.265601017046383
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,0.00440801079567743,0.00397201259061179,-0.00337713388192167,0.0121931554732765,0.267123508546546
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN2,Calsyntenin-2,42296,-0.00450154228048912,0.00407019589541573,-0.012479126235504,0.00347604167452572,0.268755982209837
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.00419107160860813,0.00380053728349045,-0.00325798146703316,0.0116401246842494,0.270155864134056
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,0.00410597427958691,0.00372419321620806,-0.0031934444241809,0.0114053929833547,0.270262553746335
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARB1,Scavenger receptor class B member 1,41839,-0.006218917251806,0.00564861577835846,-0.0172902041773886,0.00485236967377659,0.270932755896909
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,-0.00462982198698147,0.00421650554505133,-0.0128941728552821,0.00363452888131913,0.272218198442872
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,-0.00501226349848449,0.00456988507942676,-0.0139692382541609,0.00394471125719195,0.27275142064922
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,-0.0050900517511391,0.00464507212586276,-0.0141943931178301,0.00401428961555191,0.273191401541757
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,-0.00496713760023524,0.004558978756499,-0.0139027359629733,0.00396846076250279,0.275944761586843
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAPPA,Pappalysin-1,41913,0.00520510849688452,0.00482716565660015,-0.00425613619005177,0.0146663531838208,0.280921673208621
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN15,Tetraspanin-15,39575,0.00553780182434587,0.00513929778963869,-0.00453522184334596,0.0156108254920377,0.28126252361762
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAG,Myelin-associated glycoprotein,39649,0.00534832860823073,0.00496945967639294,-0.00439181235749943,0.0150884695739609,0.281843674143151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROS1,Vitamin K-dependent protein S,39979,-0.00277671369188535,0.00259093025267724,-0.00785493698713274,0.00230150960336204,0.283875147233526
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CENPJ,Centromere protein J,39757,-0.00771222509196273,0.00720038159514033,-0.0218249730184378,0.00640052283451231,0.284154108205536
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.00529138177626293,0.00495423635576354,-0.00441892148103361,0.0150016850335595,0.285520604656845
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN1,Nectin-1,39657,-0.00359454999795128,0.00337424918055576,-0.0102080783918406,0.003018978395938,0.286768502606781
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTR,Methionine synthase,39575,-0.00710025308970831,0.00667600150204039,-0.0201852160337075,0.00598470985429084,0.287556566934357
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSCA,Prostate stem cell antigen,39930,-0.0281803193385393,0.0265638680176761,-0.0802455006531845,0.023884861976106,0.288780004530368
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEX33,Testis-expressed protein 33,39757,0.0041847154162967,0.00395213641299477,-0.00356147195317304,0.0119309027857664,0.289691508362584
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NLGN1,Neuroligin-1,39649,0.00726515216862136,0.00686192391900951,-0.00618421871263727,0.02071452304988,0.289730806223387
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,-0.018584975146329,0.0175955697041088,-0.0530722917663822,0.0159023414737242,0.290885498347621
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.0070979318925258,0.00673304088055305,-0.0202946920184098,0.00609882823335818,0.291816894553918
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF75D,Zinc finger protein 75D,39757,-0.00655687621748858,0.00626780334755575,-0.0188417707786979,0.0057280183437207,0.295528164365662
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.00569871028943238,0.00549176924905851,-0.0164625780175871,0.00506515743872231,0.299440277999293
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPA33,Cell surface A33 antigen,42070,-0.0140830505258418,0.0136032003760818,-0.0407453232629621,0.0125792222112786,0.300559181077049
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,0.00245356897343669,0.00237991733116125,-0.00221106899563937,0.00711820694251274,0.302583966400341
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.0280788386304251,0.0272514277348447,-0.0814916369907208,0.0253339597298705,0.302862628192702
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD3,Bromodomain-containing protein 3,39575,-0.00499310744247689,0.00485373653502278,-0.0145064310511215,0.00452021616616777,0.303636690363378
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.00933654109964726,0.00912825695227377,-0.00855484252680933,0.0272279247261038,0.306412373134756
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYGD,Gamma-crystallin D,39929,-0.0102171650897985,0.0100127125767593,-0.0298420817402466,0.00940775156064972,0.307551437265738
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,-0.0036348521775937,0.003563232113876,-0.0106187871207907,0.00334908276560326,0.307703275500448
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICOSLG,ICOS ligand,42070,0.00198076788999141,0.00194491556204533,-0.00183126661161743,0.00579280239160026,0.308490102506503
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,-0.00458952429553568,0.00450909528471109,-0.0134273510535694,0.00424830246249806,0.308777150636151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,-0.0122565342410075,0.0121263770170651,-0.0360242331944551,0.0115111647124401,0.312162074484599
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFD,Vascular endothelial growth factor D,42275,-0.00395315229042974,0.00392259798284833,-0.0116414443368125,0.00373513975595299,0.313573453215068
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F10,Coagulation factor X,39990,-0.00298284169215277,0.00296272962547836,-0.00878979175809035,0.00282410837378481,0.314057878237426
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB2B,Ras-related protein Rab-2B,39919,-0.0063671054869282,0.00637631347875804,-0.0188646799052939,0.00613046893143755,0.318031215123385
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00299114266921681,0.00299700967166757,-0.00288299628725163,0.00886528162568524,0.318276965330686
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYTH3,Cytohesin-3,39560,-0.00745573078522518,0.00748518181609314,-0.0221266871447677,0.00721522557431738,0.319240349187946
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA8,Carbonic anhydrase-related protein,39657,-0.00269678679810923,0.00272373215157062,-0.00803530181518765,0.00264172821896919,0.322143393290669
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAD1,Glutamate decarboxylase 1,39560,0.00265954981715185,0.00269681514645123,-0.00262620786989256,0.00794530750419627,0.324065714702763
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,-0.00698849712751976,0.00709365371485536,-0.0208920584086363,0.00691506415359675,0.324559363326786
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TF,Serotransferrin,39979,-0.00215271318102878,0.00218674226498194,-0.00643872802039337,0.00213330165833582,0.32492090800616
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,-0.000818832072109179,0.000832103492522186,-0.00244975491745266,0.000812090773234305,0.325111823185211
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,-0.00652766710473911,0.00667734158696248,-0.0196152566151856,0.00655992240570735,0.328297521068744
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRN1,Neuritin,39934,0.00346015034351711,0.00355749306054369,-0.00351253605514853,0.0104328367421827,0.330754368492228
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,-0.00241702988927589,0.00249927093803554,-0.00731560092782554,0.00248154114927376,0.333517606011729
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPHS2,Podocin,39657,0.0100590738649238,0.0104178986751615,-0.0103600075383927,0.0304781552682402,0.334287072277327
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD82,CD82 antigen,39757,0.00409377192392883,0.00424628180257279,-0.00422894040911382,0.0124164842569715,0.335024758528883
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOB,Apolipoprotein B-100,39990,-0.00224453298538543,0.00233029447788311,-0.00681191016203633,0.00232284419126547,0.335469046365518
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,-0.00702591062206658,0.00730843637820408,-0.0213504459233466,0.00729862467921343,0.33640099881648
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.00840076059640979,0.00878838832057563,-0.00882448051191845,0.025626001704738,0.339143330023485
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP15,Matrix metalloproteinase-15,39958,-0.00472627930222804,0.00497061947535337,-0.0144686934739206,0.00501613486946456,0.341704254790992
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,-0.00232067638688081,0.00244294462907437,-0.00710884785986657,0.00246749508610496,0.342154381686679
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.00623708216422679,0.00657382164877216,-0.0191217725958202,0.00664760826736664,0.342755628244355
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,-0.00693144398914672,0.00731822334084179,-0.0212751617371966,0.00741227375890319,0.343580215787792
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNR,Tenascin-R,42016,0.00401858984792123,0.00425028564686262,-0.00431197001992951,0.012349149715772,0.344427329561353
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC1A4,Neutral amino acid transporter A,39649,-0.00490014376014523,0.0051898840450905,-0.0150723164885226,0.00527202896823216,0.345102350960771
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,0.00790065434510626,0.00839052945475321,-0.00854478338621003,0.0243460920764226,0.346409810948618
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFAP,Glial fibrillary acidic protein,41820,0.0043639355122838,0.00464175395937626,-0.00473390224809367,0.0134617732726613,0.347158848775787
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,-0.005729162493283,0.00609781470364033,-0.017680879312418,0.00622255432585204,0.347472398277135
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC44A4,Choline transporter-like protein 4,39649,0.00658121905025188,0.00702908792242633,-0.00719579327770372,0.0203582313782075,0.349147703911986
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB39B,Ras-related protein Rab-39B,39575,-0.00880771974490781,0.00943551499147666,-0.0273013291282021,0.00968588963838643,0.350600647134653
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNG,Uracil-DNA glycosylase,39919,-0.00335688308746186,0.0036010267967596,-0.0104148956091107,0.00370112943418695,0.351252210790175
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00683672810772932,0.00740739683856063,-0.0213552259113081,0.0076817696958495,0.356048212155489
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,0.0105122621033977,0.0114397152111104,-0.0119095797103786,0.032934103917174,0.358150326233508
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,-0.00452986817071911,0.00495020569608743,-0.0142322713350505,0.00517253499361225,0.360166201235591
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,0.00381303833935755,0.00416726200532461,-0.00435479519107868,0.0119808718697938,0.360212403573943
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,-0.00416448861502922,0.00456225363402423,-0.0131065057377167,0.00477752850765826,0.361357038996998
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPEP,Glutamyl aminopeptidase,39575,-0.00395034022138697,0.00433669945049437,-0.0124502711443559,0.00454959070158199,0.362363127082131
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,-0.00642056268291888,0.00706688469542043,-0.0202716566859429,0.00743053132010517,0.363611474178528
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,0.00327403621483274,0.0036154582790774,-0.00381226201215895,0.0103603344418244,0.365185472800431
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP4,Caspase-4,39757,-0.0153810589207106,0.0170078734330184,-0.0487164908494267,0.0179543730080056,0.365829724248175
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZPR1,Zinc finger protein ZPR1,39586,-0.00892096392832907,0.00987441220719444,-0.0282748118544302,0.010432883997772,0.366310886383322
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,-0.00283551080145603,0.00316568232931728,-0.00904024816691791,0.00336922656400585,0.370430966902219
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,0.00603252681660088,0.00674192274134065,-0.00718164175642679,0.0192466953896286,0.370925183612728
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.0042280642384385,0.00473710867270329,-0.00505666876005994,0.0135127972369369,0.372122536398114
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,-0.003669217105589,0.0041197559141304,-0.0117439386972846,0.0044055044861066,0.373142156175692
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COPE,Coatomer subunit epsilon,41839,-0.0041831018937402,0.00471673586149092,-0.0134279041822624,0.005061700394782,0.37516838841496
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPA1,Inositol monophosphatase 1,42016,0.00550078262492458,0.00620499909381341,-0.0066610155989497,0.0176625808487989,0.375359623679843
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCUN1D2,DCN1-like protein 2,39560,0.00724005379938317,0.00817256167942921,-0.00877816709229808,0.0232582746910644,0.375692078601733
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,0.00642058465816653,0.00724885276957487,-0.00778716677020022,0.0206283360865333,0.375778090376892
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEBP1,Heme-binding protein 1,41900,0.00468866596911914,0.00529364278688841,-0.00568687389318214,0.0150642058314204,0.375786408693057
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NLGN2,Neuroligin-2,39586,0.00421597498932118,0.00479049855779064,-0.00517340218394848,0.0136053521625908,0.378840535960133
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.00634067816694702,0.00726438946712482,-0.0205788815225117,0.00789752518861762,0.382766656835456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBH,Dopamine beta-hydroxylase,39978,0.0101573990506472,0.0116504233369297,-0.012677430689735,0.0329922287910295,0.383309665248578
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.00740711253179042,0.00860400078678611,-0.0242709540738912,0.00945672901031036,0.389313469515992
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,0.00222910390965304,0.00258942914510839,-0.00284617721475939,0.00730438503406548,0.38934019324625
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUOX2,Dual oxidase 2,41900,0.00613989736091196,0.00715306641882065,-0.00788011281997652,0.0201599075418004,0.390709849892677
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,0.00751999574963349,0.00877450570680142,-0.00967803543569731,0.0247180269349643,0.391448232492968
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKCQ,Protein kinase C theta type,41913,0.00372125956514991,0.0043523447698081,-0.00480933618367395,0.0122518553139738,0.39256592490402
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,-0.00942259141058662,0.0110388846404845,-0.0310588053059362,0.012213622484763,0.393354789740355
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORN4,MORN repeat-containing protein 4,39560,0.00677136021473858,0.0080148742184353,-0.00893779325339461,0.0224805136828718,0.398213472332339
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENOPH1,Enolase-phosphatase E1,39919,0.00460055180293157,0.00545066220794357,-0.00608274612463783,0.015283849730501,0.398667467316491
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,-0.00532100569471914,0.00631174283064745,-0.0176920216427881,0.00705001025334986,0.399228544656987
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,-0.0044688026672541,0.00531391787263048,-0.0148840816976098,0.00594647636310164,0.400387604880535
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD70,CD70 antigen,42119,-0.00377844884992322,0.00449438730204874,-0.0125874479619387,0.0050305502620923,0.400528714272372
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,-0.00347693003829286,0.00414617860789992,-0.0116034401097767,0.00464958003319099,0.401716288681093
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF6,Fibroblast growth factor 6,39657,-0.00334304895376024,0.00399492907595819,-0.0111731099426383,0.00448701203511782,0.402710093257168
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00583174694895278,0.00699371540162241,-0.0195394291361327,0.00787593523822715,0.40438035669023
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,-0.00427784701919837,0.00517797564859852,-0.0144266792904515,0.00587098525205473,0.408727056089208
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSG1,Tryptase gamma,39657,-0.00218775224882678,0.00267892936195387,-0.00743845379825637,0.00306294930060282,0.414145088251508
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL9,Interleukin-9,39757,-0.00468367704746806,0.00575410251694892,-0.0159617179806879,0.00659436388575182,0.415678491210206
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,0.00215202687709448,0.00265819075725455,-0.00305802700712443,0.00736208076131339,0.418196650251708
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTNL10,Butyrophilin-like protein 10,39560,0.00330215392886817,0.0040839512738634,-0.00470239056790409,0.0113066984256404,0.41878100039631
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL36A,Interleukin-36 alpha,39657,0.00472964433040827,0.00587340022183924,-0.00678222010439663,0.0162415087652132,0.420684021271812
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,-0.00180736794270943,0.0022454313068216,-0.00620841330407977,0.00259367741866091,0.420889011655117
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,0.00348051026014695,0.00435457479128478,-0.00505445633077121,0.0120154768510651,0.424147271392513
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN4,Prefoldin subunit 4,39560,0.00430123552945554,0.005404752984591,-0.00629208032034281,0.0148945513792539,0.426151210989413
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASA1,Ras GTPase-activating protein 1,41839,-0.0026333900168382,0.00331425687974666,-0.00912933350114165,0.00386255346746524,0.426881266482511
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,0.0030948984354034,0.00391133160801635,-0.00457131151630865,0.0107611083871154,0.428803633866197
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,-0.00271856573585163,0.00343585423864487,-0.00945284004359558,0.00401570857189232,0.428824399231202
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,0.00402006352131984,0.00508733570011562,-0.00595111445090678,0.0139912414935465,0.429422212776616
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL3,Myosin light chain 3,39638,-0.00633825387065455,0.0080333741120015,-0.0220836671301775,0.00940715938886839,0.430134649421648
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM19,Probable RNA-binding protein 19,39575,-0.003834331114317,0.0049144297054471,-0.0134666133369933,0.00579795110835931,0.435278844529763
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSHB,Follitropin subunit beta,39638,-0.00324523205924779,0.00419374700649686,-0.0114649761919816,0.00497451207348605,0.439050043590404
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,0.00284931600607972,0.00369797593515026,-0.00439871682681478,0.0100973488389742,0.441015732921564
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STEAP4,Metalloreductase STEAP4,39586,-0.00574752146399166,0.00746000159175096,-0.0203691245838235,0.00887408165584021,0.441052493232207
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMCH,Pro-MCH,39575,-0.00647901914613583,0.00843325674117162,-0.0230082023588322,0.0100501640665605,0.442343254224641
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD200,OX-2 membrane glycoprotein,42119,-0.00211749512576907,0.00276496876024958,-0.00753683389585823,0.0033018436443201,0.443791025322195
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F2,Prothrombin,39979,0.00115749059627967,0.00151717722917664,-0.00181617677290655,0.00413115796546589,0.445524664892915
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN7,Septin-7,39757,0.00414186726458835,0.00545244027999024,-0.00654491568419252,0.0148286502133692,0.447488535598135
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTTG1,Securin,39757,0.00323799275423179,0.00426462872575889,-0.00512067954825563,0.0115966650567192,0.447708769104161
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM132A,Transmembrane protein 132A,39638,0.00483754208842914,0.00641600549911682,-0.00773782868983982,0.0174129128666981,0.450877102813625
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1B,Protein phosphatase 1B,39657,-0.00474513180182251,0.00630727888639456,-0.0171073984191559,0.00761713481551083,0.451870869193248
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLU,Clusterin,39979,-0.00230657583173346,0.00307082399771854,-0.00832539086726179,0.00371223920379487,0.452592346002219
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00347471106617523,0.00464098102944159,-0.0125710338838807,0.00562161175153029,0.454052867787888
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,-0.00449768266394932,0.00602001042011518,-0.0162969030873751,0.00730153775947643,0.455005866991548
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00275553301863277,0.00373519192931298,-0.0100765092000862,0.00456544316282067,0.460699106406636
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,0.00886384216374919,0.0120410666482213,-0.0147366484667646,0.0324643327942629,0.461664687921551
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP73,Tumor protein p73,39649,0.00256663234307541,0.00350074384262329,-0.00429482558846625,0.00942809027461707,0.463471701841022
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRC,Chymotrypsin-C,42122,-0.00484491473482072,0.00664318061272122,-0.0178655487357543,0.00817571926611287,0.465826835241773
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,0.00311457553512978,0.00429216691346117,-0.00529807161525411,0.0115272226855137,0.468073785171392
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,-0.00678310703181816,0.0094192294064068,-0.0252447966683755,0.0116785826047392,0.471457836779401
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,-0.00408150313885263,0.00568131384767075,-0.0152168782802873,0.00705387200258203,0.472520601783
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANK2,Ankyrin-2,39575,0.00509950531749685,0.00714319577421017,-0.00890115839995509,0.0191001690349488,0.475306115916266
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN1,Contactin-1,42310,0.00193387402691528,0.00271350898360166,-0.00338460358094397,0.00725235163477454,0.476053541663989
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00321073146596636,0.00450591099187111,-0.0120423170100337,0.00562085407810101,0.47613282357864
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,0.0029325965884187,0.00415187824571452,-0.00520508477318176,0.0110702779500192,0.479997770701653
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.00469981035143633,0.00668615022710604,-0.0084050440936915,0.0178046647965642,0.482122227784882
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,-0.00297678538123504,0.00423800626934166,-0.0112832776691447,0.00532970690667461,0.482440656083032
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,-0.00288788492348736,0.00411186331221374,-0.0109471370154263,0.00517136716845157,0.482488203775468
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00280151089830965,0.00399423444938217,-0.00502718862247941,0.0106302104190987,0.483075264198993
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNC,Tenascin,42217,0.00344084798738111,0.00490888941057332,-0.00618057525734259,0.0130622712321048,0.483351033393365
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,-0.00442198728584622,0.00633779327864753,-0.0168440621119954,0.00800008754030294,0.48536884461403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPA,Apolipoprotein(a),39775,0.0129648514620009,0.0186143664950415,-0.0235193068682805,0.0494490097922823,0.486132086836411
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,-0.00435104921658374,0.00624873205007241,-0.0165985640347257,0.00789646560155819,0.48624709846138
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAGLN3,Transgelin-3,39560,-0.00425457041978196,0.00614571820861962,-0.0163001781086764,0.00779103726911248,0.488774884590089
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDM1,Nuclear protein MDM1,39649,-0.00220883937557241,0.00321371629289503,-0.00850772330964667,0.00409004455850186,0.491897897915724
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,-0.00219382428673442,0.00321830672603786,-0.00850170546976863,0.00411405689629979,0.495461704778451
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB6B,Ras-related protein Rab-6B,41839,-0.00327590927788448,0.00481549794240865,-0.0127142852450054,0.00616246668923648,0.496336145076258
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.002547521161368,0.0037512476589202,-0.0048049242501156,0.0098999665728516,0.497078053443102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0019181318378491,0.00283445328370519,-0.00363739659821307,0.00747366027391127,0.498594916037339
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPGN,Epigen,39919,0.00319290244422267,0.00473471872726325,-0.0060871462612133,0.0124729511496586,0.500096571264533
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,-0.00359113676002617,0.00533732828275001,-0.0140523001942162,0.00687002667416385,0.501066992053698
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MLLT1,Protein ENL,39560,0.00452577250687508,0.00679442824778786,-0.00879130685878912,0.0178428518725393,0.50536084170128
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6,Seizure protein 6 homolog,39649,-0.00211589181806364,0.00319883312229515,-0.00838560473776213,0.00415382110163486,0.508332822973628
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,0.00393196415939177,0.0059542803810637,-0.00773842538749309,0.0156023537062766,0.509037157679463
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,-0.00598149213663759,0.00906547631103832,-0.0237498257062727,0.0117868414329975,0.509389493097745
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALLD,Palladin,39657,0.00256894233051525,0.0038984338637852,-0.00507198804250374,0.0102098727035342,0.509930177708278
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP1,Methionine aminopeptidase 1,41839,-0.00194483706181993,0.00295220331592165,-0.00773115556102637,0.00384148143738651,0.510051867514011
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00395356928074808,0.0060152795231092,-0.0157435171460421,0.00783637858454594,0.51103099525732
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,0.00195317989360269,0.00297302808578385,-0.00387395515453365,0.00778031494173903,0.511216122453011
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KHDC3L,KH domain-containing protein 3,39560,0.00450140606321275,0.00687178146057699,-0.00896728559951815,0.0179700977259437,0.512445036209362
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH22,Cadherin-22,39757,-0.0018399495980214,0.00282481460291855,-0.00737658621974175,0.00369668702369895,0.514832485058529
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BSND,Barttin,39560,-0.00223585482695949,0.00343615461222798,-0.00897071786692632,0.00449900821300734,0.515263382352888
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,-0.00299234571013016,0.00461764826117477,-0.0120429363020327,0.00605824488177238,0.51698304953661
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF174,Zinc finger protein 174,39657,-0.00241707433809616,0.00375994176256775,-0.00978656019272896,0.00495241151653664,0.520335494720134
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCL2,Phosducin-like protein 2,39560,-0.00342937518066619,0.00534736236374897,-0.0139102054136142,0.00705145505228179,0.521327631154721
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EXOSC10,Exosome component 10,39575,0.0038121071969617,0.00595739764519502,-0.00786439218762054,0.0154886065815439,0.522254415092476
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,-0.0036451592758665,0.00571947964149479,-0.0148553393731963,0.00756502082146329,0.523927371783386
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,0.00168040848923754,0.00263994452891857,-0.00349388278744286,0.00685469976591794,0.52444071510373
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL31,Interleukin-31,39657,0.00360091594333362,0.00568440819696081,-0.00754052412270957,0.0147423560093768,0.52643827372294
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.00325299384441149,0.00516262396512151,-0.0133717368160496,0.00686574912722666,0.528639175180432
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,-0.0044851458955091,0.00713734790864908,-0.0184743477964613,0.00950405600544309,0.529751579776906
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL24,Interleukin-24,41913,-0.00307893801253842,0.00490710364913983,-0.0126968611648525,0.00653898513977565,0.530378290468263
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,-0.00624421885059622,0.0100985190707856,-0.026037316229336,0.0135488785281436,0.536368145807026
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM25,Transmembrane protein 25,39934,-0.00294892813904403,0.00479430246960708,-0.0123457609794739,0.00644790470138584,0.538507547473222
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,-0.00395715823511932,0.00650276129248509,-0.0167025703683901,0.00878825389815146,0.542845271201103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,-0.00285717940666155,0.00470234553017682,-0.0120737766458081,0.00635941783248501,0.543460140437708
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB116,Beta-defensin 116,39586,-0.00467006624663224,0.00769353845675674,-0.0197494016218755,0.010409269128611,0.54385583103527
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,-0.00379022814230686,0.00626303321957992,-0.0160657732526835,0.00848531696806979,0.545075165621109
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD5,Sushi domain-containing protein 5,39695,-0.0021238425473653,0.00351889509257587,-0.009020876928814,0.00477319183408341,0.546152667065591
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00339454496259677,0.00563979460476006,-0.00765945246273294,0.0144485423879265,0.547258721078845
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00376518320040553,0.00628126521384998,-0.00854609661874043,0.0160764630195515,0.548897707972937
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,-0.00390584895086203,0.00653162621574633,-0.0167078363337248,0.00889613843200077,0.54985858338048
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,-0.00613309942502821,0.0102959546495958,-0.0263131705382359,0.0140469716881795,0.551400777335603
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00252918897158172,0.00426043763181535,-0.00582126878677636,0.0108796467299398,0.552761191873201
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPT,Microtubule-associated protein tau,41839,-0.0031804300198082,0.00537212846848251,-0.0137098018180339,0.00734894177841752,0.553844498022382
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,0.00326335529734677,0.00552205655393007,-0.00755987554835616,0.0140865861430497,0.554554463654998
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TJP3,Tight junction protein ZO-3,39586,0.00248701848181867,0.00426224620676596,-0.00586698408344262,0.01084102104708,0.559569079648193
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00389163585473831,0.00669347504504087,-0.0170108469430184,0.0092275752335418,0.560977663608653
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,-0.00744011080699487,0.0128689033233189,-0.0326631613206999,0.0177829397067102,0.563175077782848
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPTC,Opticin,42070,0.00266527129922815,0.00461636016420008,-0.006382794622604,0.0117133372210603,0.563710387448205
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKKL1,Dickkopf-like protein 1,42070,-0.00490783847346405,0.00851957943056585,-0.0216062141573731,0.011790537210445,0.564580320701251
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD1,Bromodomain-containing protein 1,39757,-0.00179563224815537,0.00311791145303459,-0.00790673869610317,0.00431547419979243,0.564688528847337
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,-0.00389467482761202,0.00679664370879197,-0.0172160964968443,0.00942674684162023,0.566634703150447
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,-0.00156366530262763,0.00273114308371945,-0.00691670574671776,0.00378937514146249,0.566973731284076
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,0.00619140474311561,0.010827868599128,-0.0150312177111752,0.0274140271974065,0.567467343188515
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL7,Interleukin-7,42119,-0.0037394009139247,0.00656587400458867,-0.0166085139629185,0.00912971213506909,0.56901231501658
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP7,Dipeptidyl peptidase 2,42054,-0.00361453512658969,0.00639303387532904,-0.0161448815222346,0.00891581126905522,0.571820324417614
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00232230384667584,0.0041276511051758,-0.00576789231946873,0.0104125000128204,0.573704361305093
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,-0.00308998694499509,0.00551063661303795,-0.0138908347065495,0.00771086081655929,0.574991922845239
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,0.0022937073416584,0.00410195312513823,-0.00574612078361252,0.0103335354669293,0.57605410073568
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00223679716562373,0.00403813405852035,-0.0101515399203236,0.00567794558907616,0.579645723717371
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBR1,T-box brain protein 1,39649,0.00270932771230856,0.0049008271962706,-0.00689629359238182,0.0123149490169989,0.580390530774562
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.00141230230134199,0.002554870978108,-0.00359524481574969,0.00641984941843367,0.580417523064887
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,0.00299453028357597,0.00541713035324789,-0.0076230452087899,0.0136121057759418,0.580418968379222
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAP1A,Ras-related protein Rap-1A,39657,-0.00390392541577796,0.00707105004287458,-0.0177631834998121,0.0099553326682562,0.580891127822962
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYBB2,Beta-crystallin B2,39929,-0.00393778634971531,0.00714228718456918,-0.0179366692314709,0.0100610965320403,0.581415552105203
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.00433089327113141,0.00788679245664007,-0.0111272199438831,0.0197890064861459,0.582925688632481
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSAP,Gamma-secretase-activating protein,41843,0.00468238432660313,0.00858538322361824,-0.0121449667916886,0.0215097354448949,0.58549432817605
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMOD2,Leiomodin-2,39586,-0.00343091179189499,0.00630093588704663,-0.0157807461305064,0.0089189225467164,0.586102800525424
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARG2,"Arginase-2, mitochondrial",39919,-0.00234048146306644,0.00431166138330836,-0.0107913377743508,0.00611037484821795,0.587260368114288
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUMF1,Formylglycine-generating enzyme,39657,-0.00366550632322062,0.00675537866115316,-0.0169060484990808,0.00957503585263958,0.587412315361955
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP13,Collagenase 3,41839,-0.00175938694053853,0.00328082824426734,-0.00818981029930252,0.00467103641822545,0.591785777960519
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,0.0039521137943825,0.00741479076340206,-0.0105808761018855,0.0184851036906505,0.594041531229
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.00314874798718105,0.00593632803818607,-0.00848645496766364,0.0147839509420257,0.595829516390019
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECM1,Extracellular matrix protein 1,39720,0.0019721560825133,0.00372277489020998,-0.00532448270229826,0.00926879486732485,0.596292856368612
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL11,Interleukin-11,41913,-0.00327529096353393,0.0061995225561165,-0.0154263551735223,0.00887577324645441,0.59729062502601
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13,Interleukin-13,41913,-0.00260767557112582,0.00494535653112006,-0.0123005743721211,0.00708522322986949,0.597995595182651
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,-0.00324630008041561,0.00636958155105527,-0.015730679920484,0.00923807975965272,0.610302146637504
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLL4,Delta-like protein 4,39638,-0.00457820994526345,0.00901540277056144,-0.0222483993755639,0.013091979485037,0.611589098504645
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CX3CL1,Fractalkine,42016,-0.00171269328817076,0.00339196725828034,-0.00836094911440022,0.0049355625380587,0.613618933974321
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IKZF2,Zinc finger protein Helios,41843,-0.00449278161248374,0.00905878946009795,-0.0222480089542757,0.0132624457293082,0.619932078838512
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF830,Zinc finger protein 830,39919,-0.00389828454146556,0.00793539466458427,-0.0194516580840507,0.0116550890011196,0.623257210925207
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.0027137817950843,0.00554752229296684,-0.0081593618991307,0.0135869254892993,0.624718335065854
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00292897582055985,0.00606303280122083,-0.00895456846983297,0.0148125201109527,0.629042898539461
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR5,Complement factor H-related protein 5,39864,0.00205327483821306,0.0042606376153044,-0.00629757488778357,0.0104041245642097,0.629874082026031
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00316449606617806,0.00658109482925827,-0.0160634419315243,0.00973444979916815,0.630635157476778
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,0.00240198826264037,0.00500616717786233,-0.0074100994059698,0.0122140759312505,0.631375032341215
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00212016031111349,0.00447782745105563,-0.0108967021151825,0.00665638149295554,0.63588040243456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL3,Interleukin-3,39560,0.00296855906488088,0.00627159697749428,-0.00932377101100791,0.0152608891407697,0.635984451762185
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM2,Myomesin-2,39575,-0.0026914536162423,0.00569611177778544,-0.0138558327007018,0.00847292546821715,0.636574225596274
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASQ2,Calsequestrin-2,39575,0.00229644974386267,0.00486295352364067,-0.00723493916247304,0.0118278386501984,0.636769493272851
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP6,Platelet glycoprotein VI,42115,-0.00421093266211867,0.0089335619100805,-0.0217207140058764,0.0132988486816391,0.637390571088426
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,-0.00411048616925402,0.00873189414740475,-0.0212249986981673,0.0130040263596593,0.637831364661695
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN7,Tetraspanin-7,39586,-0.0047047314330813,0.0099969276759532,-0.0242987096779496,0.014889246811787,0.637923085590705
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.0028317489942149,0.00601982325978641,-0.00896710459496648,0.0146306025833963,0.63807576106997
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB6,Integrin beta-6,41913,-0.001461050333174,0.00312655956025085,-0.00758910707126566,0.00466700640491766,0.640290833858543
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DENND2B,DENN domain-containing protein 2B,39575,-0.0023393291819555,0.00500748439916534,-0.0121539986043196,0.00747534024040857,0.640390002104253
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00325126679431406,0.00697317629334939,-0.0169186923292789,0.0104161587406507,0.641043421032329
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,0.00120375703000849,0.00261864091311214,-0.00392877915969131,0.00633629321970828,0.645749449823421
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN4,Contactin-4,42137,-0.00109557723740276,0.00238426029590902,-0.00576872741738444,0.00357757294257892,0.645879630698617
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINC1,Antithrombin-III,39959,0.000678134651187808,0.00147678394434065,-0.00221636187971986,0.00357263118209548,0.646101543087438
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,-0.00540319429184548,0.0117859978680519,-0.0285037501132273,0.0176973615295363,0.646642536892333
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.00786119911515135,0.0171584148274557,-0.0257692939466618,0.0414916921769645,0.646849156253708
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,-0.00325166912711402,0.00712791215545364,-0.0172223769518032,0.0107190386975751,0.648261937436817
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYO6,Unconventional myosin-VI,39934,-0.00171808147335829,0.00382816424843281,-0.0092212834002866,0.00578512045357002,0.653584262977451
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,-0.0039335146357117,0.00883027935768379,-0.0212408621767719,0.0133738329053485,0.655997771192449
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B4,Protein ATP1B4,39560,0.00190550402087772,0.00428884906545119,-0.00650064014740662,0.0103116481891621,0.656839802841989
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PVALB,Parvalbumin alpha,42208,0.00491998935806937,0.0113563597554695,-0.0173384757626508,0.0271784544787895,0.664849843914629
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.0029544914828369,0.00685863585928218,-0.01639741776703,0.0104884348013562,0.666644401742675
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,-0.00106975975656507,0.00251058065707595,-0.00599049784443394,0.0038509783313038,0.670042886006911
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK1,Kallikrein-1,42016,0.00549114994422269,0.0129810964219564,-0.0199517990428119,0.0309340989312573,0.6722938264378
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF7,Fibroblast growth factor 7,39560,0.00335332311553535,0.00795904955265435,-0.0122464140076672,0.0189530602387379,0.673528189406192
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.00136006485307271,0.00324079540646284,-0.00771202384973987,0.00499189414359445,0.674733296337313
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00234445467414586,0.00563626454929761,-0.0133915331907692,0.00870262384247747,0.677448187192857
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PITHD1,PITH domain-containing protein 1,39539,0.00326287459968595,0.00790885826461741,-0.0122384875989642,0.0187642367983361,0.679937465243115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,H2AP,Huntingtin-interacting protein M,39560,0.00212265876029061,0.00515912759168756,-0.00798923131941701,0.0122345488399982,0.680759777670457
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNL2,Interferon lambda-2,39586,-0.00241038398795031,0.00599817098610818,-0.0141667991207223,0.00934603114482172,0.687799910694112
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTNNA1,Catenin alpha-1,39586,-0.00134552417267597,0.00346538375490989,-0.00813767633229935,0.00544662798694741,0.697819569416081
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNC5D,Netrin receptor UNC5D,39657,-0.00102816055581527,0.00266987866307979,-0.00626112273545166,0.00420480162382111,0.700173431746863
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREG1,Protein CREG1,41960,0.0015780034877683,0.00410443494607525,-0.0064666890065392,0.0096226959820758,0.700641412735771
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,-0.000705996585501429,0.00187233064603117,-0.00437576465172253,0.00296377148071967,0.706129859353378
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00187853395733134,0.00500614563451055,-0.00793351148630934,0.011690579400972,0.707485088498166
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.00154778299937291,0.00413274264591467,-0.00655239258661983,0.00964795858536566,0.708026786648564
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP4,Bone morphogenetic protein 4,41992,-0.00175630589767474,0.00480540971944299,-0.011174908947783,0.00766229715243352,0.714755061243044
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHC1,SHC-transforming protein 1,39560,-0.00435165470540535,0.0119805452941176,-0.0278335234818758,0.0191302140710651,0.71644250081958
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,-0.00229624231894532,0.00633367522308882,-0.0147102457561994,0.0101177611183088,0.716950553152336
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM171A2,Protein FAM171A2,39934,-0.00572868547229296,0.0159776987554945,-0.0370449750330622,0.0255876040884763,0.719943980160422
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEF,Thyrotroph embryonic factor,39575,-0.00156621843561618,0.00437688879174826,-0.0101449204674428,0.00701248359621042,0.72047120955628
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.0012349022342924,0.00347690122270477,-0.00804962863079375,0.00557982416220895,0.722466644275519
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,-0.00369901829295034,0.0105969515625372,-0.0244690433555232,0.0170710067696225,0.72704763137927
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFAP1,Actin filament-associated protein 1,39736,-0.00297167908062957,0.00854430243578753,-0.0197185118547731,0.013775153693514,0.727999539230398
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALMS1,Alstrom syndrome protein 1,39757,-0.00157678788188038,0.00455053388861269,-0.0104958343035613,0.00734225853980049,0.728968913494635
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.0015320145764941,0.00447588576615241,-0.0103047506781528,0.00724072152516462,0.732145122641871
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL4,Interleukin-4,41913,-0.00325243775419649,0.00960488569045087,-0.0220780137074802,0.0155731381990872,0.734898894186541
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.00152423697512012,0.00450547924236103,-0.00730650233990749,0.0103549762901477,0.735138026744226
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00207185871357594,0.00613942303668296,-0.00996141043832265,0.0141051278654745,0.735769493435883
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,-0.00132153746906798,0.00394663810752795,-0.00905694815982276,0.0064138732216868,0.737742456613731
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,-0.00240649094017344,0.00719020308212376,-0.016499288981136,0.0116863071007891,0.737865145292788
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO1,Alpha-enolase,42119,-0.00267086383679551,0.00799315417837499,-0.0183374460264105,0.0129957183528195,0.738276145705158
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,0.0016383095569252,0.00490734842283441,-0.00798009335183025,0.0112567124656806,0.738499377317578
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH5,Cadherin-5,42310,0.00102902465727544,0.00308647765557996,-0.00502047154766128,0.00707852086221216,0.738839171664183
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLGAP5,Disks large-associated protein 5,39934,0.00166760498648982,0.00505526136107958,-0.00824070728122615,0.0115759172542058,0.741500414202024
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN6,Prefoldin subunit 6,39649,0.00216911105900126,0.00662477376786711,-0.0108154455260183,0.0151536676440208,0.74335329041745
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.00114578663489546,0.00351491042173248,-0.0057434377917002,0.00803501106149111,0.744446533897988
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASN,Vasorin,41975,-0.000898961318792609,0.00278859151117267,-0.00636460068069104,0.00456667804310583,0.747176612413092
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,-0.00216391148770868,0.00671296369618991,-0.0153213203322409,0.0109934973568235,0.747193873179199
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,-0.000961806611622057,0.00300962922109239,-0.00686067988496314,0.00493706666171903,0.74929546939602
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN2,Prefoldin subunit 2,41839,-0.00178960837228733,0.00561034247427263,-0.0127858796218617,0.00920666287728702,0.749743828329585
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20,Interleukin-20,41913,-0.00151444194157995,0.00474779333953046,-0.0108201168870597,0.00779123300389975,0.74974814912448
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APPL2,DCC-interacting protein 13-beta,39736,-0.00366954046953656,0.0115440936774695,-0.0262959640773768,0.0189568831383037,0.750588234367826
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.0026004504765063,0.00820475566034724,-0.0186817715707869,0.0134808706177743,0.751291803005315
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOS,Proto-oncogene c-Fos,39539,-0.00116310909583163,0.00369705426823835,-0.00840933546157879,0.00608311726991553,0.75306812925853
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.0021660012776339,0.00698904671763152,-0.0158645328441917,0.0115325302889239,0.756632481956806
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00193750887389129,0.00629137038179818,-0.0142685948222157,0.0103935770744331,0.758116286673992
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.00195264854593021,0.00635405728738796,-0.0144066008292106,0.0105013037373502,0.758615186601949
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,0.0014816732775679,0.00484191162760313,-0.00800847351253424,0.01097182006767,0.759602851809375
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.00167448759159378,0.00548049982224721,-0.00906729206001074,0.0124162672431983,0.759963066593118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,-0.00285188012693225,0.00937308100436955,-0.0212231188954966,0.0155193586416321,0.760933439392133
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,-0.0011863813890924,0.00391590424012186,-0.00886155369973125,0.00648879092154645,0.761922219546769
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RLN1,Prorelaxin H1,39934,-0.00137163750163404,0.00453367530946169,-0.0102576411081789,0.00751436610491087,0.762242740447198
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINI1,Neuroserpin,39713,0.000879070472298735,0.00295998574768444,-0.00492250159316278,0.00668064253776025,0.766483742409336
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,0.000746086336937431,0.00251288896285732,-0.00417917603026292,0.00567134870413778,0.766544478804188
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,0.00109219377543123,0.00370668635156395,-0.00617291147363411,0.00835729902449657,0.768262816561874
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,-0.00124652769620676,0.0043062750412451,-0.00968682677704715,0.00719377138463363,0.772228940197856
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNM1,Dynamin-1,39930,0.00341316726281239,0.011831826080459,-0.0197772118548872,0.026603546380512,0.772989655618242
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERC2,ERC protein 2,39649,-0.00215987895873172,0.00753179009061387,-0.0169221875363349,0.0126024296188715,0.774295081581024
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,-0.00129417228718803,0.00451549347256048,-0.0101445394934066,0.00755619491903051,0.774418590884183
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.00153263131679374,0.00535417451183587,-0.0120268133599921,0.00896155072640457,0.774692210798617
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00176530447916096,0.00620804265416969,-0.0104024591230116,0.0139330680813335,0.776141662391044
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,-0.00087161097503935,0.00307052115829319,-0.00688983244529399,0.00514661049521529,0.776518905974097
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.00200412069679985,0.00710147680903083,-0.0159230152425003,0.0119147738489006,0.777786416759441
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,0.00197947092314995,0.00710288253103376,-0.0119421788376762,0.0159011206839761,0.780491376626722
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.00117896321346518,0.00436502234272451,-0.00973440700520521,0.00737648057827486,0.78709353047955
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.000934230033190035,0.00352841988552047,-0.00598147294243008,0.00784993300881015,0.791189367573427
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK12,Kallikrein-12,41843,-0.00355981405787663,0.0135954224869484,-0.0302068421322956,0.0230872140165423,0.793449515873914
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLG,Plasminogen,39742,-0.000583349289392301,0.00222992609226906,-0.00495400443023965,0.00378730585145505,0.793634463832208
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISM2,Isthmin-2,39966,0.00114764195252661,0.00443094013760969,-0.00753700071718839,0.00983228462224161,0.795634975648009
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17F,Interleukin-17F,41913,-0.00193145017289735,0.00746841131106745,-0.0165695363425896,0.0127066359967949,0.795935585261863
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,-0.00115127977414874,0.00446223564748736,-0.00989726164322396,0.00759470209492648,0.796407619269155
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTN2,Alpha-actinin-2,39575,0.00169083892845629,0.00660241771990469,-0.0112498998025569,0.0146315776594695,0.797883128842331
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,-0.00130221927870334,0.00518196198252873,-0.0114588647644597,0.00885442620705296,0.801588007279308
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,0.0023860199225892,0.00949988505069247,-0.016233754776768,0.0210057946219464,0.801691881242422
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00138134631223441,0.00551588438211578,-0.0121924797011813,0.00942978707671252,0.802259040174683
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.000793989382617291,0.00320524541027654,-0.00707627038675931,0.00548829162152473,0.804359041607988
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA4,Apolipoprotein A-IV,39979,-0.000838287753631955,0.00351005173507665,-0.0077179891543822,0.00604141364711828,0.81124566251476
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA4,Annexin A4,42088,-0.00175615515529829,0.00736382167842371,-0.0161892456450088,0.0126769353344122,0.811509187882255
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,0.00179512494151854,0.00760847717847468,-0.0131174903282918,0.0167077402113289,0.813485446440836
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN1,Calsyntenin-1,41839,-0.00121478259524571,0.00515268300001546,-0.011314041275276,0.00888447608478459,0.813624656153803
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,-0.00165292323546579,0.00701310306187862,-0.0153986052367479,0.0120927587658163,0.813677005682534
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,0.000960828160049719,0.00409276437602388,-0.00706099001695709,0.00898264633705653,0.814397353766421
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00156604089164731,0.006778352928183,-0.014851612630886,0.0117195308475914,0.817291375307246
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH7B,Myosin-7B,39560,0.00098198836869889,0.00439221246399929,-0.00762674806073972,0.0095907247981375,0.823092279725851
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,0.000763220572297522,0.00347573674893417,-0.00604922345561344,0.00757566460020849,0.826198123151023
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,0.00087119541583357,0.00400229285874269,-0.00697329858730211,0.00871568941896925,0.827687107235507
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,-0.00102700363070986,0.0047640977540668,-0.0103646352286808,0.00831062796726106,0.829325790216313
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,-0.00137647205906604,0.00648921476370934,-0.0140953329959363,0.0113423888778043,0.832019717387961
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCNA,Proliferating cell nuclear antigen,39560,-0.00136410577491818,0.00660265591952653,-0.0143053113771902,0.0115770998273538,0.836326445568991
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAM,Signal transducing adapter molecule 1,39919,0.000749786425842292,0.00369823910597815,-0.00649876222187488,0.00799833507355946,0.839340753318994
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRR5,Proline-rich protein 5,39657,0.00096432774582349,0.00482448959905319,-0.00849167186832077,0.0104203273599677,0.84157668740286
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.000849816572504664,0.00426953221516627,-0.00921809971423056,0.00751846656922123,0.842233490470161
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,0.00125044758943935,0.00628996430061047,-0.0110778824397572,0.0135787776186359,0.842422544349028
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGM2,Phosphoglucomutase-2,39649,-0.00120275711854697,0.00620073836638608,-0.0133562043166637,0.0109506900795698,0.8462029510085
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNPO1,Transportin-1,39757,-0.00069718006699391,0.00363599260334264,-0.00782372556954548,0.00642936543555766,0.847946162855029
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,-0.000945394673235177,0.00505749970127375,-0.0108580940877317,0.00896730474126137,0.851719553124919
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,0.000861627699577898,0.0046431939367379,-0.00823903241642839,0.00996228781558418,0.852787062395169
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,0.000880550907155136,0.00512213746304378,-0.00915883852041068,0.0109199403347209,0.863510797975059
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF20,Fibroblast growth factor 20,39657,-0.000754233183629598,0.0044128552047123,-0.00940342938486571,0.00789496301760651,0.864291940985753
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,0.000527512354363908,0.00310566741428957,-0.00555959577764365,0.00661462048637146,0.865127497701148
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP2,Retinol-binding protein 2,42070,-0.00131378788002421,0.00792588245370789,-0.0168485174892917,0.0142209417292432,0.868348948640562
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCP11,T-complex protein 11 homolog,39757,-0.000962329804765681,0.00592711671512482,-0.0125794785664103,0.010654818956879,0.871024891988826
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.000823109354533175,0.00507739716385549,-0.00912858908662359,0.0107748077956899,0.871220277115653
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPE4,NXPE family member 4,39575,0.000522209156660343,0.0032698372445682,-0.00588667184269333,0.00693109015601402,0.873116449256662
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTO1,Protein LTO1 homolog,41913,-0.000659223372610707,0.00420326948036373,-0.00889763155412361,0.0075791848089022,0.875376590710596
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.000899029833439256,0.00601354642423546,-0.0108875211580622,0.0126855808249408,0.881161247183519
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,-0.000524895513236633,0.00351154915322205,-0.00740753185355185,0.00635774082707858,0.881180054799425
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F13B,Coagulation factor XIII B chain,39925,0.000388425294566723,0.00261463889596827,-0.00473626694153108,0.00551311753066453,0.881905130854824
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,-0.000512186608606156,0.0035306015082935,-0.00743216556486142,0.00640779234764911,0.884657234074887
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP350,Centrosome-associated protein 350,39560,-0.000533211087191472,0.00374345345628635,-0.00787037986151272,0.00680395768712977,0.886736442495019
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,-0.000475608038907722,0.00336876284867733,-0.00707838322231528,0.00612716714449984,0.88772845326169
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOC,Brother of CDO,41900,0.000326033344885632,0.00236625108080659,-0.00431181877349529,0.00496388546326656,0.890412612475993
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-0.000515348157941365,0.00374797266547416,-0.00786137458227072,0.00683067826638799,0.890637694050829
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PXDNL,Peroxidasin-like protein,39919,-0.000802899908409538,0.00585025336107504,-0.0122693964961166,0.0106635966792975,0.89084203089479
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00065902237202702,0.00485315235406212,-0.0101712009859888,0.00885315624193473,0.891987683114538
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,-0.00134548240773926,0.0101166047461184,-0.0211740277101313,0.0184830628946528,0.894197776774116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOH,Beta-2-glycoprotein 1,42137,0.000462830685135043,0.00371239481302333,-0.00681346314839068,0.00773912451866077,0.900785289817254
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGS10,Regulator of G-protein signaling 10,39934,0.000757455486402963,0.00609142611447491,-0.0111817396979679,0.0126966506707738,0.901042100645091
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,0.000401697908699074,0.00328254371986622,-0.00603208778223871,0.00683548359963686,0.902604708873507
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,-0.000809410427514995,0.00666074890032004,-0.0138644782721423,0.0122456574171123,0.903281846215057
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESPL1,Separin,39560,-0.000657187655435847,0.00546548200500694,-0.0113695323852495,0.0100551570743778,0.904292613046275
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LHB,Lutropin subunit beta,41843,0.00108382252145327,0.00901672262286213,-0.0165889538193565,0.018756598862263,0.904325446382869
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAGE2A,G antigen 2A,39560,0.000752170124171584,0.00669296681092833,-0.0123660448252479,0.0138703850735911,0.910522451317257
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMOD4,Tropomodulin-4,39560,0.000455498843946097,0.0041008510436701,-0.0075821692016473,0.00849316688953949,0.911559523053403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA10,Ephrin type-A receptor 10,41839,0.000716581643029941,0.00668545070362713,-0.0123869017360792,0.0138200650221391,0.914643648300428
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HK2,Hexokinase-2,41900,-0.000297346524207526,0.00277812771493175,-0.00574247684547377,0.00514778379705871,0.914765790512139
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.000406009349579352,0.00390533809239858,-0.00806047201068058,0.00724845331152187,0.917200877884331
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLI2,Zinc finger protein GLI2,39657,-0.000349129896205172,0.00339370673313911,-0.00700079509315783,0.00630253530074748,0.918063503499972
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA13,Carbonic anhydrase 13,41967,0.00108877183559917,0.0107313657512429,-0.0199447050368369,0.0221222487080353,0.919189237226987
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YY1,Transcriptional repressor protein YY1,39657,-0.000284740009088868,0.00285203873346512,-0.00587473592668051,0.00530525590850277,0.920475259616137
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,-0.00190170666208549,0.0195274636915979,-0.0401755354976174,0.0363721221734465,0.922421102868054
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,-0.000624002796338311,0.00642398696255867,-0.0132150172429533,0.0119670116502767,0.92261986933695
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,0.001628253398682,0.016978968682644,-0.0316505252193002,0.0349070320166642,0.923603079796797
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPC5,Glypican-5,42016,0.000531857660026414,0.00571727522122479,-0.0106740017735742,0.011737717093627,0.925883959216402
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,0.000676772592261242,0.00739120155351313,-0.0138099824526245,0.015163527637147,0.927045577919634
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK14,Kallikrein-14,42262,-0.000425287972936139,0.00470809794156192,-0.00965315993839751,0.00880258399252523,0.928025379340142
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL3,Insulin-like 3,39929,0.000825760128679917,0.00919924944378689,-0.0172047687811424,0.0188562890385022,0.928476455456687
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPS,Calcyphosin,39929,0.000867950685506024,0.00970127933807009,-0.0181465568171114,0.0198824581881234,0.928711841801926
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF3,Fibroblast growth factor 3,39657,-0.000269960608179263,0.00302860256839858,-0.00620602164224048,0.00566610042588195,0.928974631036923
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH4,Cadherin-4,39586,-0.000401640741984652,0.00476705582144943,-0.00974507015202553,0.00894178866805622,0.932856483660858
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,0.000531916432626276,0.00642822519802684,-0.0120674049555063,0.0131312378207589,0.934054213329518
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,-0.000452753078215786,0.00558146864464236,-0.0113924316217148,0.0104869254652832,0.935350220646578
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,-0.000625551589294549,0.00853025737964829,-0.0173448560534052,0.0160937528748161,0.94154225968764
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPT1,Translationally-controlled tumor protein,41913,0.000466644428406743,0.00651974851434373,-0.012312062659707,0.0132453515165205,0.942942013438295
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGT,Angiotensinogen,39990,0.000150605873540241,0.00222529624623556,-0.00421097476908145,0.00451218651616193,0.946042337000213
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSC1,Hamartin,39657,0.000509399690893778,0.00756605535066166,-0.0143200687964031,0.0153388681781906,0.946322612468636
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.000247835828480419,0.00369972172091521,-0.0070036187445134,0.00749929040147423,0.946592711580049
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.000271482204526404,0.00422966350563757,-0.00856162267557604,0.00801865826652323,0.948823845545643
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.000490873625188922,0.0077337587828552,-0.0146672935892073,0.0156490408395851,0.949391970503926
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,-0.000186719928859321,0.00307740464460435,-0.00621843303228384,0.0058449931745652,0.95161955301443
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,-0.000248026656987855,0.00410641197428669,-0.00829659412658977,0.00780054081261406,0.951838279875203
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,-0.000233017845834366,0.00392284814790502,-0.0079218002157282,0.00745576452405946,0.952634425564999
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMA1,Laminin subunit alpha-1,39575,-0.000275344833918091,0.00528216991908233,-0.0106283978753195,0.0100777082074833,0.958428272639454
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGLON5,IgLON family member 5,39560,-0.000481399271985703,0.00948824477830332,-0.0190783590374602,0.0181155604934888,0.959536504827394
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,0.000395144019282803,0.00809444124323022,-0.0154699608174484,0.016260248856014,0.961066236391596
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,0.000207132931352048,0.00469046225376294,-0.00898617308602332,0.00940043894872742,0.964777303762102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,0.000240327457277134,0.00549813499750766,-0.0105360171378379,0.0110166720523921,0.965135650677505
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHH,Sonic hedgehog protein,39657,-0.000184420579539337,0.00436190884537079,-0.00873376191646608,0.0083649207573874,0.966276421440448
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA6,Integrin alpha-6,42119,0.00021563522670235,0.00517776944475427,-0.00993279288501602,0.0103640633384207,0.966781233988861
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,0.00024023549445436,0.00585580563654036,-0.0112371435531647,0.0117176145420735,0.967276565596251
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECE1,Endothelin-converting enzyme 1,41839,0.000128331999810216,0.00359140103149581,-0.00691081402192156,0.007167478021542,0.971495692248981
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,-0.000143721456522271,0.00404058184685221,-0.0080632618763526,0.00777581896330806,0.97162615723836
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKIV2L,Helicase SKI2W,39575,0.000135871707538789,0.00404441507043149,-0.00779118183050692,0.0080629252455845,0.97320080253825
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GJA8,Gap junction alpha-8 protein,39560,-0.000201620690319969,0.00639061777399046,-0.0127272315273413,0.0123239901467013,0.97483190407859
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABO,Histo-blood group ABO system transferase,39990,0.000385582904958214,0.0148147726958772,-0.0286513715789611,0.0294225373888775,0.979236322556387
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MN1,Transcriptional activator MN1,39649,0.000156429842281112,0.0060171989876821,-0.0116372801735758,0.011950139858138,0.979260105317877
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMI,N-myc-interactor,39875,-0.000179552260572486,0.00744571795786485,-0.0147731594579876,0.0144140549368426,0.980761436830583
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-8.47829558778531e-05,0.00374996717692375,-0.0074347186226484,0.00726515271089269,0.981962584035469
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,8.26083083703172e-05,0.00376812186138211,-0.00730291053993862,0.00746812715667925,0.982509809953018
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1A,Interleukin-1 alpha,41913,-0.000115298082282683,0.00588891908315559,-0.0116575794852676,0.0114269833207023,0.984379653794919
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,-9.87503402343701e-05,0.00522803058495974,-0.0103456902867555,0.0101481896062867,0.984930233680126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,-0.000141563368685937,0.00766051963606136,-0.0151561818553662,0.0148730551179943,0.985256584087885
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAP1,Antigen peptide transporter 1,39757,9.51673802794612e-05,0.00597871417660198,-0.0116231124058604,0.0118134471664193,0.987300333634148
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,-3.34568992822403e-05,0.00291355967305857,-0.00574403385847703,0.00567712005991255,0.990838158897089
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,1.92143828025765e-05,0.00350344254560768,-0.00684753300658847,0.00688596177219362,0.995624176825906
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRP15,RRP15-like protein,39586,3.34838065822227e-05,0.00934483935103507,-0.0182824013214465,0.018349368934611,0.997141144306449
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENSA,Alpha-endosulfine,39919,1.82513713851929e-05,0.00541994736180292,-0.0106048454577485,0.0106413482005189,0.997313232525895
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-2.3976913878617e-05,0.00726540871101825,-0.0142641779874744,0.0142162241597171,0.997366928676377
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EXTL1,Exostosin-like 1,39575,6.38421858754555e-06,0.0048642390200385,-0.00952752426068792,0.00954029269786301,0.99895281627237
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-8.87202605896847e-06,0.00835711005709854,-0.0163888077379721,0.0163710636858542,0.999152973962407
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,-1.44655861855264e-06,0.00432251516007339,-0.0084735762723624,0.00847068315512529,0.999732988581497
